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ABSTRACT 
 
  Clostridium difficile is a Gram-positive spore-forming strict anaerobe that can 
cause severe colitis in humans. C. difficile is best known as the leading cause of 
nosocomial-acquired diarrhea, particularly in people undergoing antibiotic therapies, 
since it is naturally resistant to most antibiotics. A clinical feature that makes C. difficile 
infection, or CDI, particularly difficult to treat is the organism’s inherent ability to resist 
antibiotic therapies while in its spore form. Since oxygen is toxic to C. difficile, spores 
are the major transmissive form; they are also resilient to most disinfectants, which 
makes them extremely difficult to eliminate to prevent additional infections.   
 While over fifty years of studies on the spore-forming model organism Bacillus 
subtilis laid the foundation of how sporulation and germination occurs, little was known 
about how C. difficile regulates spore formation and/or what proteins are necessary for 
sporulation and germination processes. The work presented in this dissertation addresses 
how C. difficile regulates sporulation, identifies genes that are regulated during 
sporulation, and characterizes some key proteins that are required for either sporulation 
or germination.  
  During the developmental process of sporulation, a cell divides into two 
asymmetrical compartments. In each compartment, specific transcriptional programs 
controlled by sporulation-specific sigma factors, drive the cell through a series of 
morphological events, culminating in the formation of a spore. Using genetic and cell 
biological techniques, we show that mutations in the genes encoding the master 
transcriptional regulator Spo0A and the sporulation-specific sigma factors σF, σE, σG, and 
σK block sporulation at various stages. Analysis of the mutants and wild type C. difficile 
strain using RNA-Sequencing identified genes regulated by a given sigma factor and 
revealed that the sigma factors control sporulation in a manner that differs from B. 
subtilis. Whereas the sporulation-specific sigma factor activity is regulated in a sequential 
manner involving cross talk between the different compartments in B. subtilis, C. difficile 
regulates these factors in a bifurcated manner, with less cross-compartment regulation.   
 Guided by our RNA-Sequencing results, we constructed targeted gene mutations 
in spoIIQ and spoIIIA-H, which are important for forming a channel known as the 
“feeding tube” in B. subtilis. We demonstrated that these proteins are necessary for 
maintaining forespore integrity, tethering the coat to the forespore, and engulfment. 
Using metabolic labeling, we show that while spoIIQ and spoIIIA mutants cannot finish 
the phagocytic-like process of engulfment, they are capable of transforming 
peptidoglycan, which is a necessary step for engulfment to occur. 
 We also constructed a targeted gene mutation in a gene that is highly transcribed 
during sporulation, now known as gerS. We show that a gerS mutant cannot degrade 
cortex during germination and is required for SleC-mediated cortex hydrolysis, making 
GerS a novel regulator of C. difficile spore germination.  
Altogether, this research provides a framework for understanding how the 
pathogen C. difficile undergoes sporulation and is therefore capable of infecting humans. 
Further, our studies reveal important factors that mediate the essential process of 
engulfment during sporulation and an important factor that mediates cortex hydrolysis 
during germination. This work has demonstrated that C. difficile regulates sporulation 
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW 
1.1. The Pathogen Clostridium difficile  
 
1.1.1. Clostridium difficile discovery and classification 
 Clostridium difficile was discovered in 1935 in the intestinal flora of infants and 
given the name Bacillus difficilis due to the difficulty in culturing the organism under 
anaerobic conditions [1]. Initially, the organism disappeared in the literature, until in 
1960, the renamed C. difficile surfaced as an isolate from the intestinal contents of an 
Antartic Wedell seal [2]. Later, it was reported that isolates had been documented 
between 1943 and 1961, from seven human wound sites, including a case of gas gangrene 
and a case of septicemia, implicating it as a human pathogen [3]. Human disease caused 
by C. difficile infections (or CDI) remained elusive due to its low incidence, until in 
1978, C. difficile was correlated with cases of pseudomembranous colitis associated with 
the use of antibiotics [4]. Around the turn of the century, CDI outbreaks were being 
documented with the emergence of epidemic strains, which caused a spike in the 
mortality rate of CDI related deaths [5-7]. What was once a manageable disease became a 
challenge for clinicians to treat and hospitals to manage in a very short time. 
 C. difficile is a strictly anaerobic Gram-positive rod of the phylum Firmicutes, 
which includes other anaerobic Clostridia and aerobic or facultative aerobic Bacilli [8]. 
Other clostridial species, part of the Clostridia class, include the human pathogens 
Clostridium perfringens, Clostridium botulinum, Clostridium tetani, and the solvent 
producing Clostridium acetobutylicum. The original classification of C. difficile into the 
phylum Firmicutes, class Clostridia, was due to the presence of phenotypic traits, such as 
 2 
sporulation and toxin production. However in 1994, it was suggested by Collins et. al. 
that C. difficile be reclassified into the Peptostreptococcaceae family, distinct from other 
characterized Clostridium spp. [9]. In 2013, Yutin et. al. suggested renaming C. difficile 
to “Peptoclostridium difficile” to distinguish C. difficile from other (very distinct) 
Clostridium spp., based on the absence of conserved sporulation genes in C. difficile 
strains [10]. Although C. difficile is commonly identified as such, there is a growing 
understanding that C. difficile is distinct from other Clostridium spp. based on its protein 
content [11] and regulation of both sporulation and germination [12-14]. 
 
1.1.2. C. difficile infection and treatment 
C. difficile is the leading cause of nosocomial diarrhea worldwide [15, 16]. In the 
United States, treating CDI is estimated to cost 1-3 billion dollars annually [17, 18]. The 
major source of spread in healthcare facilities is passive transmission of C. difficile spores 
on skin, clothing/bedding, or the equipment that has come in contact with a person with 
CDI [19]. Additionally, some individuals can carry epidemic and nonepidemic C. difficile 
strains without succumbing to disease, however it is unclear if these individuals 
contribute to outbreaks in healthcare facilities [20]. 
The gastrointestinal (GI) tract of humans is protected by indigenous microflora 
that can inhibit growth of potential pathogens; this property is known as colonization 
resistance [21]. When this innate system is disrupted by antimicrobial therapies, C. 
difficile can flourish since it is inherently resistant to most antibiotics [22, 23], and 
bacteria that create conditions in the gut that inhibit vegetative C. difficile growth are no 
longer present ([24], described in detail in later sections). C. difficile produces many 
 3 
virulence factors including surface layer and flagella proteins; however, the glucosylating 
toxins, TcdA and TcdB, are the major virulence factors that cause colonic inflammation 
during infection [25, 26]. TcdA and TcdB modify host cell small Rho GTPases causing 
disruption of the actin cytoskeleton leading to cell death [27] and can induce a damaging 
proinflammatory cytokine response that activates neutrophil migration to the infection 
site [28]. TcdA and TcdB antibody-mediated neutralization protects against a lethal dose 
of C.difficile in a hamster model [29], and in humans, high TcdA and TcdB IgG titers 
post-initial CDI are correlated with reduced risk of recurrence [30]. Unfortunately, there 
is not enough supportive clinical trial data to merit intravenous immunoglobulin as a 
therapy [31, 32].  
Traditional ways to combat bacterial infections have had deleterious effects for 
controlling CDI. The increased use of broad-spectrum fluoroquinolone antibiotics has 
contributed to the rise of fluoroquinoline-resistant, epidemic strains that have made C. 
difficile one of the leading nosocomial pathogens in hospitals [22, 33-35]. One major 
problem associated with CDI is its high rate of recurrent infections mediated by 
reinfection with a new strain or reoccurrence with the same strain, with disease symptoms 
reappearing 14 days or 42 days after clearance of the initial infection, respectively [36-
38]. Recurrent infections are associated with causing potentially life-threatening diseases, 
including pseudomembranous colitis, and in some studies occur up to 35% of the time 
after certain antibiotic therapies [39-41]. Mortality from CDI ranges from 6-30% when 
pseudomembranous colitis is detected [5, 42]. 
In 2011, the bacteriocidal RNA polymerase interference drug fidaxomicin was 
approved by the FDA and found to be a potent inhibitor of Clostridium spp. [43, 44]. CDI 
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is commonly treated with one of three antibiotics, metranidozole, vancomycin, or 
fidaxomicin, all of which have been shown to provide varying degrees of clearance and 
protection from recurrent CDI, the latter two being the current therapies of choice to treat 
recurrent CDI [43, 45, 46]. In severe CDI cases, tigecycline has been used in combination 
with antibiotics described above with some success; however, more studies are warranted 
[47]. While earlier studies provide evidence that metronidazole and vancomycin 
treatment may result in similar rates of recurrence [39], more recent clinical studies have 
shown that fidaxomicin and vancomycin treatment result in similar and lower rates of 
recurrence compared to metranidozole treatment, supporting the use of vancomycin due 
to cost and accessibility [5, 48]. 
In contrast to antibiotic use, the efficacy of fecal transplants or “microbiome-
therapy” [49] for treatment of recurring CDI has been positive, likely due to the 
repopulation of commensal flora, (which trigger T regulatory cell accumulation in the 
mucosa) [50]. This immune system reaction can balance the damaging proinflammatory 
cytokine response, decreasing disease symptoms [50]. Additionally, repopulation of 
intestinal microflora jump-starts the re-establishment of an ecosystem [21, 51], in which 
community members compete for nutrients and produce bacteriocins, which can have 
bacteriocidal activity against invading pathogens, which likely contributes to controlling 
the growth of vegetative C. difficile [52-55]. 
 
1.1.3. The role of spores in C. difficile infection and transmission 
 Sporulation is a developmental process that involves a vegetative bacterial cell 
differentiating into a metabolically dormant cell known as a spore. More astonishing is 
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that once in this resistant, dormant state, the bacterial spore can detect when conditions 
are favorable for vegetative growth and can transform from a spore back into a vegetative 
cell, in the process known as germination. These transformation processes are conserved 
to various degrees in spore-formers and have evolved with specialized checkpoints in 
some species [56, 57]. Since C. difficile is a strict anaerobe, spores are essential for 
causing natural infection in humans. C. difficile spores are expelled from infected humans 
and other mammals and ingested via the fecal-oral route. During transit through the 
gastrointestinal tract, spores sense specific bile salt germinants, which induce spores to 
transform back into a vegetative cell [58]. During vegetative growth, C. difficile produces 
toxins (discussed earlier), which are the major factors responsible for inducing the 
immune response that leads to the CDI symptoms. While undergoing vegetative growth 
in the gut, sporulation is induced [59], spores are excreted, and the cycle of spore 
transmission can go full circle.  
 
1.2. The “vessel” known as a spore 
 Spores are vessels containing a single bacterial chromosome surrounded by 
various elements, ultrastructures, and membranes designed to protect the spore from 
environmental insults (Figure 1, [60]). Spores are capable of withstanding most 
environmental and chemical conditions including but not limited to heat, radiation, 
dessication, genotoxic agents, and most disinfectants [60]. They consist of three major 
layers: core, cortex, and coat. The core contains DNA, ribosomes, and proteins necessary 
for the spore to transform back into a vegetative cell [61]. Inside the core, cytosolic water 
is exchanged with dipicolinic acid chelated to divalent cations, usually calcium ions, to 
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form Ca-DPA; this exchange dehydrates the core and largely renders it metabolically 
inert [61]. In 2012, Segev et. al. reported activity of low temperature acting transcription 
factors in spores [62]; their evidence suggests that a spore can induce transcription while 
at cold temperatures; however, this evidence remains somewhat controversial in the field. 
The inner membrane surrounding the core, also known as the inner forespore membrane 
during sporulation, Figure 1, is dense and largely impermeable [63]. The germ cell wall 
made of peptidoglycan surrounds the inner forespore membrane, which, together with the 
inner membrane, will become the cell wall membrane during outgrowth into a vegetative 
cell [64, 65]. Surrounding the germ cell wall is a thick modified layer of peptidoglycan 
known as the cortex. Surrounding the cortex is the outer cell membrane, known as the 
outer forespore membrane during sporulation, which is derived form the mother cell 
membrane after the completion of engulfment. Layered atop the outer membrane is the 
outer protein wall, which is comprised of multiple spore coats that make up the inner and 
outer coat [56]. 
 These features are retained in all spore-formers studied to date, and each structure 
or membrane surrounding the spore contributes to the maintenance of dormancy, 
resiliency in variable environments, and/or the process of re-gaining metabolic function 
during germination. Intrinsically, these vessels are capable of surviving for extremely 
long periods of time. Reports of Bacillus spp. spores recovered from permafrost after at 
least 10,000 years have been revived [66]; a more controversial claim that 25 million year 
old Bacillus spp. spores isolated from the guts of extinct bees preserved in amber in the 
Dominica has also been documented [67].     
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1.2.1. The core 
 In the core, the bacterial genome is bound by double-stranded DNA binding 
proteins, known as small acid soluble binding proteins, or SASPs, which constitute up to 
20% of the B. subtilis spore core [68]. SASPs physically bind to DNA causing it to reside 
in an A-form, (right-handed duplex with shorter distance between nucleic acids) [69]. 
The conformational change and the physical barrier created by SASPs protect DNA from 
chemical and enzymatic cleavage, confer resistance to heat, UV radiation, and other 
DNA damaging treatments [70-72]. Upon germination, SASPs are degraded early, by an 
endoprotease (GPR) that recognizes specific sequences in SASPs [73]. This proteolysis 
provides amino acids for protein synthesis when metabolic activity re-commences [73]. 
There are two distinct families of SASP proteins, α/β-SASPs and γ-SASPs. α/β-SASPs 
confer the resistance properties while γ-SASPs appear to mainly provide amino acids for 
outgrowth [73, 74]. In C. difficile, sspA and sspB encoding α/β-SASPs are transcribed in 
high abundance during sporulation [12], and while a GPR homologue also exists [12], a 
gpr mutant germinates to wild type levels (further analysis is required). 
 The core of a spore is in a dehydrated state, since water is displaced by dipicolinic 
acid associated with divalent calcium cations (Ca-DPA) during sporulation. Ca-DPA has 
been found to make up to 10% of Bacillus spore dry weight [75] and is important for wet-
heat and hydrogen peroxide resistance [76]. In C. perfringens, while water replacement 
with DPA is essential for moist heat, UV radiation, and chemical resistance, DPA release 
is not required for germination [77]. In B. subtilis, DPA release is an important trigger for 
CwlJ-mediated cortex hydrolysis during germination (described later in detail) [78]; in 
contrast, in C. difficile, the only known cortex hydrolase, SleC, is activated prior to DPA 
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release [79, 80]. Whether or not DPA is necessary for downstream germination events in 
C. difficile remains to be determined. 
 
1.2.2. The cortex 
 The thick cortex is a specialized layer of modified peptidoglycan that physically 
prevents the expansion of the core and confers resistance to heat [81]. Vegetative 
peptidoglycan is composed of glycan strands consisting of repeating N-
acetylglucosamine (NAG) and N-acteylmuramic acid (NAM) residues. NAM residues 
contain peptide side chains that crosslink between strands. The modified peptidoglycan 
that makes up the cortex of a spore has been best characterized in B. subtilis: every other 
NAM residue is replaced by a muramic-delta-lactam residue [82-86], an alteration that 
reduces the number of peptide linkages and creates a looser association between 
peptidoglycan strands. This modification is thought to facilitate contraction of the spore 
and maintain the spore core in a dehydrated state [84, 85, 87-89]. Since cortex has a more 
significant range of motion than vegetative peptidoglycan, it is hypothesized that it has 
mechanical action in response to pH changes and can contribute to dehydration of the 
core [12, 90]. However, contrary to this hypothesis, mutant spores that exhibit a four-fold 
increase in cortex crosslinking, causing lower flexibility, maintain wildtype levels of 
spore core dehydration [90]. 
 While the structure of C. difficile cortex is unknown, we know that C. difficile 
vegetative cell peptidoglycan is unique in that it contains a high level of deacteylated N-
acetylglucosamine groups and a high amount of 3è3 peptide crosslinks mediated by L,D-
transpeptidases in contrast to the usual 4è3 crosslinks mediated by D,D-transpeptidases 
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[91]. Whether or not C. difficile cortex has unique linkages remains to be characterized. 
 
1.2.3. The coat 
 The inner and outer coat layers of spores provide resistance to many 
environmental insults including hydrogen peroxide, artificial UV and solar UV radiation 
[92-94], and are involved in coat assembly [95-100] and germination [101]. The coat 
layers consist primarily of protein, making up about 30% of the total protein composition 
of a spore [102, 103]. There are 4 layers to the B. subtilis coat, the basement layer, inner 
coat, outer coat, and the crust, which are made up of over 70 proteins [56]. By TEM, the 
numerous coat layers that make up the inner and outer coat are visible and differentiated 
into two zones: outer layers are described as having course striations, and inner layers are 
described as being lamellar in appearance (Figure 1 [104]). The basement layer includes a 
well-described protein SpoIVA, conserved in all spore-formers to date [56], that mediates 
the initial assembly of coat proteins to the forespore [56, 105]. In B. subtilis, SpoVM, 
SpoIVA, and SpoVID are involved in basement layer formation and are necessary for full 
encasement of the spore by additional coat proteins, since loss of any results in coat 
mislocalized to the mother cell cytosol [56, 106]. Proteomic analyses of C. difficile spores 
[11] and genomic analyses [107] revealed that only 18 B. subtilis spore coat orthologues 
exist. These analyses suggest that many other spore coat proteins comprise C. difficile 
spore coat, since over three times as many proteins have been identified to make up the B. 
subtilis spore coat [108]. In C. difficile, the morphogenetic coat protein conserved in 
Clostridium spp., SipL, interacts with SpoIVA which together are important for the 
localization of other coat proteins to the forespore [105]. While a C. difficile SpoVM 
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homolog exists, it is not essential for coat assembly (Aimee Shen, personal 
communication). In addition to C. difficile SpoIVA and SipL, other coat proteins have 
been identified, including CotA-G and SodA [108, 109], with CotCB, CotD, and CotE; 
the latter three have been shown to have some specific enzymatic activities. Clearly, 
additional C. difficile spore coat proteins remain to be discovered. 
 B. subtilis are also surrounded by a “crust” layer that is thought to contribute to 
the packing of all the coat layers, since spores lacking crust proteins tend to clump and 
are more easily disrupted by TEM processing procedures [110, 111]. Whether or not a 
crust layer exists in C. difficile remains to be seen.  
 
1.2.4. The exosporium 
 C. difficile spores have a proteinaceous ultrastructure layer known as an 
exosporium [11, 112]. This outermost layer is not made by all spore formers; however, it 
is produced by Bacillus anthracis, Bacillus cereus, and by the insecticide-producing 
Bacillus thuringiensis. Analysis of the C. difficile proteome [11] and genome [107] 
revealed that only 3 B. anthracis and B. cereus exosporium orthologues exist, suggesting 
that the make-up of the spore ultrastructure’s are divergent. The loosely assembled B. 
anthracis exosporium consists of a basal layer of proteins that are surrounded by a hair-
like glycoprotein nap [103, 113], which consists of glycosylated proteins [114]. This 
structure conveys heat and ethanol resistance properties in C. difficile [115]. Interestingly, 
removal of C. difficile spore exosporium proteins using mechanical or chemical agitation 
results in increased adherence to gut-derived Caco-2 cells, suggesting that the 




 Sporulation is defined by a series of morphological events starting with the 
formation of a polar septum, which creates two morphologically distinct compartments: a 
larger mother cell and smaller forespore  ([117-119]). While these compartments contain 
the same genetic material, different genetic programs are regulated within each, resulting 
in different fates. The mother cell aids in building the spore from the outside-in and 
mediates a phagocytic-like event known as engulfment, in which the mother cell 
membrane migrates around the forespore, such that the forespore exists as a double 
membrane-bound protoplast free in the mother cell. The thick peptidoglycan cortex forms 
between the double membranes, while the proteinaceous coat layers form around the 
forespore (Figure 2B, [103, 120]). Once forespore maturation is complete, the mother cell 
undergoes programmed lysis, releasing a mature spore into the environment [121]. 
Extensive studies of this developmental process in B. subtilis indicate that sporulation is 
primarily controlled at the transcriptional level by four sporulation-specific sigma factors, 
σF, σE, σG, and σK [122]. During sporulation, these sigma factors are post-translationally 
activated at specific times in specific compartments. This pattern of regulation produces 
distinct lines of gene expression in the mother cell and forespore that drive sporulation 
through its morphological stages. While the morphological changes required to form a 
spore are generally conserved [123], recent studies in Clostridium spp. have revealed that 
diverse mechanisms control the activation and function of the sporulation-specific sigma 
factors, resulting in the discovery that there are many paths to producing a spore.   
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1.3.1. Sporulation initiation 
 Significant differences exist in the initiation of sporulation among Firmicutes. In 
B. subtilis, the master transcriptional regulator, Spo0A, is regulated by σH during the 
transition from exponential to stationary growth [124]. A complex, multicomponent, 
phosphorelay system exists for the post-translational activation of Spo0A, involving the 
interplay of five ligand specific sensor kinases (KinA-E), phosphotransferases (Spo0B 
and Spo0F), and phosphatases that respond to nutrient availability [125]. B. subtilis also 
produces quorum-sensing molecules, known as Phr peptides, in a cell density dependent 
manner, that positively control sporulation via Spo0A phosphorylation [126, 127], and 
are transported by oligopeptide permeases, Opp and App [128, 129]. 
 Phosphotransferase proteins Spo0B and Spo0F are absent in Clostridium spp. 
[130, 131]. While C. difficile Spo0A is σH-dependent, it is regulated by a more “typical” 
two-component system with associated kinases that are predicted to directly 
phosphorylate Spo0A, some of which have some homology to the sensor kinases found in 
B. subtilis [132]. Interestingly, while Opp and App homologs exist in C. difficile, 
inactivation of these genes results in increased sporulation in vitro and increased 
virulence and spore recovery in a hamster model, suggesting that these transporters likely 
inhibit sporulation by uptake of environmental peptides [133]. 
 
1.3.2. Regulation of sporulation in Bacillus subtilis 
Activation of the master transcriptional regulator Spo0A leads to the sequential 
activation of σF in the forespore, σE in the mother cell, σG in the forespore, and σK in the 
mother cell. Multiple transmembrane signaling events are required to produce this 
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“crisscross” pattern of sigma factor activation, which links transcriptional changes to 
morphological changes (Figure 3, black arrows [122]).  
The early sigma factors σF and σE are produced in a Spo0A-dependent manner 
prior to the formation of a polar septum; however, these factors remain inactive until a 
polar septum is formed. σF is transcribed as part of a three-gene operon spoIIAA-spoIIAB-
spoIIAC encoding the anti-anti- sigma factor SpoIIAA, the anti-sigma factor SpoIIAB, 
and σF, respectively. σF activation begins when the polar septum bound phosphatase 
SpoIIE, activates the anti-anti sigma factor phosphate bound SpoIIAA following polar 
septum formation [134, 135]. Activated SpoIIAA antagonizes the anti-sigma factor 
SpoIIAB dimer that complexes with σF in the forespore compartment [136].  
Exclusive σF activation in the forespore is mediated by two important factors, 
chromosomal spatial asymmetry and localization of SpoIIE. First, during polar septum 
formation, about 30% of the bacterial chromosome is trapped within the forespore 
compartment. The remaining 70% is translocated to the forespore compartment mediated 
by SpoIIIE translocase [137-139]. Prior to completion of the chromosomal translocation, 
two copies of spoIIAB are present inside the mother cell compartment, since spoIIAB is 
distal to the origin of replication on the chromosome [140]. Since SpoIIAB is 
proteolytically unstable, a build up of SpoIIAB in the mother cell reduces σF activation in 
this compartment, while a reduction in the amount of SpoIIAB in the forespore 
compartment increases σF activation [141]. Second, since SpoIIE is localized to the polar 
septum and thus has the potential to activate σF in either compartment, the smaller 
volume of the forespore compartment increases the relative concentration of SpoIIE in 
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the forespore, reducing the replenishment of SpoIIAB in this compartment. The net result 
is that σF is activated in a forespore-specific manner. 
Active σF can interact with RNA polymerase and induce the first compartment-
specific transcriptional program. This program includes sigG and spoIIR expression. 
spoIIR is located close to the origin of replication and therefore is one of the first genes 
transcribed when σF is activated in the forespore [142]. SpoIIR is secreted into the 
intermembrane space, where it activates the SpoIIGA protease to remove an inhibitory 
pro-peptide from σE in the mother cell [143-145].   
 In the mother cell, σE activation drives the transcription of genes encoding a 
hydrolase complex SpoIID/SpoIIP/SpoIIM, or D/P/M, [146, 147] which mediates the 
first step during engulfment, peptidoglycan thinning [148-150]. The D/P/M complex 
degrades the peptidoglycan layer of the polar septum and permits the interaction of two 
membrane bound proteins, forespore derived SpoIIQ (σF-controlled) and mother cell 
derived SpoIIIAH (σE-controlled) [151, 152]. These two proteins form a complex that 
can be visualized as foci surrounding the engulfing forespore compartment [151]. Later, 
there are additional SpoIIIA proteins recruited to the SpoIIIAH side of the complex to 
form a channel known as the “feeding tube”. This channel bridges the mother cell and 
forespore compartments and is necessary for σG to become activated in the forespore 
[153-155].  
The feeding tube channel has homology to secretion systems and is thought to 
transport small molecules into the forespore that are required for sustained RNA and 
protein synthesis corresponding to σG activation [153-155]. σG activity also appears to 
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require completion of engulfment, [156] although recent studies challenge this notion 
[157]. Regardless, σG activation depends both on the status of the mother cell and 
forespore. Active σG auto-activates its own production [158], inhibits σF production 
[159], and drives a new transcriptional program encoding determinants important for late 
sporulation sigma factor σK activation in the mother cell [160].  
How is σF inhibited? σF inhibition is hypothesized to be mediated in two ways: (i) 
the production of YabK or “Fin”, which is initially regulated by σF and depends on σG for 
sustained function, and (ii) an unknown σG-mediated (Fin-independent) mechanism 
[159]. Additional contributing factors that may contribute to the switch from σF to σG 
activity include the notion that the sigma factors could be competing for RNA polymerase 
[161].  
σF is also responsible for the production of σG-inhibitor, CsfB or “Gin” [162, 
163]. σG activity leads to the production of the forespore-specific transcription factor 
SpoVT [164-167] and the germinant receptors (GRs), which are essential for sensing 
nutrients, i.e. GerA, B, and K [168-172]. While SpoVT can be a positive or negative 
regulator of σG-mediated transcription, it has been shown that SpoVT is important for 
regulating factors of germination and resistance properties of spores. Specifically, SpoVT 
is important for the down-regulation of genes encoding GRs involved in nutrient sensing, 
the production of SpoVAD which is involved in DPA release, and production of SASPs, 
which aid in resistance to UV radiation [171].  
The mother cell-specific σK, the last sigma factor in the sporulation pathway, is 
regulated by multiple mechanisms (Figure 5). sigK expression requires both σE and 
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SpoIIID, a σE-regulated transcription factor [173]. σK production depends on σE- and 
SpoIIID-mediated activation of spoIVCA, which encodes the recombinase required for 
excising the skin element, a phage DNA-like insertion that disrupts sigK [174]. σK 
activity requires proteolytic cleavage by the intramembrane protease SpoIVFB [175], 
which removes an inhibitory pro-peptide from σK similar to σE. Since SpoIVFB activity 
depends on the σF-/σG-dependent protease, SpoIVB [175], σK activation in the mother 
cell is coupled to σG activity in the forespore. Active σK induces the expression of genes 
whose products are required for cortex and coat formation [147].  
Altogether, this regulatory framework is characterized by a series of 
transcriptional programs containing feedback and feedforward loops that allow the late 
sigma factors (σG and σK) to replace the activity of the early sigma factors (σF and σE) in 
their respective compartments [176]. σE-regulated gene products activate σK and down-
regulate σE-mediated gene expression [177], while a σF-regulated anti-σF factor promotes 
σG activation [159]. Both sigF and sigE mutants arrest at asymmetric division, which is 
consistent with their roles in regulating engulfment ([178], Figure 2B), a sigG mutant 
completes engulfment but fails to make σK-dependent cortex or coat [154, 179], and a 
sigK mutant resembles a sigG mutant [180]. Thus, the B. subtilis sporulation cascade is 
organized such that the sporulation-specific sigma factors are sequentially activated 
through a series of intercompartmental signaling events, which in turn are coupled to 
morphological changes. Events in the forespore are intimately tied in space and time to 
events in the mother cell, and additional regulatory loops fine-tune the activity of each 
sporulation-specific sigma factor. 
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1.3.3. Regulation of sporulation in the clostridia 
Phylogentic analyses indicate that the sporulation-specific sigma factors are 
strictly conserved among spore-forming bacteria [95, 176, 181]. Since the signaling 
proteins controlling their activity in B. subtilis are largely conserved, the sigma factors 
were predicted to be sequentially activated across the Firmicutes. This prediction, 
however, has not been borne out by recent studies in other Clostridium spp.  
Studies of sporulation sigma factor function in Clostridium spp. have mainly been 
limited to C. acetobutylicum, C. perfringens, and C. botulinum. While most sporulation 
sigma factor mutants have been constructed, the mechanisms controlling sporulation 
sigma factor activation have not been fully characterized. Based on gene conservation, 
the minimal machinery for activating σF, σE, σG, and σK are conserved in these species 
[95, 131, 176, 181], and both σE and σK carry a propeptide predicted to inhibit their 
function [176]. Despite this gene conservation, C. acetobutylicum SpoIIE is necessary for 
sigF expression [182] in contrast with B. subtilis [135], and no processing of σE is 
observed [183] in contrast with B. subtilis and C. difficile, suggesting that divergent 
mechanisms control sigma factor activation in Clostridium spp. Indeed, the timing of σK 
activation in Clostridium spp. exhibits clear differences relative to B. subtilis and C. 
difficile, with σK being activated early during sporulation (Figure 3, [184-186]) and 
independent of skin excision (Figure 4). In C. acetobutylicum, σK surprisingly functions 
at two discrete stages of sporulation (Figure 3, [184]). Prior to sporulation initiation, σK 
activates spo0A expression, while at late stages of sporulation, σK activates coat protein 
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gene expression [184]. Since σK carries a pro-peptide and spoIVFB is only expressed late 
during sporulation [184], it is unclear how early σK activity is achieved; an intriguing 
mechanism that has been proposed is that active σK is epigenetically inherited by later 
cell generations [184].  
In C. acetobutylicum, differences in sporulation sigma factor gene expression are 
also observed. While σF induces sigG expression similar to B. subtilis, C. acetobutylicum 
σF activates sigE expression [187] in contrast with B. subtilis. Late during sporulation, σE 
induces sigK expression [184] similar B. subtilis; whether SpoIIID is required for this 
induction is unclear.  
In contrast with B. subitlis, C. acetobutylicum sigK, sigF, and sigE mutants are 
blocked prior to asymmetric division ([183, 184, 187], Figure 2B). Since σF activation 
depends on polar septum formation in B. subtilis [136], and C. acetobutylicum σE is 
required for asymmetric division [187], C. acetobutylicum σF may require σE for activity. 
While a C. acetobutylicum sigG mutant completes engulfment similar to B. subtilis, coat 
fragments are visible around the forespore [183] in contrast with B. subtilis. Further, a C. 
acetobutylicum sigG mutant makes cortex (although to a lesser extent than wild type, 
Figure 2B, [183]). Notably, artificial expression of spo0A in a sigK mutant allows 
sporulation to proceed past engulfment but is blocked prior to coat and cortex formation 
[184].  
The mechanisms controlling C. perfringens have not been characterized, although 
both σE and σK undergo proteolytic processing [185]. Consistent with the early function 
of σK during sporulation, C. perfringens σK is required for sigE expression, even though 
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σE induces late stage σK production [185]. Whether C. perfringens σK activates spo0A 
expression, and whether SpoIIID activates sigK expression, remains to be tested. 
However, in contrast with B. subtilis, C. perfringens spoIIID expression occurs 
independent of σE [185]. While Western blot analyses indicate that σF controls σE 
production [188] similar to C. acetobutylicum, semi-quantitative RT-PCR analyses 
suggest that σK up-regulates sigF [185], highlighting the need for further studies in C. 
perfringens.  
The morphological stage(s) at which C. perfringens sigF and sigG mutants are 
arrested are unknown, although a sigK mutant is blocked before asymmetric division 
[185] similar to C. acetobutylicum. In contrast with C. acetobutylicum, a sigE mutant 
arrests after asymmetric division ([185], Figure 2B).  
In C. botulinum, studies of sporulation sigma factor regulation have been 
restricted to transcriptional analyses. sigK exhibits a similar two-stage expression profile 
[189] as C. acetobutylicum and C. perfringens, with sigK being expressed early during 
sporulation but rising dramatically in a σE- and σF-dependent manner late during 
sporulation [189]. Similar to C. acetobutylicum and C. botulinum, σK activates spo0A and 
sigF [186]. Whether σK also regulates late stages of sporulation needs to be determined, 
as do the regulatory mechanisms controlling σF and σG function. Intriguingly, spo0A 
transcripts are under-expressed in sigF, sigE, and sigG mutants via an unknown 
mechanism [189].   
C. botulinum sigF and sigE mutants arrest at asymmetric division [189] in 
contrast with C. acetobutylicum, while a C. botulinum sigG mutant completes engulfment 
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and forms coat fragments but no cortex [189]. Thus, σG regulates cortex but not coat 
formation similar to C. difficile and C. acetobutylicum. Whether a sigK mutant is arrested 
at an earlier stage of sporulation than sigF and sigE mutants is unclear. 
While further analyses are clearly needed to elucidate the mechanisms controlling 
the activity and compartmentalization of Clostridium spp. sporulation sigma factors, the 
control of the master transcriptional regulator Spo0A by σK defined in C. acetobutylicum 
may be broadly conserved in Clostridium spp., since a C. perfringens sigK mutant arrests 
at an earlier stage of sporulation than a sigE mutant. Nevertheless, since variation in 
sporulation sigma factor mutant phenotypes are observed between Clostridium spp. 
(Figure 2B), divergent mechanisms may control sigma factor function in different 
Clostridium spp. Transcriptional profiling of sigma factor mutants in multiple 
Clostridium spp. would provide critical insight into these questions. Lastly, it should be 
noted that σK regulates additional cellular processes beyond sporulation in these species: 
in C. botulinum it controls stress responses [190], and in C. acetobutylicum it controls 
solventogenesis [184].  
 
1.4. Germination 
 While the phenomenon of sporulation is advantageous for bacterial survival, 
reversing that transformation to become a living cell again is essential and is done via the 
processes of germination and outgrowth. The biophysical process of germination requires 
no macromolecular synthesis; essentially, everything that is required for germination is 
contained within the spore. Cues that trigger germination are typically environmental 
signals that represent optimal living conditions. In the case of B. subtilis, germination 
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receptor-dependent germination can be triggered by multiple substances including, amino 
acids, and DPA [191], while in C. difficile, receptor-dependent germination is triggered 
by specific bile salts such as taurocholate and a co-germinant glycine [192]. While these 
germinants bear little structural resemblance, the stark differences are not surprising 
based on the various living requirements between these organisms. Consistent with its 
strict anaerobic conditions, C. difficile has evolved to sense germinants detected in the 
mostly anaerobic environment of the mammalian gastrointestinal environment. 
Additionally, since vegetative C. difficile would not survive entry and passage through 
the stomach of the GI system, germination of spores is essential for causing CDI [193]. 
 After germination is initiated by the sensing of germinant, a cascade of events 
follows. After germinant detection, a spore degrades its cortex layer, rehydrates its core, 
and “cracks” its multiple coat layers before outgrowth can proceed. In C.difficile, these 
events occur in a different order relative to what has been described in B. subtilis. 
 
1.4.1. Clostridium difficile germinants 
 Cholesterol-derived bile salts produced by the liver are C. difficile germinants or 
germinant inhibitors. Chenodeoxycholate and cholate are conjugated to glycine or taurine 
in the liver, to yield taurochenodeoxycholate or glycochenodeoxycholate and 
taurocholate or glycocholate, respectively (Figure 5, [194]). Upon entrance into the 
gastrointestinal tract, these derivatives are converted back to chenodeoxycholate or 
cholate (considered primary bile acids) by bile salt hydrolases produced by the gut flora 
[194]. These various bile salts can act as initiators of germination or inhibitors of 
vegetative cell growth [192, 195]. When primary bile acids reach the lower ileum, they 
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can be converted to the secondary bile acids, lithocholate and deoxycholate, by bacteria 
that produce 7α-dehydroxylase [194]. While cholate, taurocholate and glycocholate can 
act as germinants along with the co-germinant glycine, chenodeoxycholate has been 
shown to be a competitive inhibitor (Figure 5).  In silico studies evaluating microbiomes 
of people after bone marrow transplantation both inflicted with CDI or not, correlated 
microbiomes containing the 7α-hydroxylase producing Clostridium scindens with 
resistance to CDI infection [24].  
   
1.4.2. Clostridium difficile germination cascade 
 Germination can be initiated in vitro when bile salts combined with glycine 
interact with C. difficile germinant receptors, which have been hypothesized to be located 
on the spore outer membrane [192]. Genetic analyses suggest that taurocholate interacts 
with the pseudoprotease germinant receptor CspC, the only described germinant receptor 
in C. difficile [191, 196]. While many sporulating bacterial species use multiple different 
germinant receptors to interact with i) a specific germinant (such as B. subtilis GerA 
[197]) or ii) multiple germinants (such as B. anthracis receptors GerK/GerL that respond 
in concert with inosine [198], some bacteria have different receptors that interact with 
specific germinants and together work cooperatively to induce germination (such as B. 
subtilis GerB/GerK, which interact with L-alanine, D-glucose, D-fructose, and K+ ions 
[75]). While the mechanism by which the C. difficile glycine co-germinant receptor has 
not been described, it is hypothesized to work cooperatively with the CspC germinant 
receptor [196]. 
 The signaling cascade that proceeds after sensing germinant in C.difficile is just 
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beginning to be elucidated. The finding that CspC functions as a germinant receptor in C. 
difficile was particularly interesting, since in C. perfringens, CspC was identified as one 
of three subtilisin-like serine proteases (CspA, B, and C) that could proteolytically 
activate the cortex hydrolase pro-SleC [199, 200]. In C. difficile, homologues of these 
three proteases exist; however, CspB is the only active protease, since CspC and CspA 
are catalytically inactive [201]. Additionally, CspB and CspA are fused, resulting in a 
bicistronic operon consisting of cspBA-cspC. Based on studies comparing sporulating 
cells to isolated spores, the CspB-CspA fusion protein is cleaved in a YabG-dependent 
manner prior to being packaged into spores [202]. In contrast, C. perfringens strains that 
have been studied encode one or all, cspC, cspB, and cspA, with intact catalytic triads 
[123, 191, 196, 199, 200, 203].  
 When C. difficile CspC interacts with germinant, it presumably activates the 
subtilisin-like ezyme CspB, which is responsible for the proteolytic cleavage of the pro-
SleC zymogen form of the cortex lytic enzyme SleC [204]. Activated SleC degrades the 
protective peptidoglycan cortex in a process known as cortex hydrolysis. SleC is a 
germination-specific lytic enzyme [205, 206], similar to cortex lytic enzymes CwlJ and 
SleB in B. subtilis, which specifically target peptidoglycan with muramic-δ-lactam, 
leaving germ cell wall peptidoglycan intact [83]. Interestingly, one group described that 
pro-SleC pro-peptide processing is dispensable for cortex hydrolysis in vitro [205], 
although it is unclear whether removal of the pro-peptide increases SleC activity. 
Recently, it has been shown that after C. difficile cortex hydrolysis, Ca-DPA is released 
from the core [79], followed by core hydration and outgrowth.  
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1.4.3. Bacillus subtilis and other Bacillus spp. germination cascade 
 While the basic macromolecular constituents of the spore remain consistent 
between spore-fomers, the regulatory proteins and the order of germination events varies 
in Bacillus spp. relative to C. difficile. In B. subtilis spores, multiple different types of 
germinant receptors have been described and are located on the inner membrane (Figure 
1), in contrast to the hypothesized outer membrane location in C. difficile [79, 207].  
When B. subtilis germinant receptors sense germinant, H+ is excreted from the core 
(which is thought to provide the physiologic pH change required for enzymatic activity), 
and the core then releases Ca-DPA, allowing water to rehydrate the core and cortex 
hydrolysis to be activated [172]. Notably, cortex is hydrolyzed after DPA is released, in 
contrast to C. difficile, since the cortex hydrolase CwlJ is activated by Ca-DPA [78, 208]. 
While Bacillus spp. encode multiple different cortex lytic enzyme homologues within 
their genomes, including CwlJ, SleB, and SleL, only CwlJ or SleB is required for cortex 
hydrolysis [206, 209-212]. CwlJ, is located in the coat [78, 208], while SleB, a lytic 
transglycosylase, is located not only in the coat, but also the inner and outer membranes 
and cortex, and is triggered by an unknown mechanism [211, 212]. sleB is part of the 
two-gene operon sleB-ypeB that is expressed in the forespore during sporulation; the 
resulting protein products are co-dependent for incorporation into spores. While an 
interaction has not been demonstrated for SleB and YpeB, it is hypothesized that an 
interaction can only occur when SleB is interacting with peptidoglycan via an N terminal 
peptidoglycan-binding domain [213]. YpeB is required for stable SleB incorporation into 
spores. YpeB contains a transmembrane anchor and is thought to localize the protein to 
the inner forepore membrane during sporulation [211, 214]. Recently in B. anthracis, it 
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was shown that forespore-produced protease, HtrC, can proteolytically process YpeB, 
which is thought to liberate SleB during germination [215]. The interplay between YpeB 
and SleB is a topic that remains elusive and requires more studies in order to understand 
SleB-mediated cortex hydrolysis. 
 
1.5. Lipoproteins 
Bacterial lipoproteins are a class of membrane proteins that contain an N-terminal 
signal peptide that allows them to be transported and anchored within membranes. These 
proteins regulate diverse cellular processes, including both B. subtilis sporulation and 
germination (described below). In Gram-negative organisms, lipoproteins can be isolated 
in the periplasmic leaflet, anchored in the plasma membrane or outer membrane [216]. 
On rare occasions, lipoproteins have known to face the external environment in Gram-
negative bacteria [217]. In Gram-positive organisms, lipoproteins typically isolate to the 
cell membrane outer leaflet [218]. For these organisms, membrane anchoring is important 
for protein retention, since the peptidoglycan cell wall is porous and they lack an outer 
membrane [219]. Altogether, bioinformatics analyses indicate that lipoproteins represent 
1-3% of the gene products encoded within bacterial genomes [220]. Lipoproteins have 
been found to be important in many physiologic processes, including transmembrane 
signaling, signal transduction, nutrient uptake, and also bacterial virulence [221-223]. 
Lipoprotein signal peptide sequences are readily identifiable based on their 
tripartite structure containing a positively charged “N” region, a hydrophobic “H” region, 
and a cleavage “C” region (Figure 6). The Sec (Secretion) and Tat (Twin Arginine 
protein transport) systems can both recognize these specialized N-terminal signal peptide 
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sequences, although the Sec system transports unfolded proteins, while the Tat system 
can transport folded proteins and sometimes oligomers [224]. The Tat system, 
nevertheless, stringently requires the presence of two arginines at the end of the N-region 
of the signal peptide.  
All lipoproteins are characterized by the presence of a “lipo-box” containing an 
invariant cysteine within the “C” region [218]. The lipo-box is directly post-
translationally modified by the addition of a lipid moiety, known as lipidation, at the 
cysteine residue. Lipidation allows proteins to carry out function where insoluble cell 
constituents interface with aqueous environments.  
 
1.5.1. Mature lipoprotein transport in Gram-positive bacteria 
Lipoproteins are designated by precursor names depending on where they are in 
the series of transport and processing steps after translation, which is also known as 
lipoprotein biogenesis: i) preprolipoprotein is the form of the protein that is transported 
via a secretion system across membranes, ii) prolipoprotein designates when a lipidation 
event has occurred, and iii) mature lipoprotein (or just “lipoprotein”) indicates when the 
signal peptide signal has been cleaved [225] (Figure 6). Once the preprolipoprotein is 
transported to the outer leaflet, it is retained membrane bound by the H region of the 
signal peptide sequence. Lipidation at the invariant cysteine thiol group occurs by 
covalent attachment of a diacylglycerol mediated by a lipoprotein diacylglycerol 
tranferase (Lgt), resulting in prolipoprotein formation [226]. The signal sequence is then 
cleaved from the prolipoprotein by a lipoprotein signal peptidase (Lsp) [227], resulting in 
a membrane bound mature lipoprotein (Figure 6). While lipoprotein biogenesis is highly 
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conserved, the steps leading to mature lipoprotein formation are not always essential for 
lipoprotein function. In Listeria monocytogenes and Streptococcus agalactiae, Lsp was 
found to be capable of cleaving non-lipidated lipoproteins, indicating that lipoprotein 
biogenesis requirements are different in some instances [228, 229]. 
 
1.5.2. Bacillus subtilis lipoproteins involved in sporulation or germination 
Lipoproteins involved at different stages of sporulation have been described in B. 
subtilis. Mutations in the spo0K loci, containing a five-gene operon encoding Opp 
(Oligopeptide transport proteins), affect sporulation [219]. Specifically, OppA is 
annotated as a putative lipoprotein and important for the initiation of sporulation [126, 
230]. Mutations in the lipoprotein SpoIIIJ results in a late sporulation blockage [231]. 
SpoIIIJ is made during vegetative growth and was thought to be important for 
communication between mother call and forespore, involving σG activation. More recent 
studies show that SpoIIIJ localizes to the polar septum during sporulation, suggesting that 
it may recruit sporulation-specific proteins necessary for σG activation, such as those 
encoded by the SpoIIIA operon [232]. σG-dependent germinant receptors GerAA-AC are 
membrane-bound proteins; GerAC is predicted to be a lipoprotein that localizes to the 
inner forespore membrane and has been shown to be important for germination by 
nutrient detection [160, 233]. GerD is a σG-dependent lipoprotein that localizes to the 
outer leaflet of the inner membrane of the spore during sporulation, and is thought to be 
involved in the signal transduction process of germinant detection [170, 234, 235]. GerD 
has been shown to be essential for co-localizion of germinant receptors into small clusters 
in the inner membrane [236], to form what is known as the “germinosome”. While GerD 
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 While a lot is known about B. subtilis sporulation, the role of conserved and non-
conserved proteins during C. difficile sporulation is not clear. How does C. difficile 
regulate sporulation? Prior to the studies presented in this dissertation, we anticipated 
similarities since spo0A, sigF, sigE, sigG, and sigK are conserved. With that said, we 
expected to see differences, since C. difficile σK lacks a pro-peptide and only ~20% of the 
B. subtilis coat proteins are conserved. This dissertation addresses how these said 
conserved sigma factors and Spo0A control sporulation in C. difficile, and further 
describes what genes are turned on during sporulation. As a result of these studies, it was 
found that conserved proteins, important for mediating transcriptional regulation in B. 
subtilis, are important for engulfment in C. difficile. Furthermore, this dissertation goes 
on to describe a novel regulator of cortex hydrolysis during germination, which is 
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1.8. Figure Legends 
 
Figure 1. Spores contain multiple layers that create a vessel surrounding a copy of 
the bacterial chromosome. Spores are comprised of multiple layers. A) The inner most 
compartment is the core (shown in light blue) which contains a copy of the genome (dark 
blue). The core is housed by the inner membrane (black), which is surrounded by the 
germ cell wall (yellow), followed by the thick peptidoglycan cortex (green), which is 
contained by the outer membrane (orange). Proteinaceous inner coat (gray) and outer coat 
red layers surround the outer membrane.  Exosporium forms the outer most crust in some 
formers such as C. difficile (not shown).  
 
Figure 2. Morphological Phenotypes of Sigma Factor Mutants in Bacillus subtilis, 
Clostridium acetobutylicum, Clostridium perfringens, and Clostridium botulinum. 
(Pepto)Clostridium difficile characterization to be determined. Mutations in 
sporulation specific sigma (σ) factor genes, sigF, sigE, sigG, and sigK, result in a variety 
of phenotypes. A. Morphological stages of sporulation (I-VII) defined by transmission 
electron microscopy (TEM) studies in B. subtilis [118]. Stage I, decision to sporulate (no 
morphological phenotype); Stage II, completion of asymmetric division; Stage III, 
completion of engulfment; Stage IV cortex formation (pink) between the inner and outer 
forespore membrane; Stage V, coat assembly around the outer forespore membrane 
(blue); Stage VI, spore core maturation, e.g. chromosome condensation; Stage VII, 
release of fully mature spore following mother cell lysis. Key structures that comprise a 
mature spore are labeled. B. B. subtilis sigF– and sigE– complete asymmetric division 
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(Stage II), while sigG– and sigK– complete engulfment but fail to make coat or cortex 
(Stage III). C. difficile has yet to be characterized. C. acetobutylicum sigF–, sigE–, and 
sigK– do not complete asymmetric division (Stage I), although a small population (< 2%) 
of sigE– mutants complete asymmetric division [183]; sigG– completes engulfment and 
makes some cortex along with coat-like fragments that localize next to the forespore. C. 
perfringens sigE– is blocked at asymmetric division (Stage II), while sigK– does not 
initiate asymmetric division (Stage I); sigF– and sigG– phenotypes have yet to be 
analyzed by TEM. C. botulinum sigF– and sigE– complete asymmetric division (Stage II); 
sigG– completes engulfment and appears to make coat fragments that localize around the 
forespore; sigK– TEM has not been performed.  
 
Figure 3. Conserved sporulation-specific sigma factors regulate sporulation in 
diverse ways in the Firmicutes. In B. subtilis, sigma factor activity is regulated in a 
“crisscross” pattern: σF, σE, σG, and σK are sequentially and alternately activated in the 
forespore and mother cell compartment, respectively [237]. After Spo0A-mediated 
activation of sigF and sigE, σF becomes active in the forespore. Expression of the σF 
regulon leads to the activation of σE in the mother cell. Products of the σF and σE regulon 
activate σG in the forespore compartment. σG auto-activates its production and induces σK 
activation in the mother cell. σF and σE are required for sigG and sigK expression in the 
forespore and mother cell, respectively. In C. difficile, it is known that spo0A, sigF, sigE, 
sigG, and sigK are conserved [12]. In C. acetobutylicum, σK activates spo0A expression. 
Spo0A in turn activates sigF and sigE transcription. The mechanisms controlling the 
activity of σE, σG, and/or σK are unknown (question marks), although initial studies 
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suggest that σG may be dispensable for late σK function. It is hypothesized that σK may be 
epigenetically inherited so that Spo0A can be activated during vegetative growth ([184], 
red arrow). Green arrows designate transcriptional activation; black arrows designate 
post-translational activation; dotted arrow indicates partial requirement for activation; 
question marks indicate that more work needs to be done to determine the mechanisms 
controlling sigma factor gene transcription and/or sigma factor activation.  
 
Figure 4. Regulation of σK activity differs in the Firmicutes. σK is regulated by 
transcriptional and post-translational mechanisms during sporulation.  In B. subtilis and 
C. difficile, a phage DNA-like skin element must excise from genomic DNA prior to sigK 
transcription. In B. subtilis, after skin element excision, σE and the σE-regulated 
transcription factor SpoIIID activate sigK expression. σK is produced with an inhibitory 
pro-peptide that undergoes proteolytic activation via SpoIVFB. In C. difficile, sigK 
contains a skin element like in B. subtilis, however, C. difficile σK lacks a pro-peptide. In 
C. acetobutylicum, σK acts at two stages during sporulation. Early σK function has been 
hypothesized to occur via epigenetic inheritance or by early activation of sigK 
transcription by σA [184]. However, these hypotheses have not been tested. Late sigK 
transcription is mediated by σE, although the involvement of SpoIIID for transcriptional 
activation remains to be determined. It is unclear whether σK undergoes proteolytic 
activation, although SpoIVFB would be predicted to cleave σK. In C. perfringens, early 
sigK transcription appears to occur via read-through transcription of CPR_1739 [185], 
while late transcription is mediated by σE. Whether SpoIIID activates sigK transcription 
has not been determined, although σE does not control spoIIID expression. While 
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SpoIVFB is conserved, it is unclear if it removes the pro-peptide from σK; whether 
cleaved σK is the active form has also not been determined. In C. botulinum, factors 
controlling sigK transcription are unknown. Whether σK undergoes proteolytic activation 
is also unclear. Based on gene conservation, it is hypothesized that σE and SpoIIID 
activate sigK transcription, and SpoIVFB activates σK pro-peptide cleavage.  
 
Figure 5. C. difficile exposure to bile acids and the microbiome community during 
transit through the gut. Figure used with permission from Aimee Shen [58]. Liver 
produced bile acids are released into the intestine conjugated to glycine or taurine. These 
bile acids are deconjugated by gut microflora to primary bile acids [194], which can be 
made into secondary bile acids by the 7-dehydroxylases producing organism known as 
Clostridium scindens, which are toxic to C. difficile. 
 
Figure 6. Lipoprotein modifications and maturation. Lipoproteins are translated as a 
preprolipoprotein with n N terminal signal peptide (light blue) and a lipobox containing 
an invariable cysteine (dark blue and red). After transport across a membrane, Ldt 
(lipoprotein diacylglycerol transferase) transfers a diacyl glycerol to the thiol group of the 
cysteine within the lipobox. Lsp (lipoprotein signal peptidase; orange pac man) cleaves 


















Figure 2. Morphological Phenotypes of Sigma Factor Mutants in Bacillus subtilis, 
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Figure 5. C. difficile exposure to bile acids and the microbiome community during 























































CHAPTER 2:  






Kelly A. Fimlaid1,2, Jeffrey P. Bond1, Kristin C. Schutz1, Emily E. Putnam1, Jacqueline  




1Department of Microbiology and Molecular Genetics, University of Vermont, 
Burlington, Vermont, 05405, USA; 2Program in Cellular, Molecular & Biomedical 
Sciences, University of Vermont, Burlington, Vermont, 05405, USA; 3Microbial 
Pathogenesis Laboratory, The Wellcome Trust Sanger Institute, Wellcome Trust Genome 
Campus, Hinxton, CB10 1SA, United Kingdom. 
 
Running head: Regulation of sporulation in C. difficile 
 




The Gram-positive, spore-forming pathogen Clostridium difficile is the leading definable 
cause of healthcare-associated diarrhea worldwide. C. difficile infections are difficult to 
treat because of their frequent recurrence, which can cause life-threatening complications 
such as pseudomembranous colitis. The spores of C. difficile are responsible for these 
high rates of recurrence, since they are the major transmissive form of the organism and 
resistant to antibiotics and many disinfectants. Despite the importance of spores to the 
pathogenesis of C. difficile, little is known about their composition or formation. Based 
on studies in Bacillus subtilis and other Clostridium spp., the sigma factors σF, σE, σG, 
and σK are predicted to control the transcription of genes required for sporulation, 
although their specific functions vary depending on the organism. In order to determine 
the roles of σF, σE, σG, and σK in regulating C. difficile sporulation, we generated loss-of-
function mutations in genes encoding these sporulation sigma factors and performed 
RNA-Sequencing to identify specific sigma factor-dependent genes. This analysis 
identified 224 genes whose expression was collectively activated by sporulation sigma 
factors: 183 were σF-dependent, 169 were σE-dependent, 34 were σG-dependent, and 31 
were σK-dependent. In contrast with B. subtilis, C. difficile σE was dispensable for σG 
activation, σG was dispensable for σK activation, and σF was required for post-
translationally activating σG. Collectively, these results provide the first genome-wide 
transcriptional analysis of genes induced by specific sporulation sigma factors in the 
Clostridia and highlight that diverse mechanisms regulate sporulation sigma factor 
activity in the Firmicutes. 
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2.2. Author Summary 
C. difficile is the leading cause of healthcare-associated infectious diarrhea in the United 
States in large part because of its ability to form spores. Since spores are resistant to most 
disinfectants and antibiotics, C. difficile infections frequently recur and are easily spread. 
Despite the importance of spores to C. difficile transmission, little is known about how 
spores are made. We set out to address this question by generating C. difficile mutants 
lacking regulatory factors required for sporulation and identifying genes that are 
regulated by these factors during spore formation using whole-genome RNA-Sequencing. 
We determined that the regulatory pathway controlling sporulation in C. difficile differs 
from related Clostridium species and the non-pathogenic model spore former Bacillus 
subtilis and identified 224 genes that are induced during C. difficile spore development. 
Collectively, our study provides a framework for identifying C. difficile gene products 
that are essential for spore formation. Further characterization of these gene products may 




 Clostridium difficile is a Gram-positive, spore-forming, obligate anaerobe that 
causes gastrointestinal diseases including diarrhea, pseudomembranous colitis, and toxic 
megacolon [1-3]. C. difficile infections and C. difficile-related deaths have risen 
dramatically in the past decade, increasing the financial burden on health care systems [4-
7]. While C. difficile is best known for causing hospital-acquired antibiotic-associated 
infections, recent epidemiologic studies indicate that community-acquired C. difficile 
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infections are increasingly more common and associated with significant morbidity [6,7]. 
A key element to the success of C. difficile as a pathogen is its ability to produce spores. 
Spores are resistant to most disinfectants and antibiotics, making them difficult to 
eliminate both from infected humans and the environment [1,2,8]. As a result, C. difficile 
spores disseminate readily from person to person and cause high rates of recurrent 
infections, which can lead to serious illness or even death [1-3,9]. 
 Although spores are critical to the pathogenesis of C. difficile, their composition 
and formation remain poorly characterized. Less than 25% of the spore coat proteins 
identified in the well-characterized spore-former Bacillus subtilis have homologs in C. 
difficile [10]. In contrast, the regulatory proteins that control spore coat gene expression 
and other sporulation events in B. subtilis are conserved in C. difficile and all other spore-
forming Firmicutes [10-13]. These include the master sporulation transcriptional 
regulator, Spo0A, and the sporulation sigma factors σF, σE, σG, and σK.  
In B. subtilis the sporulation sigma factors function at discrete stages during spore 
development to couple changes in gene expression with specific morphological changes 
in the cell [14-16]. The morphological changes begin with the formation of a polar 
septum, which creates two compartments, the mother cell and the forespore. The mother 
cell engulfs the forespore and guides the assembly of the spore until it lyses once spore 
maturation is complete. By coupling these developmental changes to the sequential 
activation of compartment-specific sporulation sigma factors, the mother cell and 
forespore produce divergent transcriptional profiles that coordinately lead to the 
formation of a dormant spore [16].  
Sporulation gene transcription in B. subtilis begins with the activation of the 
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transcription factor Spo0A, which in turn activates early sporulation gene transcription, 
such as the genes encoding the early sigma factors σF and σE. σF is initially held inactive 
by an anti-σ factor and only undergoes activation after septum formation is complete; this 
mode of regulation couples σF activation in the forespore to a morphological event 
[17,18]. Active σF induces the transcription of genes whose products mediate cleavage of 
an inhibitory pro-peptide from σE in the mother cell via trans-septum signaling [19]. 
Active σE induces the transcription of genes whose products lead to the activation of the 
late sporulation sigma factor σG in the forespore, which occurs during or after engulfment 
[20,21]. Activated σG in the forespore subsequently induces the expression of genes 
whose products proteolytically activate σK in the mother cell via trans-septum signaling 
[22]. Notably, the activity of each sigma factor relies on the activation of the preceding 
sigma factor [11,14-16,23]. As a result, the sigma factors operate in a sequential, “criss-
cross” manner and collectively control the expression of hundreds of genes during 
sporulation [24-26]. 
 The regulatory pathway controlling sporulation sigma factor activation in B. 
subtilis is thought to be conserved across endospore-forming bacteria, since all four 
sigma factors are conserved [11,12]. However, a growing body of work in the Clostridia 
suggests that diverse pathways regulate sporulation sigma factor activity in the 
Firmicutes. In C. perfringens, a sigG– mutant still produces cleaved σK, suggesting that 
σG does not control the proteolytic activation of σK as it does in B. subtilis [27]. 
Furthermore, a C. perfringens sigK– mutant exhibits a phenotype more severe than a B. 
subtilis sigE– mutant in that it fails to initiate asymmetric division or produce σE [28], 
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suggesting that in C. perfringens σK functions upstream of σE. Indeed, C. perfringens σE 
and σK have been suggested to be dependent on each other for full activity, in contrast 
with B. subtilis [28]. A similar early sporulation defect has been observed in a sigK– 
mutant of C. botulinum, which also exhibits reduced expression of early sporulation 
genes spo0A and sigF [29]. In contrast with B. subtilis and C. perfringens, however, a C. 
acetobutylicum sigF– mutant does not initiate asymmetric division [30], and a sigE– 
mutant fails to complete asymmetric division [31]. In addition, a C. acetobutylicum sigE– 
mutant produces wildtype levels of σG [31] in contrast with B. subtilis, and a sigG– 
mutant exhibits elongated forespores and pleiotropic defects in coat and cortex formation 
[31].  
To determine how these sporulation sigma factors regulate sporulation in C. 
difficile, we constructed mutations in the genes encoding the sporulation transcription 
factor Spo0A and the sigma factors σF, σE, σG, and σK and determined the transcriptional 
profiles of these mutants using RNA-Sequencing (RNA-Seq). The transcriptional 
analyses, combined with cytological characterization of the sigma factor mutants, suggest 
that divergent mechanisms regulate the activity of σG and σK in C. difficile relative to B. 
subtilis and other Clostridium spp. In addition, these analyses have identified a set of 314 
genes that are upregulated during sporulation in a Spo0A-, σF-, σE-, σG-, and/or σK-
dependent manner. These sporulation-induced genes provide a framework for identifying 
and characterizing C. difficile spore proteins that may have diagnostic or therapeutic 
utility. 
 
2.4.  Materials and Methods 
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2.4.1. Bacterial strains and growth conditions 
All C. difficile strains are listed in Table 1 and derive from the parent strain 
JIR8094 [33], an erythromycin-sensitive derivative of the sequenced clinical isolate 630 
[34]. C. difficile strains were grown on solid brain heart infusion media supplemented 
with yeast extract (BHIS: 37 g brain heart infusion, 5 g yeast extract, 0.1% (w/v) L-
cysteine, 15 g agar per liter) [74]. Taurocholate (TA; 0.1% w/v), thiamphenicol (5-10 
µg/mL), kanamycin (50 µg/mL), cefoxitin (16 µg/mL), FeSO4 (50 µM), and/or 
erythromycin (10 µg/mL) were used to supplement the BHIS media as indicated. 
Cultures were grown at 37˚C, under anaerobic conditions using a gas mixture containing 
85% N2, 5% CO2, and 10% H2. 
Sporulation was induced on media containing BHIS and SMC (90 g 
BactoPeptone, 5 g protease peptone, 1 g NH4SO4, 1.5 g Tris base, 15 g agar per liter) 
[50], at 70% SMC and 30% BHIS (70:30 media, 63 g BactoPeptone, 3.5 g Protease 
Peptone, 11.1 g BHI, 1.5 g yeast extract, 1.06 g Tris base, 0.7 g NH4SO4, 15 g agar per 
liter) [37]. 70:30 agar (supplemented as appropriate with thiamphenicol at 5-10 µg/mL) 
was inoculated from a starter culture grown on solid media.  
HB101/pK424 strains were used for conjugations and BL21(DE3) strains were 
used for protein expression. E. coli strains were routinely grown at 37˚C, shaking at 225 
rpm in Luria-Bertani broth (LB). Media was supplemented with chloramphenicol (20 
µg/mL), ampicillin (50-100 µg/mL), or kanamycin (30 µg/mL) as indicated.  
 
2.4.2. E. coli strain construction 
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All strains are listed in Table S11; all plasmids are listed in Table S12; and all 
primers used are listed in Table S13. For disruption of spo0A, sigE, sigG, sigK, and sigF, 
a modified plasmid containing the retargeting group II intron, pCE245 (a gift from C. 
Ellermeier, University of Iowa), was used as the template. Primers used to amplify the 
targeting sequence from the template carried flanking regions specific for each gene 
target and are listed as follows: spo0A (#539, 540, 541 and 532, the EBS Universal 
primer as specified by the manufacturer (Sigma Aldrich), sigE (#653, 654, 655 and 532), 
sigG (#728, 729, 730, and 532), sigK (#681, 682, 683, and 532) and sigF (#775, 776, 
777, and 532). The spo0A disruption mutant was constructed using the same primers as 
Underwood et al. [36]. The resulting retargeting sequences were digested with BsrGI and 
HindIII and cloned into pJS107 (a gift from J. Sorg, University of Texas A&M), a 
derivative of pJIR750ai (Sigma Aldrich) [32]. The ligations were transformed into DH5α 
and confirmed by sequencing. The resulting plasmids were used to transform 
HB101/pK424. 
To construct the sigE complementation construct, primers #725 and 726 were 
used to amplify a fragment containing 252 bp upstream and 156 bp downstream of the 
two gene spoIIGA-sigE operon using 630 genomic DNA as the template. To construct the 
sigG complementation construct, primers #835 and 836 were used to amplify 288 bp 
upstream and 16 bp downstream of sigG using 630 genomic DNA as the template. The 
sigK complementation construct was made using PCR splicing by overlap extension 
(SOE) [75]. Primer pair #734 and 736 was used to amplify the 5’ SOE product, while 
primer pair #735 and 737 was used to amplify the 3’ SOE product. The resulting 
fragments were mixed together, and the flanking primers #734 and #737 were used to 
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amplify an 898 bp fragment corresponding to the sigK gene including 256 bp region of 
upstream sequence. This strategy was used to clone an intact sigK gene with the skin 
element excised [43]. To construct the sigF complementation construct, primers #954 and 
#956 were used to amplify 88 bp upstream and 19 bp downstream of spoIIAA-spoIIAB-
sigF operon, using 630 genomic DNA as the template. All complementation constructs 
were digested with NotI and XhoI and ligated into pMTL83151 [48] digested with the 
same enzymes, with the exception of the sigF complementation construct, which was 
cloned into pMTL84151 digested with the same enzymes [48].  
To construct strains producing recombinant CD3522, σE, σG, σF, Gpr, SpoVT, 
and SspA for antibody production, primer pairs #498 and 499; #596 and 597; #727 and 
688; #723 and 724; #790 and 791; #883 and 884; #975 and 976; and #885 and 886 were 
used to amplify the cd3522, sigE, sigG, sigF, gpr, spoVT, and sspA genes lacking stop 
codons, respectively, using 630 genomic DNA as the template. The sigE expression 
construct deletes the sequence encoding the first 23 amino acids of σE, which removes its 
membrane-tethering domain and improves the solubility of the protein in E. coli. The 
resulting PCR products were digested with NdeI and XhoI, (or NheI and XhoI for gpr) 
ligated to pET22b (or pET21a for gpr and sspA), and used to transform DH5α. To 
construct a strain producing recombinant σK, PCR SOE was used to amplify the sigK 
gene lacking the skin element. Primer pair #689 and 736 was used to amplify the 5’ SOE 
product, while primer pair #735 and 737 was used to amplify the 3’ SOE product. The 
resulting fragments were mixed together, and the flanking #689 and #737 primers were 
used to amplify the sigK gene including the TAA stop codon. The resulting PCR product 
was digested with NcoI and XhoI, ligated to pET30a digested with the same enzymes, 
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and used to transform DH5α. The resulting pET22b-cd3522, pET22b-sigE, pET22b-
sigG, pET30a-sigK, pET22b-sigF, pET21a-gpr, pET22b-spoVT, and pET21a-sspA 
plasmids were used to transform BL21(DE3) for protein expression.  
 
2.4.3. C. difficile strain construction 
C. difficile strains were constructed using TargeTron-based gene disruption as 
described previously (Figure S1, [32,37,76]). TargeTron constructs in pJS107 were 
conjugated into C. difficile using an E. coli HB101/pK424 donor strain. HB101/pK424 
strains containing the appropriate pJS107 construct were grown aerobically to 
exponential phase in 2 mL of LB supplemented with ampicillin (50 µg/mL) and 
chloramphenicol (10 µg/mL). Cultures were pelleted, transferred into the anaerobic 
chamber, and resuspended in 1.5 mL of late-exponential phase C. difficile JIR8094 
cultures (grown anaerobically in BHIS broth). The resulting cell mixture was plated as 
seven 100 µL spots onto pre-dried, pre-reduced BHIS agar plates. After overnight 
incubation, all growth was harvested from the BHIS plates, resuspended in 2.5 mL pre-
reduced BHIS, and twenty-one 100 µL spots per strain were plated onto BHIS agar 
supplemented with thiamphenicol (10 µg/mL), kanamycin (50 µg/mL), and cefoxitin (16 
µg/mL) to select for C. difficile containing the pJS107 plasmid. After 24-48 hrs of 
anaerobic growth, single colonies were patched onto BHIS agar supplemented with 
thiamphenicol (10 µg/mL), kanamycin (50 µg/mL), and FeSO5 (50 µM) to induce the 
ferredoxin promoter of the group II intron system. After overnight growth, patches were 
transferred to BHIS agar plates supplemented with erythromycin (10 µg/mL) for 24-72 
hrs to select for cells with activated group II intron systems. Erythromycin-resistant 
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patches were struck out for isolation onto the same media and individual colonies were 
screened by colony PCR for a 2 kb increase in the size of spo0A (primer pair #556 and 
557), sigE (primer pair #687 and 688), sigG (primer pair #723 and 724), sigK (primer 
pair #689 and 690), and sigF (primer pair #790 and 791) (Figure S1). A minimum of two 
independent clones from each mutant strain was phenotypically characterized. 
 
2.4.4. C. difficile complementation 
HB101/pK424 donor strains carrying the appropriate complementation construct 
were grown in LB containing ampicillin (50 µg/mL) and chloramphenicol (20 µg/mL) at 
37˚C, 225 rpm, under aerobic conditions, for 6 hrs. C. difficile recipient strains spo0A–, 
sigE–, sigG–, sigK–, and sigF–, containing group II intron disruptions, were grown 
anaerobically in BHIS broth at 37˚C with gentle shaking for 6 hrs. HB101/pK424 
cultures were pelleted at 2500 rpm for 5 min and the supernatant was removed. Pellets 
were transferred to the anaerobic chamber and gently resuspended in 1.5 mL of the 
appropriate C. difficile culture. The resulting mixture was inoculated onto pre-dried, pre-
reduced BHIS agar plates, as seven 100 µL spots for 12 hrs. All spots were collected 
anaerobically and resuspended in 1 mL PBS. The resulting suspension was spread onto 
pre-dried, pre-reduced BHIS agar plates supplemented with thiamphenicol (10 µg/mL), 
kanamycin (50 µg/mL), and cefoxitin (10 µg/mL) at 100 µL per plate, five plates per 
conjugation. Plates were monitored for colony growth for 24-72 hrs. Individual colonies 
were struck out for isolation and analyzed for complementation by phase contrast 
microscopy, Western blot analysis and transmission electron microscopy. A minimum of 
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two independent clones from each complementation strain was phenotypically 
characterized. 
For the sigF complementation, a pMTL84151 plasmid backbone was used. The 
complementation protocol was followed as described except that after spots were 
collected from overnight growth on BHIS plates, the resulting PBS suspension was 
spotted onto three BHIS agar plates supplemented with thiamphenicol (10 µg/mL), 
kanamycin (50 µg/mL), and cefoxitin (16 µg/mL) with 7-100 µL spots per plate. 
 
2.4.5. Sporulation assay 
C. difficile strains were grown from glycerol stocks on BHIS plates supplemented 
with TA (0.1% w/v), or with both TA and thiamphenicol (5-10 µg/mL) for strains with 
pMTL83151-derived or pMTL84151-derived plasmids. Cultures grown on BHIS agar 
plates were then used to inoculate 70:30 agar plates (with thiamphenicol at 5-10 µg/mL 
as appropriate) for 18 - 48 hrs as previously described [37]. Sporulation induced lawns 
were harvested in PBS, washed once, resuspended in 0.2 mL of PBS, visualized by phase 
contrast microscopy, and/or further processed for analysis by transmission electron 
microscopy or Western blotting. 
 
2.4.6. Heat Resistance Assay 
C. difficile strains grown from glycerol stocks on BHIS plates supplemented with 
taurocholate and thiamphenicol (described above) were inoculated on to 70:30 media 
containing thiamphenicol (5-10 µg/mL).  After 30 hrs of growth, cells were harvested in 
1.0 mL PBS, and split into two tubes.  One tube was heat shocked at 60-65˚C for 25 
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minutes. Both heat-shocked and non-heat shocked cells were serially diluted, and cells 
were plated on pre-reduced BHIS-TA plates. After 20 hrs on BHIS-TA, colonies were 
counted, and cell counts were determined. The percent of heat-resistant spores was 
determined based on the ratio of heat-resistant cells to total cells, and sporulation 
efficiencies were determined based on the ratio of heat-resistant cells for a strain 
compared to wild type. Results are based on a minimum of three biological replicates. 
spo0A– containing empty vector was included as a control for all assays [77]. 
 
2.4.7. Fluorescence and light microscopy 
For fluorescence microscopy studies, C. difficile strains were harvested in PBS 
after 18 hours of growth on 70:30 media, pelleted, and resuspended in 1.0 mL PBS 
containing 1 µg/mL FM4-64 (Molecular Probes) and 15 µg/mL Hoechst 33342 
(Molecular Probes). The bacterial suspension (4 µL) was added to a freshly prepared 1% 
agarose pad on a microscope slide, covered with a 22 x 22 mm #1 coverslip and sealed 
with VALAB (1:1:1 of vaseline, lanolin, and beeswax) as previously described [78]. 
Phase and fluorescence microscopy were performed using a Nikon PlanApo 100X Ph3 
oil immersion objective (1.4 NA) on a Nikon Eclipse TE300 epifluorescence microscope. 
Five fields for each sample were acquired with an iXon3 885 EMCCD camera (Andor) 
cooled to -70°C with frame averaging set to 4 and an EM gain setting of 3, and driven by 
NIS-Elements software (Nikon). Images were subsequently imported into Adobe 
Photoshop CS6 for minimal adjustments in brightness/contrast levels and pseudocoloring. 
Phase-contrast microscopy for imaging the samples used for RNA-Seq was 
performed as previously described [37]. 
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Quantification of total cells undergoing sporulation was determined by analyzing 
multiple fields for each strain at random. Greater than 200 cells were enumerated for each 
strain.  For cultures analyzed by fluorescence microscopy, sporulating cells were 
identified as either having a polar septum with or without DNA staining in the forespore, 
a phase-dark forespore with or without DNA staining in the forespore compartment, a 
phase-bright forespore without DNA staining, or a free spore (no mother cell 
compartment).  
 
2.4.8. Electron microscopy 
 One hundred microliters of bacterial cell suspension samples from sporulation 
assays were prepared as previously described [37]. 
 
2.4.9. Western blot analyses 
Sporulation assay C. difficile cells (50 µL of PBS suspension) were freeze-thawed 
three times, diluted in 100 µL EBB buffer (8 M urea, 2 M thiourea, 4% (w/v) SDS, 2% 
(v/v) β-mercaptoethanol), and incubated at 95˚C for 20 min with vortexing every 5 min. 
Samples were centrifuged for 5 min at 15,000 rpm and 7 µL of 4X sample buffer (40% 
(v/v) glycerol, 1 M Tris pH 6.8, 20% (v/v) β-mercaptoethanol, 8% (w/v) SDS, and 0.04% 
(w/v) bromophenol blue), was added. Protein samples were incubated again at 95˚C for 
15 minutes with vortexing followed by centrifugation for 5 min at 15,000 rpm. SDS-
PAGE gels (12% - 15%) were loaded with 5 µL of protein prep. Gels were transferred to 
Bio-Rad PVDF membrane and blocked in 50% PBS:50% Odyssey® Blocking Buffer 
with 0.1% (v/v) Tween for 30 min at RT. Polyclonal rabbit anti-σE, anti-σG, anti-σF, anti-
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SpoIVA [37], and anti-CD1433 [76], anti-CD1067, anti-Gpr, anti-SpoVT, and anti-SspA 
antibodies were used at a 1:1,000 dilution and anti-σK, anti-CD1511, anti-SleC [76], and 
anti-CD3522 at a 1:5,000 dilution. Monoclonal mouse anti-Spo0A [37] was used at a 
1:10,000 dilution. IRDye 680CW and 800CW infrared dye-conjugated secondary 
antibodies were used at a 1:20,000 dilutions. The Odyssey LiCor CLx was used to detect 
secondary antibody fluorescent emissions for Western blots.  
 
2.4.10. Antibody production 
The anti-∆230aa-σE, anti-σG, anti-σK, anti-σF, anti-CD3522, anti-Gpr, anti-
SpoVT, and anti-SspA antibodies used in this study were raised in rabbits by Cocalico 
Biologicals (Reamstown, PA). The antigens ∆230aa-σE-His6, σG-His6, His6-σK, σF-His6, 
CD3522-His6, Gpr-His6, SpoVT-His6, and SspA-His6, were purified on Ni2+-affinity resin 
from E. coli strains #755, 743, 756, 921, 577, 853, 881, and #SspA respectively, as 
described above. Cultures were grown and protein expression was induced with 250 µM 
IPTG overnight at 19˚C. E. coli cells were harvested, pelleted, and resuspended in 25 mL 
of  low imidazole buffer (LIB; 500 mM NaCl, 50 mM Tris-HCl, pH 7.5, 15 mM 
imidazole, 10% (v/v) glycerol). Cells were flash frozen in liquid nitrogen, thawed, and 
lysed by sonication (45 sec burst followed by 5 min on ice for 3 cycles). For protein 
affinity purification, the lysate was centrifuged at 16,000 x g for 30 min, supernatant was 
collected and added to pre-washed Ni2+-affinity resin for 4 hrs at 4˚C. Bound beads were 
centrifuged at 2,000 x g for 2 min at 4˚C and washed once in LIB. Beads were 
reconstituted in 375 µL of high imidazole buffer (HIB; 500mM NaCl, 50mM Tris-HCl, 
pH 7.5, 200mM imidazole, 10% (v/v) glycerol), incubated on a nutator for 15 min at RT, 
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centrifuged, and eluate was collected.  Beads were reconstituted with HIB for a total of 
five sequential elutions. 
Polyclonal antibodies against CD1067 were raised in rabbits against a peptide 
derived from CD1067 (INSEDMRGFKKSHHC, Genscript); the polyclonal antibodies 
were affinity-purified using the indicated peptide (Genscript). 
 
2.4.11. RNA processing 
RNA for RNA-Seq was extracted from WT, spo0A–, sigE–, sigF–, sigG–, and 
sigK– C. difficile cell suspensions, from an 18 hr sporulation assay (described earlier), 
using a FastRNA Pro Blue Kit (MP Biomedical) and a FastPrep-24 automated 
homogenizer (MP Biomedical, setting 6.0, 45 seconds for 3 cycles). Contaminating 
genomic DNA was depleted using a column-bound DNase treatment with an RNeasy Kit 
(Qiagen) followed by two suspension DNase treatments (New England Biolabs), 
according to manufacturer’s recommendations. Samples were tested for genomic DNA 
contamination using quantitative PCR for 16S rRNA and the sleC gene. DNAse-treated 
RNA (5 µg) was mRNA enriched using a Ribo-Zero Magnetic Kit (Epicentre).  
RNA isolated for qRT-PCR was processed identically except that mRNA 
enrichment was done using an Ambion MICROBExpress Bacterial mRNA Enrichment 
Kit (Invitrogen). Reverse transcription of enriched RNA was done using the Super 
Script® First Strand cDNA Synthesis Kit (Invitrogen) with random hexamer primers.   
 
2.4.12. RNA-Seq library construction and sequencing 
Enriched mRNA (100 ng) was submitted to the Advanced Technology Genome 
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Center Core Lab at the University of Vermont for massively parallel sequencing on an 
Illumina HiSeq 1000. cDNA synthesis was carried out using the Ovation Prokaryotic 
RNA-Seq System (Nugen), according to manufacturer’s instructions. Libraries were 
prepared using the Ovation ultralow multiplex kit (Nugen, 0304/0305-32) according to 
manufacturer’s instructions. Briefly, samples were end-repaired, mono-adenylated, 
ligated to index/adaptors, and then amplified for 15 cycles (after a PCR titration was 
performed). Completed libraries were quantitated using a SYBR Fast Universal qPCR Kit 
(KAPA Biosystems). Paired end sequencing of samples was performed using a total of 10 
pM of library in each flow cell lane. The samples were indexed and pooled in equal 
amounts to generate equal read coverage.  
 
2.4.13. RNA-Seq Analysis 
Sequence calls and quality scores were produced in BCL format from images using 
Illumina RTA v1.13 with default parameters. Read pairs were mapped to libraries 
(demultiplexed) and converted to Fastq format using Illumina CASAVA 1.8.2 with 
default parameters. Adapters were clipped and reads were trimmed to remove the first 12 
and last 11 cycles using Trimmomatic [79], dropping read pairs for which at least one 
read was less than 50 bp.  The C. difficile 630 genome (NC_009089) sequence was 
modified by removing the sigK intervening (skin) element. The C. difficile 630 genome 
annotation was modified by the addition of sigK. Read pairs were aligned to the modified 
C. difficile 630 genome (NC_009089) using BWA 0.6.1 with default parameters with one 
exception (–q 20). Read pairs were mapped to NC_009089 gene annotation using the 
countOverlaps procedure of the R/Bioconductor IRanges package [80-82]. Counts 
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associated with rRNA were removed. Counts associated with the same library were 
pooled. Reads were of high quality (median Phred score of 39 and a first quartile of 35) 
as were alignments (median mapping quality score, MAPQ of 60). Median fragment 
lengths were between 180 and 250. 
The vast majority of unmapped sequences failed to align to sequences in the 
NCBI non-redundant database using a blastn and blastx search. There was no indication 
of highly represented reads among unmapped sequences. Since the majority of reads 
failed to map to known natural sequences, and since sequences can arise during library 
preparation particularly when the input sample is small, sequences that failed to map to 
the C. difficile genome likely represent spurious sequences produced during library 
construction.   
Differential expression statistics reflecting both effect size (fold-change) and 
statistical significance (p-value adjusted based on the method of Benjamini and Hochberg 
[83]) were calculated using DESeq [49]. Duplicate reads were excluded from these 
analyses. Differentially expressed genes were identified based on a minimum fold-change 
(higher in the reference sample than the query) and maximum p-value.  Tables showing 
genes whose expression was downregulated by ≥ 4-fold with an adjusted p-value of ≤ 
0.05 during sporulation are provided in the Supplementary Information (Tables S3-S10). 
A table showing genes whose expression was upregulated by ≥ 4-fold with an adjusted p-
value of ≤ 0.05 in a Spo0A-dependent manner are shown in Table S14. 
The log2-transformed expression of genes that were downregulated by ≥ 4-fold 
with an adjusted p-value of ≤ 10-5 in the spo0A– strain relative to wild type expression 
were represented in a heat map using the heatmap.2 procedure of the R/Bioconductor 
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gplots package with default options [84]. Expression levels in spo0A– were not shown 
because the differential expression between spo0A– and wild type was biased by the 
method used to select genes. Expression levels in the other four strains relative to spo0A– 
were centered, scaled, and mapped to a red-green color scale.  
 
2.4.14. Quantitative RT-PCR 
For the RNA-Seq validation, expression levels of gpr, cd0125 (spoIIQ), cd2376, 
cd1511, cd3522, spoIVA, cd1433, cd1067, sleC, sspB, spoVT, dacF, and rpoB 
(housekeeping gene) were run on WT, spo0A-, sigF- sigE-, sigG-, and sigK– cDNA 
templates in three replicate reactions using gene-specific primer pairs #1187 and 1188; 
#1213 and 1214; #1191 and 1192; #796 and 797; #989 and 990; #798 and 799; #792 and 
793; #1030 and 1031; #575 and 576; #810 and 811; #995 and 996; #993 and 994; #1002 
and 1003, respectively. Quantitative real-time PCR was performed using SYBR Green 
JumpStart Taq Ready Mix (Sigma), 50 nM of gene specific primers (Table S12), and an 
ABI PRISM 7900HT Sequence Detection System (Applied Biosystems). Mean CT values 
were normalized to the spo0A– (negative control) sample and further normalized to rpoB. 
Relative expression values reported are representative of three biological replicates.  
 
2.5. Results 
2.5.1. C. difficile sporulation sigma factors are essential for mature spore formation. 
In order to identify genes that are regulated by the sporulation-specific sigma 
factors, we used a modified TargeTron gene knockout system to disrupt the genes 
encoding σF, σE, σG, and σK in C. difficile [32]. This system uses a group II intron to 
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insert an erythromycin resistance cassette into the target gene (Figure S1A). JIR8094 
[33], an erythromycin-sensitive derivative of the sequenced C. difficile strain 630 [34], 
was used as the parental strain. As a control, we also constructed a targeted disruption in 
spo0A, which encodes the master regulator of sporulation Spo0A [35,36]. Colony PCR of 
the intron-disrupted mutants confirmed the expected size change resulting from the intron 
insertion into the spo0A, sigF, sigE, sigG, and sigK genes (Figure S1B).   
 To determine the effect of blocking sigma factor production on sporulation, the 
mutants were induced to sporulate on solid sporulation media and visualized by phase 
contrast microscopy [37]. It should be noted that sporulation is asynchronous in this 
assay, and the extent and timing of sporulation exhibits variability even between 
biological replicates (Figure S2). Nevertheless, after 18 hrs of growth, sufficient numbers 
of cells have initiated sporulation to detect the production of immature phase-dark 
forespores and mature phase-bright spores in the wildtype strain (Figure 1 and S2). In 
contrast, spo0A–, sigF–, sigE–, sigG–, and sigK– cultures failed to produce phase-bright 
spores (Figure 1). No phase-dark or phase-bright forespores were observed in the spo0A–, 
sigF–, or sigE– strains, suggesting a block early in sporulation.  
 Analysis of live, sporulating cultures with the lipophilic dye FM4-64 (to stain 
mother cell and forespore membranes) and Hoechst 33342 (to stain cell nucleoids) 
revealed polar septum formation in wild type and the sigma factor mutants but not in the 
spo0A– mutant (Figure 1). This result was consistent with the observation that Spo0A is 
necessary to induce the sporulation pathway in C. difficile [35,36]. Overall, the 
proportion of sporulating cells detected by membrane and DNA staining in the culture 
was 25%, 41%, 24%, 26%, and 18% for wildtype, sigF–, sigE–, sigG–, and sigK–, 
 74 
respectively, as indicated by the presence of a polar septum, immature forespore 
compartment, or mature forespore (Table S1). Wildtype cultures contained a 
heterogenous population of sporulating cells at discrete stages of sporulation: 28% of 
sporulating cells exhibited intense DNA staining of an FM4-64-labeled forespore 
compartment (yellow arrows, Figure 1, Table S1); 28% showed phase-dark forespores 
that stained with both FM4-64 and Hoechst (Table S1), 28% exhibited phase-dark 
forespores that stained intensely with FM4-64 but not Hoechst (green arrows, Figure 1, 
Table S1), and 16% contained a phase-bright forespore that failed to be stained with 
either FM4-64 or Hoechst (pink arrows, Figure 1, Table S1). In contrast, sigF– and sigE– 
sporulating cells were arrested at the asymmetric division stage, with 95% and 92% of 
sporulating cells, respectively, exhibiting intense DNA staining of an FM4-64-labeled 
forespore compartment (yellow arrows, Figure 1, Table S1). The sigG– mutant strain was 
arrested at the phase-dark forespore stage, with 69% of sporulating cells exhibiting 
intense forespore membrane and nucleoid staining (yellow arrows, Figure 1, Table S1). 
While only 4% of the sigG– cells were observed to produce forespores that stained only 
with FM4-64, 44% of sporulating sigK– cells were captured at this stage of sporulation, a 
phenotype that was also observed in wildtype (green arrows, Figure 1, Table S1). Taken 
together, these results indicate that all four sporulation sigma factors are required to 
complete spore formation and suggest that σG is necessary to complete the stage of 
sporulation development required to exclude the Hoechst dye from staining the forespore 
chromosome. The results are also consistent with studies investigating B. subtilis 
forespore development, which indicate that nucleic acid stains are excluded earlier than 
membrane stains during spore development [38-40].  
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 To confirm that the gene disruptions prevented sigma factor production in each of 
the respective sigma factor mutants, we performed Western blot analyses using 
antibodies raised against C. difficile sigma factors. Similar to B. subtilis, Spo0A was 
required for the production of all the factors, and σF was observed in the sigE–, sigG–, and 
sigK– strains at wildtype levels (Figure 2, [41]). σE was detected in both its pro- and 
cleaved form in wildtype, sigG– and sigK– strains, whereas the majority of σE was 
unprocessed in the sigF– strain (Figure 2). This result slightly deviates from the B. subtilis 
model, where pro-σE processing is completely abrogated in a B. subtilis sigF– strain [42]; 
in contrast, a C. perfringens sigF– mutant fails to produce pro-σE altogether [27], and σE 
processing has not been demonstrated in C. acetobutylicum [31]. σK was present in 
wildtype and sigG– mutant strains but absent in the sigF– and sigE– strains (Figure 2), 
analogous to observations in B. subtilis where σE is required for sigK expression. A C. 
perfringens sigE– strain in contrast produces low amounts of σK [28]. Consistent with the 
observation that C. difficile σK lacks an N-terminal pro-peptide [43], no processing of σK 
was observed in wildtype C. difficile (Figure 2), even though σK undergoes proteolytic 
activation in B. subtilis and C. perfringens [27]. σG was detected in the C. difficile sigF–, 
sigE– and sigK– mutants (Figure 2) in contrast with studies of other endospore-forming 
bacteria, where σG activity and auto-activation of sigG transcription is partially 
dependent on σE in B. subtilis [44-46], and σG production depends on σF in C. 
perfringens and C. acetobutylicum [27,30].   
We next performed transmission electron microscopy (TEM) to identify the 
precise developmental stage at which each sigma factor mutant was stalled. Cortex and 
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coat layers were present on forespores in wildtype sporulating cells, while the spo0A– 
mutant exhibited no signs of spore formation (Figure 3). The sigF– mutant failed to 
progress beyond asymmetric division (Figure 3), similar to a B. subtilis sigF– mutant [47] 
but in contrast with a C. acetobutylicum sigF– mutant which does not initiate asymmetric 
division [30]. Nevertheless, unlike B. subtilis, a more electron-translucent region in the 
mother cell cytosol surrounded by electron dense layers was observed in some sigF– 
mutant cells; this region resembled mislocalized spore coat ([37], Figure 3). The C. 
difficile sigE– strain was arrested at the asymmetric division stage similar to the sigF– 
mutant, although electron-translucent regions surrounded by coat-like layers were not 
observed in any sigE– cell analyzed. The C. difficile sigE– mutant phenotype resembled 
the phenotype of sigE– mutants of B. subtilis [47] and C. perfringens [28], with frequent 
observations of disporic cells or cells with multiple septa at one pole (Figures 1 and 3). 
This observation was in contrast with a C. acetobutylicum sigE– mutant, which does not 
complete asymmetric division [31]. The C. difficile sigG– mutant produced forespores 
lacking an apparent cortex layer, similar to B. subtilis [21,44]; however, unlike B. 
subtilis, the forespores were surrounded by thin layers that resembled the spore coat 
layers visible in wildtype cells (Figure 3). In addition, the C. difficile sigG– mutant 
exhibited pleiotropic defects including forespore ruffling, incomplete membrane fission 
during engulfment, and a septated forespore compartment (Figures 3 and S3). 
Quantitation of the prevalence of each phenotype revealed that forespore ruffling, 
incomplete engulfment, and a septated forespore compartment were observed in 98, 87 
and 21% of sigG– cells, respectively (Figure S3). Lastly, the C. difficile sigK- mutant 
produced forespores surrounded by a layer that resembled the cortex layer of wildtype, 
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but no coat layers were apparent (Figure 3). This phenotype was more similar to a B. 
subtilis sigK– mutant, which lacks both cortex and coat [22], than C. perfringens, which 
fails to initiate polar septum formation [28]. 
 
2.5.2. Plasmid complementation rescues the sporulation defects of sigF–, sigE– sigG–, 
and sigK– mutants. 
To validate that the observed mutant phenotypes were due to the targeted 
insertions, we complemented the mutant strains by expressing a wildtype copy of the 
gene encoding the corresponding sigma factor from a plasmid. We used either the 
pMTL83151 or pMTL84151 multicopy plasmids [48] to express the complementing 
genes or operons from their native promoters. The complementation constructs all 
restored production of phase-bright spores when expressed in their respective mutant 
backgrounds (Figure S4A), although phase-bright spore formation by the sigK 
complementation strain was delayed relative to wildtype. Western blot analysis further 
confirmed that the complementation constructs restored production of the respective 
sigma factor to wildtype levels (Figure S4B). TEM analysis revealed that all four 
complementation constructs restored coat and cortex formation to their respective mutant 
strains (Figure S5). Heat resistance assays to measure complementation strain sporulation 
efficiency revealed that the sigF– and sigE–constructs fully complemented heat resistance 
relative to wildtype and that the sigG– and sigK– constructs partially complemented heat 
resistance (70 and 23%, respectively, Figure S4C).  
 
2.5.3. RNA-Seq analysis reveals the regulatory relationships between C. difficile 
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sporulation sigma factors. 
While these analyses showed that σF, σE, σG, and σK were all required for mature 
spore formation, they did not reveal which genes were being misregulated in the 
sporulation sigma factor mutants to produce their respective sporulation defects. To 
identify these genes and gain insight into the regulatory network controlling sporulation 
sigma factor activity, we used RNA-Sequencing (RNA-Seq) to transcriptionally profile 
our sporulation mutants and wild type during sporulation. Three biological replicates of 
wildtype, spo0A–, and sporulation sigma factor mutant strains were grown on sporulation 
media (Figure S2), and RNA was isolated. Following DNase-treatment, ribosomal RNA 
depletion and reverse transcription, Illumina-based RNA-Seq was used to determine the 
complete transcriptome of wildtype C. difficile and the sporulation mutants. Genome 
coverage and sequencing counts for each strain and replicate can be found in Table S2. 
The DeSeq variance analysis package [49] was used to identify genes that were 
downregulated by ≥ 4-fold with an adjusted p-value of ≤ 0.05 in the spo0A– strain relative 
to wild type. This pair-wise analysis identified 276 genes as being Spo0A-dependent 
(Table S3). Consistent with the role of Spo0A as the master regulator of sporulation, 65 
of these genes were predicted to be involved in sporulation (Table S4) [11,50-52]. Six of 
these Spo0A-dependent genes were recently identified as encoding components of the C. 
difficile spore coat [50,53], and 36 sporulation-related genes (Table S4) were shown to 
depend on σH, the stationary phase sigma factor that induces spo0A transcription in C. 
difficile [51] and B. subtilis [54]. σF-, σE-, σG-, and σK-dependent genes were identified 
by comparing the transcriptional profiles of the sigF–, sigE–, sigG–, and sigK– strains to 
wild type, respectively, using the same parameters as above. This analysis identified 183 
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genes as being dependent on σF for their expression (Table S5). One hundred eighteen of 
these σF-dependent genes were also σE-dependent (Table S6), indicating that σE has some 
activity in a sigF– mutant consistent with the reduced levels of cleaved σE being detected 
by Western blot (Figure 2); 29 of the σF-dependent genes formed a separate subset of 
genes that were also σG-dependent but σE-independent. Indeed, the majority of the 34 σG-
dependent genes identified in this analysis were not dependent on σE for their expression 
(Table S7), since only four of the σG-regulated genes were also σE-regulated. Notably, 
none of the genes identified as being σG-dependent required σK for their expression 
(Table S8), suggesting that the σG produced in the sigE– and sigK– mutants is active 
(Figure 2). This result differs from the B. subtilis model where σE is needed to fully 
activate σG function [20,21,46,55,56]. 
Of the 169 genes that depended on σE for their expression (Table S6), 85% and 
78% of these genes were dependent on Spo0A and σF, respectively (Figure 4). The 
expression of 29 of these genes was also σK-dependent (Table S5). Indeed the majority of 
the 31 σK-dependent genes were σE-dependent (Table S8; Figure 4), consistent with σE 
being required for σK production (Figure 2). In contrast, as described earlier, no overlap 
was observed between σG- and σK-dependent genes (Figure 4). Taken together, the RNA-
Seq analyses suggested that (1) a small subset of σF-dependent genes are neither σE, σG, 
nor σK-dependent; (2) σE activity depends on Spo0A and σF but not σG or σK; (3) σK 
activity depends on Spo0A, σF, and σE but not σG, and (4) σG activity depends on Spo0A 
and σF but not σE or σK. The latter two findings differ from the B. subtilis model, where 
the σK-dependent genes are also σG-dependent because σK activity depends on σG 
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[11,15,22], and σG-dependent genes are σE-dependent because full activation of σG 
requires σE [20,21,46,55,56]. 
To visually represent the differences in gene expression profiles between the 
sigma factor mutants and wild type, we generated a heat map for genes downregulated by 
≥ 4-fold with an adjusted p-value of ≤ 10-5 in the spo0A– strain relative to wild type. The 
expression levels of wild type and the sigma factor mutants relative to spo0A– strain were 
centered, scaled, and mapped to a red-green color scale. The heat map revealed a cluster 
of genes that was poorly expressed in the sigE– mutant relative to the wildtype, sigG–, 
and sigK– strains; these genes were also expressed at reduced levels in the sigF– mutant 
(Figure 5) and were primarily σE-dependent (Table S4). A separate cluster of genes was 
downregulated in both the sigK– and sigE– mutants relative to the wildtype and sigG– 
strains (Figure 5); these genes were all identified as σK-dependent genes (Table S5). 
Another discrete cluster of genes was downregulated in the sigG– and sigF– strains 
relative to the wildtype, sigE–, and sigK– strains (Figure 5); again, most of these genes 
were identified as σG-dependent genes, although two genes were σF-dependent but not 
σG-dependent (Tables S5 and S7). Thus, identification of variably expressed genes 
between the strains confirmed the findings of our earlier pair-wise analyses: σF-
dependent genes were largely Spo0A-dependent, σE-dependent genes were largely σF-
dependent, σK-dependent genes were σE-dependent, and σG-dependent genes were σF-
dependent but not σE- or σK-dependent. These results support a model where (1) σF 
controls the activation of both σE and σG, (2) σE induces the production and activation of 
σK, and (3) σE and σK are dispensable for σG activation. Alternative statistical models 
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were also employed to validate these findings (see Text S1 and Figures S6 and S7).  
 
2.5.4. Quantitative RT-PCR validates the RNA-Seq Data 
To validate the RNA-Seq data, we isolated RNA from three separately prepared 
biological replicates of wildtype, spo0A–, sigF–, sigE–, sigG–, and sigK– strains grown on 
sporulation media for 18 hrs. RNA was reverse transcribed and quantitative RT-PCR 
(qRT-PCR) was performed using primers specific for three genes within each of the 
sigma factor-dependent transcriptomes. Gene expression levels in the wildtype and the 
sigma factor mutant strains relative to spo0A– were determined by comparative CT 
analysis normalized to the housekeeping gene rpoB. These analyses confirmed that the 
transcript levels of the σF-dependent gene gpr was reduced by > 50-fold (p < 0.0001) in 
the sigF– mutant relative to wild type, and reduced in the sigG– mutant by ~4 fold (p < 
0.01); gpr expression was not affected in the sigE– and sigK– mutants. cd0125 (spoIIQ, 
[13]) transcription was reduced by > 10-fold in the sigF– mutant relative to wild type (p < 
0.01), but no reduction in transcript levels was observed in sigE–, sigG–, and sigK– 
mutants (Figure 6A). Transcription of cd2376 was reduced by 3-fold in the sigF– relative 
to wild type (Figure 6A). Although this correlation was not statistically significant, it 
approached statistical significance (p = 0.065) (Figure 6A); this result is likely due to the 
low number of overall cd2376 transcripts present in the samples. Transcript levels of the 
σG-dependent genes spoVT, sspB, and dacF showed significant reductions in the sigG– (p 
< 0.0004, < 0.0002 and < 0.0001, respectively) and sigF– mutants (p < 0.0001) compared 
to wild type but no significant reduction in the sigE– and sigK– mutants relative to wild 
type (Figure 6B). This observation was consistent with the RNA-Seq data indicating that 
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σG activity depends on σF, although it is likely that σF directly induces the transcription 
of some σG-dependent genes given the predicted overlap in their promoter specificities 
[11]. Nevertheless, given that σG is present at wildtype levels in a sigF– strain, these 
observations suggest that σF regulates σG activity through a post-translational 
mechanism.  
σE-dependent genes cd3522 and spoIVA were reduced by >100-fold, and cd1511 
by > 50-fold, in sigE– relative to wild type, (p < 0.0001, < 0.0001, and < 0.006, 
respectively), but not in sigG– and sigK– mutants (Figure 6C). Transcript levels of these 
σE-dependent genes were reduced by ~5 to 6-fold (p < 0.01) in the sigF– mutant relative 
to wildtype, indicating that, in the absence of σF, σE activity is reduced but detectable. 
Transcript levels of the σK-dependent genes cd1433, cd1067 and sleC were significantly 
reduced by >100-fold in the sigE– (p < 0.0001 for each gene) and the sigK– (p < 0.0001 
for each gene) strains compared to wild type (Figure 6D). σK-dependent gene expression 
was reduced in the sigF– mutant by 8 to 10-fold (p < 0.01), suggesting that σK has 
reduced but detectable activity in the sigF– strain. Importantly, no statistically significant 
change for any of these σK-dependent genes was observed in the sigG– mutant relative to 
wild type, consistent with the RNA-Seq results indicating that σK activity does not 
depend on σG (Figures 4 and 5). Altogether, the qRT-PCR data validated the RNA-Seq 
data identifying σF, σE, σG, and σK-dependent genes and confirmed that (1) σE, σG, and 
σK activity depend on σF, (2) full σG activity requires σF but not σE, and (3) σK activity 
requires σE but not σG. It should be noted however that, although σF is required for full 
σE and σK activity, some degree of σE- and σK-dependent gene expression is observed 
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even in the absence of σF.  
 
2.5.5. Western blot analyses confirm that σK activity depends on σE but not σG 
Having validated the RNA-Seq data at the transcript level, we next investigated 
whether changes in transcript levels correlated with changes in protein levels for σF-, σE-, 
σG-, and σK-regulated genes. To this end, we raised antibodies against proteins encoded 
by genes identified by RNA-Seq as being σF-, σE-, σG-, and σK-dependent. Western blot 
analyses of the germination protease Gpr confirmed that only σF is required for gpr 
expression, while production of the regulatory protein SpoVT and the small acid-soluble 
protein SspA depended on both σF and σG. These results indicate that σG can directly 
activate the expression of spoVT and sspA (Figure 7). Western blot analyses for CD3522, 
SpoIVA, and CD1511 demonstrated that their production depends on σE but not σG or 
σK; these proteins were detected, albeit at greatly reduced levels, in the sigF– mutant 
(Figure 7). These results were consistent with the observation that active, processed σE is 
present in both sigG– and sigK– strains, while only trace amounts of processed σE could 
be detected in the sigF– strain (Figure 2). Analysis of σK-dependent protein production 
using antibodies specific for CD1433, CD1067 and SleC confirmed that these proteins 
were absent in the sigE– and sigK– mutants and present in wild type and the sigG– mutant 
(Figure 7). Only SleC was reliably detected in the sigF– mutant, even though cd1433 and 
cd1067 transcripts could be detected in the sigF– strain (Figure 6D). Nevertheless, taken 
together these observations confirm that (1) σF does not require σE, σG, or σK for 
activation, (2) full σE activation requires σF, (3) full σG activation requires σF but not σE 
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or σK, and (4) σK activation requires σF and σE but not σG.  
 
2.6. Discussion 
The regulation of sporulation in the Clostridia has remained poorly characterized 
relative to the model spore-forming bacterium B. subtilis because the function and 
activity of all four sporulation sigma factors has not been simultaneously interrogated in a 
given Clostridium sp. to date. By constructing mutations in genes encoding for individual 
sporulation sigma factors in the nosocomial pathogen C. difficile and performing whole 
genome transcriptional profiling on these mutants, we identified 314 genes whose 
expression is activated during sporulation (Table S9) in a Spo0A, σF-, σE-, σG-, and/or 
σK-dependent manner (Tables S3, S5-S8). These experiments reveal that the sporulation 
pathway of C. difficile exhibits numerous differences relative to B. subtilis and other 
Clostridium spp., highlighting the diversity of mechanisms that regulate sporulation 
sigma factor activity in the Firmicutes.  
 
Diverse mechanisms regulate sporulation sigma factor activity in the Firmicutes 
While mutation of all four sporulation sigma factors in C. difficile abrogated 
functional spore formation, as expected given the strict conservation of these factors 
among endospore formers [11], the function and regulation of these sigma factors in C. 
difficile diverged from the regulatory pathways determined for B. subtilis and other 
Clostridium spp. The differences in C. difficile, C. perfringens, C. acetobutylicum, and B. 
subtilis are summarized in Figure 8, as are the similarities in the pathways.  
Similar to B. subtilis, our transcriptional and cytological analyses reveal that C. 
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difficile σK functions downstream of σE to regulate late-stage sporulation events, and σG 
functions downstream of σF to regulate forespore maturation (Figures 2 and 6). In 
contrast with B. subtilis, C. difficile σG is fully active in the absence of σE, and σK is fully 
active in the absence of σG (Figures 6 and 7). The latter observation could have been 
anticipated given that C. difficile σK lacks an N-terminal pro-peptide, in contrast to all 
other spore formers [43]. However, the former observation was unexpected because σE-
regulated gene products function to activate σG in the forespore of B. subtilis, initiating a 
positive feedback pathway that increases σG levels through auto-activation of the sigG 
promoter [44,46,57]. In particular, B. subtilis σG activation requires the formation of a 
σE-dependent “feeding tube” [20,21,55,58,59], which maintains forespore integrity by 
transporting small molecules from the mother cell into the forespore [20,21,55]. This 
mode of regulation couples the activation of the forespore-specific σG to σE-controlled 
events in the mother cell. In contrast, our results indicate that C. difficile σG is active in 
the absence of σE-dependent feeding tube gene expression (Figures 5 and 6, Tables S6 
and S7). Nevertheless, even though σG was active at wildtype levels in the sigE– mutant 
(Figures 6 and 7), it remains possible that σG activity may be mislocalized in the mother 
cell cytosol, similar to the premature activation of σG in Lon– and anti-σG sigma factor 
CsfB– cells [57,60,61]. 
Even though C. difficile σG can be fully activated in the absence of σE, our results 
further show that σG is post-translationally activated in a σF-dependent manner (Figures 2 
and 6). These results raise the intriguing question as to how σF activates σG independent 
of σE in C. difficile. In B. subtilis, multiple post-translational mechanisms control σG 
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activity; however, aside from the feeding tube, these mechanisms are inhibitory rather 
than activating. In B. subtilis the Lon protease reduces σG activity in the mother cell [60], 
while the anti-σ factors SpoIIAB [57,62] and CsfB (also known as Gin) [61,63,64] 
prevent σG activity in the forespore until engulfment is complete. Whether these factors 
inhibit σG activity in C. difficile is unknown, although C. difficile does not appear to 
encode a CsfB homolog. In future studies, it will be interesting to determine whether σF 
functions to activate σG directly or alleviate its inhibition, and whether C. difficile 
sporulation sigma factors exhibit compartment-specific activity similar to B. subtilis.  
Interestingly, the morphology of the C. difficile sigG– mutant differed 
considerably from a B. subtilis sigG– mutant. While B. subtilis sigG– mutant forespores 
are normal in appearance despite lacking both a coat and cortex [44], C. difficile sigG– 
mutant forespores produced layers resembling spore coat around the forespore and 
exhibited defects in engulfment and structural integrity (Figures 3 and S3). The forespore 
membrane ruffling phenotype of C. difficile sigG–mutants was reminiscent of B. subtilis 
feeding tube mutant phenotypes [21], suggesting that σG may encode proteins required to 
“nurture” the C. difficile forespore. Alternatively, σG could regulate a cytoskeletal or 
cortex component that confers structural integrity to the forespore. Such proteins could be 
represented in the σG-regulated genes identified in this study (Table S7).  
The phenotype of the C. difficile sigF– mutant also differed from its cognate 
mutant in B. subtilis, since the sigF– mutant produced low levels of σE- and σK-induced 
gene products (Figure 7) and regions that resembled mislocalized coat in the mother cell 
cytosol (Figure 3) [47]. In B. subtilis, σF is required to activate the expression of spoIIR, 
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which encodes an intercellular signaling protein that activates SpoIIGA, the protease 
responsible for activating pro-σE [65,66]. Whether the trace amounts of σE processing 
observed in the C. difficile sigF– mutant results from low-level expression of spoIIR or 
spoIIGA, or whether an unknown protease activates σE, remains to examined. 
Comparison of the sporulation pathway of C. perfringens relative to C. difficile 
indicates that both organisms proteolytically activate σE in a σF-dependent manner 
(Figure 2), although it should be noted that a C. perfringens sigF– mutant does not make 
σE, σG, or σK [27] in contrast with C. difficile (Figure 2). Since the phenotypes of C. 
perfringens sigF– and sigG– mutants have not been examined by electron microscopy, the 
precise stage at which they are arrested remains unclear. Nevertheless, unlike C. 
perfringens (and C. botulinum) where σK is essential for both early and late stage 
sporulation events (Figure 8) [28,29], C. difficile σK is needed only at late stages of 
sporulation. Furthermore, C. perfringens σK is produced at low levels in an unprocessed 
form in a sigE– mutant; σE is made at low levels in a C. perfringens sigK– mutant; and 
sigE and sigK expression appear to be auto-activated [28]. In contrast, no sigK expression 
was observed in the absence of σE in C. difficile. 
The sporulation pathway of C. difficile appears to be most similar to the C. 
acetobutylicum pathway. Both C. difficile and C. acetobutylicum sigma factors σF, σE, 
and σG appear to function at similar stages of sporulation, although C. acetobutylicum 
sigF– and sigE– mutants exhibit more severe phenotypes than in C. difficile in that they 
fail to initiate and complete asymmetric division, respectively [30,31], and σF is required 
to activate sigG transcription in C. acetobutylicum [30] unlike C. difficile. Similar to C. 
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difficile, however, C. acetobutylicum σG does not require σE for auto-activation of sigG 
expression, although it is unclear whether C. acetobutylicum σG is active in the absence 
of σE [31]. Lastly, loss of sigG expression in C. acetobutylicum results in pleiotropic 
defects in coat and cortex formation and forespore integrity similar to C. difficile (Figure 
3, [31]). Since a sigK– mutant in C. acetobutylicum has not been described, it will be 
interesting to determine whether C. acetobutylicum σK function is more similar to C. 
difficile than to C. perfringens and whether these differences correlate to the presence of 
the skin element, an ~15 kb prophage-like element that interrupts the sigK gene in C. 
difficile but not other Clostridium spp. [43]. Nevertheless, our collective transcriptional 
and cytological analyses of sporulation sigma factor function in C. difficile suggest that 
novel mechanisms regulate σG and σK activation relative to other spore-forming 
organisms (Figure 8). Further studies are needed to determine the regulatory interplay 
between C. difficile sporulation sigma factors and their downstream auxiliary regulators 
SpoVT and SpoIIID, which modulate the expression of σG- and σK-regulated genes, 
respectively, in B. subtilis [24,26,67,68] and are conserved in Clostridium spp. 
 
Transcriptional profiling of sporulation in C. difficile identifies new sporulation 
genes 
By performing whole genome transcriptional profiling on the different sporulation 
sigma factor mutants, we have identified distinct subsets of genes that are σF-, σE-, σG-, 
and σK-dependent. The number of genes determined to be σG-dependent in C. difficile 
was relatively small (34 genes) relative to B. subtilis, where the σG regulon comprises 
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~100 genes [11,25,26]. Similarly, the σE and σK-dependent genes (169 and 31 genes, 
respectively) identified by our study were smaller than their cognate regulons in B. 
subtilis (270 and 150 genes, respectively, [24]). While the parameters we used to define 
genes as being σF-, σE-, σG-, and σK-dependent were relatively stringent, relaxing these 
parameters did not result in large increases in gene numbers. One explanation for the 
smaller size is that C. difficile activates fewer genes during sporulation than B. subtilis. A 
more likely explanation is that the asynchronous population of sporulating cells (Figures 
1 and S2, [37]) limits the detection of genes that are transiently expressed during discrete 
stages of sporulation or genes that are expressed at low levels during sporulation [24-
26,69]. Since the RNA samples used in the RNA-Seq analysis were harvested from a 
sporulation timepoint in which phase-bright forespores were produced by wildtype cells 
(Figure S2), fewer cells in the population are likely to be at early stages sporulation. As a 
result, early sporulation genes may be under-represented in our data set; for example, σF-
dependent early sporulation gene transcripts from spoIIR and spoIIP were almost 
undetectable by RNA-Seq (Table S4). In addition, genes that are regulated by more 
complex mechanisms beyond upregulation by a specific sigma factor are likely to be 
under-represented in our data set. Sporulation genes that are subject to incoherent feed 
forward loop regulation, in which their expression is induced by a given sigma factor and 
repressed by a downstream regulator such as SpoVT-mediated inhibition of sigG 
transcription in B. subtilis [26], may not be detected in our data set. Unraveling the 
complexities of sporulation gene regulation in C. difficile will require further 
characterization of the kinetics of sporulation and the analysis of mutants defective in 
auxiliary sporulation regulators. 
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Of the 51 genes proposed to comprise the core set of sporulation genes in spore-
forming Firmicutes by bioinformatics analyses that are conserved in C. difficile [13], 34 
were identified in our RNA-Seq analyses, leaving 17 that were not identified in our 
transcriptional analyses (Table S4). Seven of these genes do not have detectable 
homologs in the 630 C. difficile genome, and 6 were expressed at low levels with a base 
mean of expression less than 15 (Table S4).  
Although some sporulation-induced genes were likely not detected in our analyses 
due to low levels of expression, the transcriptional profiling data presented here identify a 
promising set of genes that are likely to encode proteins with important roles in spore 
formation. Of the six spore coat proteins recently identified in a proteomic analysis of C. 
difficile [50,53], all were identified in our RNA-Seq experiments. Three of these spore 
coat genes were determined to be σK-dependent, consistent with their predicted role as 
components of the outer coat (Table S4). Notably, σK-regulated genes were among the 
most abundantly expressed genes induced during sporulation, comprising 6 of the 10 
most highly expressed sporulation genes (Table S9). The σK-regulated CD1067 gene was 
the most highly expressed gene induced during sporulation in C. difficile. Cysteine-rich 
CD1067 was also one of the most abundant spore proteins identified in proteomic 
analyses of purified spores and is encoded in a 7.5 kB region enriched in genes encoding 
spore proteins [70]. Western blot analyses of cysteine-rich CD1067 revealed that it forms 
higher order multimers that are highly resistant to denaturing conditions (data not 
shown), consistent with the proposal that CD1067 may form a rigid, disulfide-bonded 
structure around the spore coat upon exposure to atmospheric oxygen, for example during 
excretion from the host [70]. Intriguingly, CD1067 is encoded in a region enriched in 
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highly expressed, σK-regulated genes encoding hypothetical proteins unique to C. 
difficile, with 8 of the 9 genes in this region being induced during sporulation and 6 of the 
9 being σK-regulated. These genes may encode coat proteins that confer structural 
integrity and/or resistance to the C. difficile spore coat and thus may play important roles 
in disease transmission and/or represent good candidates for developing diagnostic 
reagents. 
Although the number of σG-dependent genes identified by our study was small, a 
number of these genes encode proteins with important functions in the forespore of B. 
subtilis, specifically sspA, sspB, dacF, spoVT, and spoVAD [26,67,71-73]. Since B. 
subtilis σG induces the expression of genes encoding the germinant receptors (of which 
there are no homologs in C. difficile [12,34]), it seems likely that some of the σG-
dependent genes identified in our study encode proteins that transduce the germinant 
signal into the spore core. It will be interesting to determine whether any of the σG-
regulated genes identified in our study play important roles in regulating germination and 
thus disease transmission. 
Genes encoding hypothetical proteins were the most abundant class of genes 
identified in our study (82 in total, Table S10). Twenty of these hypothetical proteins 
were detected in proteomic analyses of C. difficile spores [70]. Indeed, two of the 
hypothetical proteins were previously shown to be part of the spore coat [50], and we 
have validated three additional proteins as localizing to the spore coat (data not shown). 
BLAST searches with the hypothetical proteins identified by RNA-Seq indicate that 16 
have no known homologs. These C. difficile-specific proteins could comprise part of the 
spore coat, since coat proteins are often poorly conserved, species-specific, and 
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categorized as hypothetical proteins [10,11].  
 Taken together, by examining the regulatory interplay between sporulation sigma 
factors in C. difficile, our study highlights that diverse pathways regulate sporulation in 
the Firmicutes and that considerable work is needed to map these pathways in the 
Clostridia. By using whole genome transcriptional profiling to define a large set of genes 
that are activated by Spo0A, σF, σE, σG, and/or σK, our study also provides a framework 
for identifying new proteins that are necessary for sporulation and determining the role of 
these proteins in forming a functional, infectious spore. Studies of this nature may lead to 
the identification of biomarkers for C. difficile spores and candidates for vaccine 
development. 
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Table 1. C. difficile strains used in this study. 
Strain  C. difficile strain Relevant genotype or features 
11 JIR8094 
erm-sensitive derivative of 630 
[33] 
13 630 Clinical isolate 630 [34] 
35 spo0A– JIR8094 spo0A::ermB 
50 sigE– JIR8094 sigE::ermB 
67 sigK– JIR8094 sigK::ermB 
71 JIR8094/pMTL84151 JIR8094/pMTL84151 
99 sigG– JIR8094 sigG::ermB 
106 sigF– JIR8094 sigF::ermB 











159 sigK–/pMTL83151 JIR8094 sigK::ermB/pMTL83151 











222 sigF–/pMTL84151-spoIIAA-spoIIAB-sigF JIR8094 sigF::ermB/pMTL84151-spoIIAA-spoIIAB-sigF 




Table S1. Quantitation of sporulating cell phenotypes. 
 
Percentage of cells with phenotype WT sigF– sigE– sigG– sigK– 
1. Polar septum detected by FM4-64; forespore 
does not stain with Hoechst 0 2 2 2 0 
2. Polar septum detected by FM4-64; forespore 
stains with Hoechst 7 39 22 5 6 
3. Phase-dark forespore detected with FM4-64 
and Hoechst 7 0 0 18 4 
4. Phase-dark forespore detected with FM4-64 
but not Hoechst 7 0 0 1 8 
5. Phase-bright forespore: no FM4-64 or 
Hoechst staining 4 0 0 0 0 
% Total Sporulating Cells 25 41 24 26 18 
 
 
C. difficile strains JIR8094 (WT), sigF–, sigE–, sigG–, and sigK– exhibit asynchronous 
sporulation when grown on sporulation induction media for 18 hours. Phase-contrast 
microscopy and fluorescence light microscopy using the membrane stain FM4-64 and the 
nucleic acid dye Hoechst was used to analyze sporulation in the indicated strains. A cell 
was deemed positive for sporulation if it fell into one of five criteria: (1) a polar septum 
was detected by FM4-64, but the forespore did not stain with Hoechst; (2) Polar septum 
was detected by FM4-64, and the forespore stained with Hoechst; (3) a phase-dark 
forespore stained with both FM4-64 and Hoechst; (4) A phase-dark forespore stained 
with FM4-64 but not Hoechst, or (5) a phase-bright forespore was visible, but it failed to 
stain with either FM4-64 or Hoechst. The percent of total sporulating cells reflects the 
number of events that fall within the stated criteria relative to the total number of cells. A 





Table S2. Summary of RNA-Seq data analysis.  









WT.1 113,947,550 14,264,583 99,682,967 12.5 6,852,557 
WT.2 80,537,138 15,040,885 65,496,253 18.7 7,226,927 
WT.3 16,743,541 1,659,364 15,084,177 9.9 792,548 
spo0A–.1 71,253,577 10,567,744 60,685,833 14.8 5,065,585 
spo0A–.2 112,106,468 16,274,770 95,831,698 14.5 7,847,403 
spo0A–.3 73,104,929 8,568,662 64,536,267 11.7 4,100,037 
sigF–.1 69,900,223 10,521,022 59,379,201 15.1 5,034,154 
sigF–.2 51,963,822 11,201,068 40,762,754 21.6 5,358,384 
sigF–.3 143,499,590 16,357,171 127,142,419 11.4 7,804,423 
sigE–.1 102,404,015 14,617,494 87,786,521 14.3 7,000,863 
sigE–.2 120,157,280 17,366,729 102,790,551 14.5 8,332,138 
sigE–.3 96,783,023 11,093,658 85,689,365 11.5 5,301,435 
sigG–.1 98,108,051 15,169,368 82,938,683 15.5 7,278,297 
sigG–.2 83,085,195 18,162,565 64,922,630 21.9 8,711,979 
sigG–.3 81,216,196 16,303,158 64,913,038 20.1 7,852,446 
sigK–.1 96,155,400 12,270,298 83,885,102 12.8 5,730,184 
sigK–.2 101,062,343 10,704,279 90,358,064 10.6 5,029,183 
sigK–.3 118,029,725 11,103,107 106,926,618 9.4 5,176,107 
 
Strain.Rep refers to the strain name followed by the replicate number. Three biological 
replicates were processed for RNA-Seq analyses for each strain. WT refers to the parental 
JIR8094 strain. The total number of reads obtained and mapped to the genome is 
indicated. % mapped refers to the percentage of reads that mapped to the C. difficile 
genome. The >90% of the unmapped reads did not map to sequences in the NCBI 






Table S3. Spo0A-dependent (activated) genes. 
doi:10.1371/journal.pgen.1003660 
Table S4. Sporulation-related genes.  
doi:10.1371/journal.pgen.1003660 
Table S5. σF-dependent genes.  
doi:10.1371/journal.pgen.1003660 
Table S6. σE-dependent genes.  
doi:10.1371/journal.pgen.1003660 
Table S7. σG-dependent genes.  
doi:10.1371/journal.pgen.1003660 
Table S8. σK-dependent genes.  
doi:10.1371/journal.pgen.1003660 
Table S9. Genes induced in a Spo0A-, σF-, σE-, σG- and σK-dependent manner during 
growth on sporulation media.  
doi:10.1371/journal.pgen.1003660 
Table S10. Genes encoding hypothetical proteins induced during sporulation.  
doi:10.1371/journal.pgen.1003660
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Table S11. E. coli strains used in this study. 
Strain  
Relevant genotype or features Source or 
reference 
DH5α 
F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 
hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 
relA1 D. Cameron 
BL21(DE3) F– ompT hsdSB(rB–, mB–) gal dcm (DE3) Novagen 
HB101 
F- mcrB mrr hsdS20(rB- mB-) recA13 leuB6 ara-13 
proA2 lavYI galK2 xyl-6 mtl-1 rpsL20 C. Ellermeier 
7 pET22b in DH5α D. Higgins 
269 pET28a in DH5α M. Bogyo 
547 pET28a-cd3580 in BL21(DE3) Novagen 
556 pJS107 in DH5α J. Sorg 
577 pET29a-cd3522 clone 4 in BL21(DE3) This study 
659 pJS107-sigE targeting bp 119 HB101/pK424 This study 
680 pJS107-sigK targeting bp 230 in HB101/pK424 This study 
686 pMTL83151 in HB101/pK424 This study 
655 pMTL83151 in DH5α This study 
701 pMTL84151 in DH5α This study 
703 pMTL843151 in HB101/pK424 This study 
735 pJS107-sigG targeting bp 546 in HB101/pK424 This study 
743 pET22b-sigG in BL21(DE3) This study 
755 pET22b-∆23aa sigE in BL21(DE3) This study 
756 pET30a-sigK(TAA) in BL21(DE3) This study - SOE 
782 pJS107-sigF 459 in HB101/pK424 This study 
811 pMTL83151-spoIIGA-σE in HB101/pK424 This study 
812 pMTL83151-sigG in HB101/pK424 This study 
813 pMTL83151-sigK in HB101/pK424 
This study - 
SOE 
853 pET21a-GPR in BL21(DE3) This study 
854 pET21a-sspA in BL21(DE3) This study 
869 pMTL84151-spoIIA-spoIIAB-sigF in HB101/pK424 This study 
881 pET22b-spoVT in BL21(DE3) This study 




Table S12. Plasmids used in this study. 
Plasmids Relevant features 
Source or 
reference 
pET22b bla Novagen 
pET28a kan Novagen 
pRSFduet1 kan Novagen 
pK424 Tra+ Mob+; bla, tet C. Ellermeier 
pJS107 
TargeTron construct based on pJIR750ai (group II 
intron ermB::RAM, ltrA); catP J. Sorg 
pCE245 
TargeTron construct based on pJIR750ai (group II 
intron ermB::RAM, ltrA); catP C. Ellermeier 
pMTL83151 pCB102, Tra+; catP 
N. Minton, 
[9] 






Table S13. Primers used in this study. 
Primer Name Sequence 
596 5' NdeI CD3522  AGCCATATGGGTTCTAAAAGAAAGTTTAAAAGAG 
597 3' XhoI CD3522 AACGCTCGAGCCTAACTATATTTCTTTGTCTAG 
532 3' Universal EBS CGAAATTAGAAACTTGCGTTCAGTAAAC 
539 5' IBS1.2 spo0A 178 
AAAAAAGCTTATAATTATCCTTATTATTCCATCTAGTGCG
CCCAGATAGGGTG 
540 3' EBS1d spo0A 178 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCCATCT
AGTTAACTTACCTTTCTTTGT 
541 5' EBS2 spo0A 178 
TGAACGCAAGTTTCTAATTTCGGTTAATAATCGATAGAGG
AAAGTGTCT 
556 5' NdeI spo0A CCCCATATGGGGGGATTTTTAGTGGAAAAAATC 
557 3' XhoI spo0A  GCCCCTCGAGTTTAACCATACTATGTTCTAGTCTTAATTTATC 
575 5’ sleC 296-463 TTGAAGCAAGACAAGGAGTTCCC 
576 3’ sleC 296-463 CGAAACCAGTAGGAGGAGGTAATGG 
653 5' IBS1 sigE 119 
AAAAAAGCTTATAATTATCCTTAAAAGCCCCATTTGTGCG
CCCAGATAGGGTG 
654 3' EBS1d sigE 119 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCCCATTT
CTTAACTTACCTTTCTTTGT 
655 5' EBS2 sigE 119 
TGAACGCAAGTTTCTAATTTCGGTTGCTTTCCGATAGAGG
AAAGTGTCT 
681 5' IBS1 sigK 265 
AAAAAAGCTTATAATTATCCTTACATATCCTTCTAGTGCG
CCCAGATAGGGTG 
682 3' EBS1d sigK 265 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCCTTCTA
GATAACTTACCTTTCTTTGT 
683 5' EBS2 sigK 265 
TGAACGCAAGTTTCTAATTTCGGTTATATGTCGATAGAGG
AAAGTGTCT 
687 5' NdeI sigE AAAGCATATGTTACGATTGAAAGAAAGAATAATAAGC 
688 3' XhoI sigE 
AAAGCTCGAGTACAAATTTTTTCATTTCTTTTTGCAACCTT
GAG 
689 5' NcoI sigK AAAGCCATGGCAGCTCTTAAATCTTTTGAAAAACCC 
690 3' XhoI sigK pre skin AAAGCTCGAGATTTCATTACCTTCTTTATCTGTTCC 
723 5' NdeI sigG AAATCATATGCAAGTTAATAAGGTTGAAATATG 
724 3' XhoI sigG AAGACTCGAGTACATATTTTCTCATATTTTTTAAAGC 
725 5' NotI spoIIGA AGAATGCGGCCGCGTAAATATACCAAAAGTAGAGCG 
726 3' XhoI sigE down AAAGCTCGAGGAACTGGAAGTTCTGATGTATTAACACC 
727 5' NdeI ∆23aa sigE  AAATCATATGCCAAAGGGAATATACTATATGGGA 
728 5' IBS1 sigG 546 
AAAAAAGCTTATAATTATCCTTAGATGCCATATTCGTGCG
CCCAGATAGGGTG 
729 3' EBS1d sigG 546 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCATATT
CGTTAACTTACCTTTCTTTGT 
730 5' EBS2 sigG 546 
TGAACGCAAGTTTCTAATTTCGATTGCATCTCGATAGAGG
AAAGTGTCT 
734 5' NotI sigK up 
AGAATGCGGCCGCCTATTTCCTTTTATATTTATTGACACC
TC 
735 5' sigK SOE 
CGGAACAGATAAAGAAGGTAATGAAATAAGTCTTTTAGA
TATACTTGGTACAGAGG 
736 3' sigK rev oes 
CCTCTGTACCAAGTATATCTAAAAGACTTATTTCATTACC
TTCTTTATCTGTTCCG 
737 3' XhoI sigK TAA AAATCTCGAGTTAACTTTCTTGAACAAGCTCTTTTTCTAG 






Table S14. Genes whose expression is increased in the absence of spo0A.  
 
doi:10.1371/journal.pgen.1003660  
776 3' EBS1d sigF 459 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCGTAAT
GGCTAACTTACCTTTCTTTGT 
777 5' EBS2 sigF 459 
TGAACGCAAGTTTCTAATTTCGATTAAATCTCGATAGAGG
AAAGTGTCT 
790 5' NdeI sigF  AAATCATATGGAAGTAACTGTTGCCAG 
791 3' XhoI sigF 
AATACTCGAGCGATATATATTCTTTTAACTTAGACAATAC
TTTC 
792 5' CD1433 531-1102 TGGAATGCCAGTGATTTTACC 
793 3' CD1433 531-1102 TGTATGGGTCTGTTATTTGTGGTC 
794 5' CD3580 207-622 TGGCTTACAGGAAGAAGAACG 
795 3' CD3580 207-622 CAAAACTTTCAGGTGCTATTTCGTC 
796 5' CD1511 76-348 GCTCTTTTTTTAGAAGCAGGATTC 
797 3' CD1511 76-348 ACCAACTTGTGGGTTTACACC 
798 5' spoIVA 171-415 GGATAGAACAAGAGATGAGATACCC 
799 3' spoIVA 171-415 CTGCTGCCTTTTCAAATGTC 
810 5' spoVT 26-441 GAATAGATGATCTTGGAAGGGTAG 
811 3' spoVT 26-441 ACCTATACAGTCACCAGATGCAC 
835 5' NotI sigG  AGAATGCGGCCGCGTTGGTTATGGCACTTGACAG 
836 3' XhoI sigG ACAAGCTCGAGCAGTCCATGGATTACTTATAC 
883 5' NheI CD2470 (gpr) AAGAGCTAGCATTAGTGTAAGAACAGATTTAGCTTTAG 
884 3' XhoI CD2470 (gpr) AAGACTCGAGTACCAATCTACCTGGATGTAAAGAC 
885 5' NdeI CD2688 
(sspA) 
AAGACATATGGCAAGTAACAATAACAACAACAGAACA 
886 3' XhoI CD2688 
(sspA) 
AAGACTCGAGTCTGTTGCTTTTTCCAGCCATTTG 
954 5' Not1 spoIIAA 
ACAAGGCGGCCGCCATTGAAGGAATAAAAATATAATTAT
AG 
956 3' Xho1 sigF TAA ACAAGCTCGAGCTACATATCATAAGTATTATCACG 
989 5' CD3522 502-853 GAGTATGAAGACTATTGGGAAGATG 
990 3' CD3522 502-853 GTTTATTTCCACTCTCTCCTTGAC     
995 5' sspB 1-207 TTGAGGAGGAAATTTACTATG 
996 3' sspB 1-207 TTGTCTTTCAGCCATTTCAAC 
975 5' NdeI spoVT  AGAATCATATGAAAGCAACAGGTATAGTTAGAAG 
976 3' XhoI spoVT  ACAAGCTCGAGTTGAACTTGTTTTCCTAAAAAG 
1002 5' rpoB 235-442 GAGTGTAAAGAGAGAGATGC 
1003 3' rpoB 235-442 CTTCCGCATAGTAAACACC 
1032 5' dacF 1129-340 GATGGATGTTGGTAGTGGAC 
1033 3' dacF 1129-340 CCTTTTGAGTTTCTCCTGGC 
1187 5’ GPR 332-626 CTTCTGATGCGTTAGGACC 
1188 3’ GPR 332-626 GTATTGCCAACACCTCCAC 
1191 5’ CD2376 297-439 GTTGAGTAGGGTTTTTAGTG 
1192 3’ CD2376 297-439 CTTTTGTTGCTGTTGATGC 
1213 
5’ CD0125 (spoIIQ) 
190-553 GATGCTATCCCTACTGCAACG 
1214 
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2.10. Table Legends 
Table S1. Quantitation of sporulating cell phenotypes. C. difficile strains JIR8094 
(WT), sigF–, sigE–, sigG–, and sigK– exhibit asynchronous sporulation when grown on 
sporulation induction media for 18 hours. Phase-contrast microscopy and fluorescence 
light microscopy using the membrane stain FM4-64 and the nucleic acid dye Hoechst 
was used to analyze sporulation in the indicated strains. A cell was deemed positive for 
sporulation if it fell into one of five criteria: (1) a polar septum was detected by FM4-64, 
but the forespore did not stain with Hoechst; (2) Polar septum was detected by FM4-64, 
and the forespore stained with Hoechst; (3) a phase-dark forespore stained with both 
FM4-64 and Hoechst; (4) A phase-dark forespore stained with FM4-64 but not Hoechst, 
or (5) a phase-bright forespore was visible, but it failed to stain with either FM4-64 or 
Hoechst. The percent of total sporulating cells reflects the number of events that fall 
within the stated criteria relative to the total number of cells. A total of 200 cells were 
counted for each strain.  spo0A– cells were not evaluated for sporulation staining. 
 
Table S2. Summary of RNA-Seq data analysis. Strain.Rep refers to the strain name 
followed by the replicate number. Three biological replicates were processed for RNA-
Seq analyses for each strain. WT refers to the parental JIR8094 strain. The total number 
of reads obtained and mapped to the genome is indicated. % mapped refers to the 
percentage of reads that mapped to the C. difficile genome. >90% of the unmapped reads 
did not map to sequences in the NCBI database and appear to derive from spurious 
amplification products during library construction. 
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Table S3. Spo0A-dependent (activated) genes. † Two factors are listed in the table for 
genes whose expression was dependent on both σE and σG (adjusted p-value ≤ 0.05, 
log2FC ≤ -2). Dep. indicates the most downstream sigma factor on which gene expression 
depends upon. BM refers to base mean, the mean of the counts after they were divided by 
the size factors to adjust for different sequencing depths. This value is the mean for the 
sample relative to wild type. log2FC denotes log2fold-change. A negative value indicates 
that the gene was downregulated relative to wild type. ^ Indicates that gene product was 
detected in Lawley et al. proteomic analysis of purified spores [70]. –Inf indicates that no 
transcript was detected in the mutant relative to wild type. See Text S2 for the references. 
 
Table S4. Sporulation-related genes. † Two factors are listed in the table for genes 
whose expression was dependent on both σE and σG (adjusted p-value ≤ 0.05, log2FC ≤ -
2). Dep. indicates the most downstream sigma factor on which gene expression depends 
upon. BM refers to base mean, the mean of the counts after they were divided by the size 
factors to adjust for different sequencing depths. This value is the mean for the sample 
relative to wild type. log2FC denotes log2fold-change. A negative value indicates that the 
gene was downregulated relative to wild type. ^ Indicates that gene product was detected 
in Lawley et al. proteomic analysis of purified spores [70]. –Inf indicates that no 
transcript was detected in the mutant relative to wild type. See Text S2 for the references. 
 
Table S5. σF-dependent genes. † Two factors are listed in the table for genes whose 
expression was dependent on both σE and σG (adjusted p-value ≤ 0.05, log2FC ≤ -2). Dep. 
indicates the most downstream sigma factor on which gene expression depends upon. BM 
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refers to base mean, the mean of the counts after they were divided by the size factors to 
adjust for different sequencing depths. This value is the mean for the sample relative to 
wild type. log2FC denotes log2fold-change. A negative value indicates that the gene was 
downregulated relative to wild type. ^ Indicates that gene product was detected in Lawley 
et al. proteomic analysis of purified spores [70]. –Inf indicates that no transcript was 
detected in the mutant relative to wild type. See Text S2 for the references. 
 
Table S6. σE-dependent genes. † Two factors are listed in the table for genes whose 
expression was dependent on both σE and σG (adjusted p-value ≤ 0.05, log2FC ≤ -2). Dep. 
indicates the most downstream sigma factor on which gene expression depends upon. BM 
refers to base mean, the mean of the counts after they were divided by the size factors to 
adjust for different sequencing depths. This value is the mean for the sample relative to 
wild type. log2FC denotes log2fold-change. A negative value indicates that the gene was 
downregulated relative to wild type. ^ Indicates that gene product was detected in Lawley 
et al. proteomic analysis of purified spores [70]. –Inf indicates that no transcript was 
detected in the mutant relative to wild type. See Text S2 for the references. 
 
Table S7. σG-dependent genes. † Two factors are listed in the table for genes whose 
expression was dependent on both σE and σG (adjusted p-value ≤ 0.05, log2FC ≤ -2). Dep. 
indicates the most downstream sigma factor on which gene expression depends upon. BM 
refers to base mean, the mean of the counts after they were divided by the size factors to 
adjust for different sequencing depths. This value is the mean for the sample relative to 
wild type. log2FC denotes log2fold-change. A negative value indicates that the gene was 
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downregulated relative to wild type. ^ Indicates that gene product was detected in Lawley 
et al. proteomic analysis of purified spores [70]. –Inf indicates that no transcript was 
detected in the mutant relative to wild type. See Text S2 for the references. 
 
Table S8. σK-dependent genes. Dep. indicates the most downstream sigma factor on 
which gene expression depends upon. BM refers to base mean, the mean of the counts 
after they were divided by the size factors to adjust for different sequencing depths. This 
value is the mean for the sample relative to wild type. log2FC denotes log2fold-change. A 
negative value indicates that the gene was downregulated relative to wild type. ^ 
Indicates that gene product was detected in Lawley et al. proteomic analysis of purified 
spores [70]. –Inf indicates that no transcript was detected in the mutant relative to wild 
type. See Text S2 for the references. 
 
Table S9. Genes induced in a Spo0A-, σF-, σE-, σG-, and σK-dependent manner 
during growth on sporulation media. † Two factors are listed in the table for genes 
whose expression was dependent on both σE and σG (adjusted p-value ≤ 0.05, log2FC ≤ -
2). Dep. indicates the most downstream sigma factor on which gene expression depends 
upon. BM refers to base mean, the mean of the counts after they were divided by the size 
factors to adjust for different sequencing depths. This value is the mean for the sample 
relative to wild type. log2FC denotes log2fold-change. A negative value indicates that the 
gene was downregulated relative to wild type. ^ Indicates that gene product was detected 
in Lawley et al. proteomic analysis of purified spores [70]. –Inf indicates that no 
transcript was detected in the mutant relative to wild type. See Text S2 for the references. 
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Table S10. Genes encoding hypothetical proteins induced during sporulation. † Two 
factors are listed in the table for genes whose expression was dependent on both σE and 
σG (adjusted p-value ≤ 0.05, log2FC ≤ -2). Dep. indicates the most downstream sigma 
factor on which gene expression depends upon. BM refers to base mean, the mean of the 
counts after they were divided by the size factors to adjust for different sequencing 
depths. This value is the mean for the sample relative to wild type. log2FC denotes 
log2fold-change. A negative value indicates that the gene was downregulated relative to 
wild type. ^ Indicates that gene product was detected in Lawley et al. proteomic analysis 
of purified spores [70]. –Inf indicates that no transcript was detected in the mutant 
relative to wild type. See Text S2 for the references. 
 
Table S14. Genes whose expression is increased in the absence of spo0A. BM refers to 
base mean, the mean of the counts after they were divided by the size factors to adjust for 
different sequencing depths. This value is the mean for the sample relative to wild type. 
log2FC denotes log2fold-change. A positive value indicates that the gene was upregulated 
in the spo0A– mutant relative to wild type. +Inf indicates that no transcript was detected 
in wild type relative to the spo0A– mutant. 
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2.11. Figure Legends  
Figure 1. C. difficile sigF–, sigE–, sigG–, and sigK– sigma factor mutants are defective 
in mature spore formation. C. difficile strains wildtype (WT), spo0A–, sigF–, sigE–, 
sigG–, and sigK– were grown on sporulation media for 18 hrs and evaluated by live 
phase-contrast and fluorescence microscopy. Columns represent phase contrast, FM4-64 
membrane staining (red), nucleoid staining with Hoechst (blue), and merge of three 
images. Yellow arrowheads indicate forespore compartments that stain with FM4-64 and 
Hoechst; green arrowheads indicate phase-dark, immature forespores that stain with 
FM4-64 but not Hoechst; and pink arrowheads indicate phase-bright mature spores that 
exclude both the FM4-64 and Hoechst stains. Phase-bright spores were not observed in 
any of the mutant strains. Circular vesicles that were labeled by FM4-64, but not visible 
by phase-contrast microscopy (white arrows) were frequently observed in cultures grown 
on sporulation media, even in the spo0A– mutant (data not shown). Scale bars represent 
10 µm.  
 
Figure 2. Analysis of sporulation sigma factor production in sporulation sigma 
factor mutants. Western blot analyses of σF, σE, σG, σK, and Spo0A, respectively, in 
wildtype (WT), spo0A-, sigF-, sigE-, sigG-, and sigK- strains grown for 18 hr on 
sporulation media using antibodies raised against Spo0A and the sporulation sigma 
factors. The * demarcates a non-specific band observed in the sigF– and spo0A– mutants. 
Pro-σE indicates full-length σE prior to pro-peptide removal. 
 
Figure 3. C. difficile sigF–, sigE–, sigG–, and sigK– mutants are arrested at different 
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stages of spore formation. Transmission electron microscopy (TEM) of wildtype, 
spo0A–, sigF–, sigE–, sigG–, and sigK– strains at 18 hrs of growth on sporulation media. 
The forespore regions of wild type (WT), sigG–, and sigK– strains, and an electron-
translucent region within the sigF– mutant mother cell cytosol, are shown on the right. 
Black triangles indicate regions that resemble coat layers, while white triangles indicate 
regions consistent with cortex. Scale bars represent 500 nm. Inset scale bars represent 
250 nm. 
 
Figure 4. Venn diagram of genes identified as being dependent on either Spo0A, σF-, 
σE-, σG-, and/or σK-dependent as determined by RNA-Seq. Genes were defined as 
being dependent on their respective sigma factor for expression if their transcript levels 
were decreased by ≥ 4-fold with an adjusted p-value of ≤ 0.05 in the mutant strains 
relative to wild type. The genes identified in these analyses are listed in Tables S3 and 
S5-S8.  
 
Figure 5. Comparison of Spo0A-dependent gene expression in wildtype and 
sporulation sigma factor mutants. Heat map representation of the genes that were 
downregulated by ≥ 4-fold with an adjusted p-value of ≤ 10-5 in the spo0A– strain relative 
to wild type. Expression levels of these genes in wildtype (WT), sigF–, sigE–, sigG–, and 
sigK– strains relative to spo0A– were centered, scaled, and mapped to a red-green color 
scale, with green indicating that the gene was upregulated in the strain relative to the 
spo0A– mutant, and red indicating that the gene was downregulated, relative to the 
centered expression level. σE-regulated genes  (blue), σK-regulated genes (purple), σG-
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regulated genes (orange), σF-dependent genes (green) are colored as indicated, and 
clusters of coordinately regulated genes are bracketed. Genes colored in black were 
identified as depending only on Spo0A for expression.  
 
Figure 6. qRT-PCR validation of RNA-Seq transcriptional profiling. Transcript 
levels for three genes determined to be dependent on σF, σE, σG, and/or σK for expression 
as determined by qRT-PCR on three biological replicates that were distinct from the 
samples used for RNA-Seq. (A) σF-dependent genes included gpr, CD0125 (spoIIQ [13]) 
and CD2376. (B) σG-dependent genes included spoVT sspB, and dacF. (C) σE-dependent 
genes included CD3522, spoIVA, and CD1511. (D) σK-dependent genes included 
CD1433, CD1067 and sleC. cDNA was produced from RNA samples harvested from 
wildtype (WT), spo0A–, sigF–, sigE–, sigG–, and sigK– strains grown on sporulation media 
for 18 hrs. Data represent the averages of three biological replicates and at least two 
technical replicates. Transcripts were calculated relative to spo0A– and normalized to 
rpoB (housekeeping gene). Error bars indicate the standard error of the mean. Statistically 
significant changes in transcript levels were determined relative to WT and represented 
by adjusted p-values determined by a Dunnett’s one-way ANOVA.  ****p < 0.0001, 
***p < 0.001, **p < 0.01. CD2376 transcript levels were ~3-fold reduced in the sigF– 
mutant relative to wild type (p = 0.065). 
 
Figure 7. Western blot analyses of proteins encoded by genes induced by specific 
sigma factors during sporulation. Western blot analyses of proteins encoded by genes 
identified as being upregulated during sporulation by specific sigma factors. Wildtype 
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(WT), spo0A-, sigF-, sigE-, sigG-, and sigK- strains were grown on sporulation media for 
18 hrs. SleC undergoes multiple processing steps [76,85], but only the pro-SleC form is 
shown. Spo0A was used as a loading control. 
  
Figure 8. Comparison of sporulation regulatory network architecture in the 
Firmicutes. The temporal progression of sporulation is shown from top to bottom as 
determined in B. subtilis, C. difficile, C. perfringens, and C. acetobutylicum. 
Transcription factors and sigma factors are shown in bold, and proteins enclosed in boxes 
directly participate in trans-septum signaling. Dashed boxes indicate that the function of 
the proteins in trans-septum signaling has not been tested yet. Text color denotes whether 
the factor has been detected at both the transcript and protein level (black), at either the 
transcript or protein level (purple), or has not been tested yet at the transcript or protein 
level (blue), indicating the need for further experimentation. SpoIIQ* denotes the 
predicted clostridial homolog to B. subtilis SpoIIQ based on bioinformatics analyses [13]. 
Pro-σE in C. acetobutylicum is shown in parentheses to indicate that the pro-form has not 
been detected by Western blot [31]. Black arrows indicate transcriptional control of gene 
expression, red arrows indicator signaling pathways, dashed arrows indicate that the 
regulatory relationship between the indicated factors has not been tested, and thick 
arrows demarcate notable points of divergence from the pathway defined in B. subtilis. 
AND gates are indicated. Unique features of the sporulation pathway in C. difficile 
include the post-translational activation of σG by σF and the absence of proteolytic 
activation of σK; the σE-dependent SpoIIIA-H feeding tube also does not appear to be 
required for σG activation. 
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2.12. Supporting Figure Legends  
Figure S1. Construction of spo0A-, sigE-, sigG-, sigK- and sigF- mutants in C. difficile. 
(A) Schematic of the group II intron targeted gene disruption system. (B) Colony PCR 
analysis of spo0A–, sigE–, sigG–, sigK–, and sigF– strains compared to wild type (WT) 
using primers that flank the gene of interest. The group II intron insertion is ~2 kb.   
 
Figure S2. Phase contrast microscopy of strains used for RNA-Seq analyses. Phase-
contrast microscopy of WT, spo0A–, sigF–, sigE–, sigG–, and sigK– strains grown on 
sporulation media for 18 hrs. White triangles mark mature phase-bright spores, and black 
triangles indicate immature phase-dark forespores. Phase-bright spores were not observed 
in the sigma factor mutants. The percentage of sporulating cells, defined as containing 
phase-dark forespores, phase-bright forespores, or free spores, is shown for each of the 
biological replicates. Scale bar represents 5 µm. 
 
Figure S3. Prevalence of sigG- phenotypes. TEM of sigG– mutants during growth on 
sporulation media. sigG– mutant cells (n = 80) containing a forespore with a putative coat 
layer (black triangle) were scored for the presence of a ruffled membranes (98%), a 
double forespore compartment (21%), and incomplete engulfment (87%). A black arrow 
indicates incomplete membrane fission during engulfment, and a white arrow indicates 
septum-like structures in the forespore. No cortex was detected in any of the sigG– 
mutant cells analyzed. All wildtype forespores surrounded by a coat layer had completed 
engulfment (n = 60 cells, data not shown). Scale bar represents 500 nm. 
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Figure S4. Plasmid complementation rescues spore formation in C. difficile sigma 
factor mutants. (A) Phase-contrast microscopy of sigF–, sigE–, and sigG– strains grown 
on sporulation media for 30 hrs and the sigK– strain for 42 hrs. The strains carry either 
empty pMTL83151 or pMTL84151 vector [48] or pMTL8151-sigE, sigG, or sigK genes, 
respectively, or pMTL84151-sigF, expressed from their native promoters. White triangles 
mark mature phase-bright spores, and black triangles indicate immature phase-dark 
forespores. Phase-bright spores were not observed in the sigma factor mutants. Scale bar 
represents 5 µm. (B) Western blot analyses of wildtype (WT), spo0A-, sigF-, sigE-, sigG-, 
and sigK- carrying either empty pMTL83151 vector (EV) or a complementation construct 
using antibodies raised against σF, σE, σG, and σK. Spo0A levels were also measured to 
compare the induction of sporulation between strains [37,86]. The asterisk demarcates a 
non-specific band observed in all strains tested. (C) Sporulation efficiencies determined 
by heat resistance assays of complementation strains sigF-/pMTL84151-sigF+, sigE-
/pMTL83151-sigE+, sigG-/pMTL83151-sigG+, and sigK-/pMTL83151-sigK+ relative to 
wildtype. No heat-resistant spores were detected in mutant strains carrying empty vector. 
 
Figure S5. Plasmid complementation rescues coat and cortex formation in sigma 
factor mutants. The sigF–, sigE–, and sigG– strains were grown on sporulation media for 
28 hrs, while the sigK– strains were grown for 40 hrs. The strains carry either empty 
pMTL83151 (or pMTL84151 vector for sigF–, [48]) or sigF, sigE, sigG, or sigK genes, 
respectively, expressed from their native promoters. White triangles indicate cortex and 
black triangles indicate coat. Scale bar represents 250 nm. 
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Figure S6. Analysis of sigma factor regulation network topology in C. difficile. 
Circles represent genes and arrows indicate activation of expression (see Text S1). s0 = 
spo0A, e =  sigE, g = sigG and k = sigK. (A) Network topology proposed for B. subtilis. 
(B) Expression profile of a query sporulation gene, q, among the spo0A–, sigE–, sigG–, 
and sigK– mutants, illustrated in the context of the B. subtilis network topology.  The 
circles of the network topology (A) represent genes whereas the columns in the heat map 
(Figure 5) represent strains; by coloring the circles of the topology using the expression 
level of q in the associated knockout strain (red = low; green = high), the consistency of 
the expression profile (B) with the network topology can be readily evaluated. More 
precisely, a network is consistent with the expression profile of q if and only if the red 
circles form the path between s0 (spo0A–) and q. The example is inconsistent with the B. 
subtilis topology because there is no way to attach q that will result in a consistent 
topology. (C and D) Expression profile for σG- and σE-dependent genes, respectively, in 
the proposed topology for C. difficile. Red coloring of a gene indicates that q is 
downregulated when the former is knocked out. For example, in (D) q is downregulated 
in s0 (spo0A–) and e (sigE–) mutants but upregulated in the g (sigG–) and k (sigK–) 
mutants. 
 
Figure S7. Statistical analysis rejects the B. subtilis network topology for sporulation 
sigma factor regulation. Each gene was fit to models associated with the null, σG-, and 
σE-dependent transcriptome models to obtain p-values (see Text S1). 
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2.13 Supporting Text 
Text S1. Sigma factor regulation network topology in C. difficile 
Network analysis of sporulation sigma factor regulatory pathway topology. 
Given the importance of the conclusion that the expression data does not support 
a linear network topology we felt it appropriate to consider alternative statistical methods. 
This analysis is presented as supplementary material rather than in the main body because 
we did not want its technical nature to detract from the simplicity and clarity of our 
central result.  
Background. Consider a collection of four genes (circles shown in Figure S4) {𝑠0, 𝑒,𝑔, 𝑘}, each of which has two states with respect to expression ↓, ↑ . Consider also 
ordered pairs of genes (edges), for example 𝑠0, 𝑒 , interpreted to mean that if the first 
gene (𝑠0) is ↑ then as a direct1 consequence the second gene (𝑒) also is ↑. The network 
topology proposed for B. subtilis is shown in Figure S4A.   
Consider another gene, q (for query), that is ↑ during sporulation in the wildtype 
strain, but otherwise ↓, and that we wish to attach to the network. Finally, consider a set 
of four mutants, each obtained by knocking out (that is, setting the state to ↓ for) one gene 
of {𝑠0, 𝑒,𝑔, 𝑘}. The expression level of q in each of the mutant strains (spo0A–, sigE–, 
sigG–, and sigK–) provides information that allows us to attach Q to the network. A novel 
result of this work is that the topology proposed for B. subtilis does not account for the 
observed expression pattern of many genes (↑ in the sigE– mutant but ↓ in the sigG– 
mutant, inconsistent with an (sigE–, sigG–) edge (Figure S4A-B). Other topologies are 
                                                
1 ‘Direct’ refers to direct with respect to knockout studies on these four genes.  We do not rule 
out the possibility that a gene not studied here mediates this ‘direct’ effect. 
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consistent with this expression pattern (Figure S4A). 
 A primary goal of this work is to identify genes genome-wide that are increased in 
expression during sporulation in a sporulation sigma factor-dependent manner (that is, 
identify a network topology and assign genes to it). In the main body of the paper this 
was accomplished with pairwise comparisons. For example, q was identified as a σG-
dependent gene (Figure S4C) if it was highly expressed (with high statistical 
significance) in wild type compared with the sigG– mutant. q was identified as a σE-
dependent gene (Figure S4D) if it was highly expressed in wild type compared with the 
sigE– mutant but not compared with the sigK– mutant. 
 
Rejecting the linear topology.  
The linear topology (any topology such as Figure S4 that has one root, one leaf 
and internal nodes having one inbound and one outbound edge) can be rejected if we find 
statistical evidence for genes that partition the strains according to the 𝑆0𝐺:𝐸𝐾𝐽 (σG-
dependent gene) (with S0, G, E, K, and J referring to spo0A–, sigG–, sigE–, sigK–, and 
JIR8094 (WT) but not 𝑆0𝐸:𝐺𝐾𝐽 (σE-dependent gene) (Figure S5) as well as genes that 
partition the strains according to 𝑆0𝐸:𝐺𝐾𝐽 but not 𝑆0𝐺:𝐸𝐾𝐽. 
A graph having root 𝑆0, leaf 𝑄, and additional vertices 𝐸,𝐺,𝐾  defines a 
partition, 𝑝, of the strains 𝑆0,𝐸,𝐺,𝐾, 𝐽 , namely, strain 𝑆0 and strains on the path from 𝑆0 to 𝑄 are ↓ while all other stains are ↑. We employed network-based models  
𝑌! = 𝑋!𝛽+∈ 
where the design matrix,  𝑋!, is defined by the partition 
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𝑋!!! = 1 𝑖 ∈ 𝑒0 𝑖 ∈ 𝑒!  
where 𝑒 is one element of the partition (↓ or ↑) and 𝑒!  is its complement. We fit each 
gene to the null model (uniform expression across strains) as well as the alternatives 𝑆0𝐺:𝐸𝐾𝐽  and 𝑆0𝐸:𝐺𝐾𝐽. We derived a p-value and fold-change using analysis of 
variance. Comparison of p-values associated with alternative topologies (Figure S5) 
makes it clear that we can reject the linear topology. 
 
Text S2. References found in Tables S3-S10. (Found after References section) 
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Figure 1. C. difficile sigF–, sigE–, sigG–, and sigK– sigma factor mutants are defective 
in mature spore formation. 
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Figure S7. Statistical analysis rejects the B. subtilis network topology for sporulation 
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Sporulation is an ancient developmental process that involves the formation of a 
highly resistant endospore within a larger mother cell. In the model organism Bacillus 
subtilis, sporulation-specific sigma factors activate compartment-specific transcriptional 
programs that drive spore morphogenesis. σG activity in the forespore depends on the 
formation of a secretion complex, known as the “feeding tube,” that bridges the mother 
cell and forespore and maintains forespore integrity. Even though these channel 
components are conserved in all spore formers, recent studies in the major nosocomial 
pathogen Clostridium difficile suggested that these components are dispensable for σG 
activity. In this study, we investigated the requirements of the SpoIIQ and SpoIIIA 
proteins during C. difficile sporulation. C. difficile spoIIQ, spoIIIA, and spoIIIAH mutants 
exhibited defects in engulfment, tethering of coat to the forespore, and heat-resistant 
spore formation, even though they activate σG at wildtype levels. Although the spoIIQ, 
spoIIIA, and spoIIIAH mutants were defective in engulfment, metabolic labeling studies 
revealed that they nevertheless actively transformed the peptidoglycan at the leading edge 
of engulfment. In vitro pull-down assays further demonstrated that C. difficile SpoIIQ 
directly interacts with SpoIIIAH. Interestingly, mutation of the conserved Walker A ATP 
binding motif, but not the Walker B ATP hydrolysis motif, disrupted SpoIIIAA function 
during C. difficile spore formation.  This finding contrasts with B. subtilis, which requires 
both Walker A and B motifs for SpoIIIAA function. Taken together, our findings suggest 
that inhibiting SpoIIQ, SpoIIIAA, or SpoIIIAH function could prevent the formation of 
infectious C. difficile spores and thus disease transmission.  
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3.2. Author Summary 
 The bacterial spore-forming pathogen Clostridium difficile is a leading cause of 
nosocomial infections in the United States and represents a significant threat to healthcare 
systems around the world. As an obligate anaerobe, C. difficile must form spores in order 
to survive exit from the gastrointestinal tract. Accordingly, spore formation is essential 
for C. difficile disease transmission. Since the mechanisms controlling this process 
remain poorly characterized, we analyzed the importance of highly conserved secretion 
channel components during C. difficile sporulation. In the model organism Bacillus 
subtilis, this channel had previously been shown to function as a “feeding tube” that 
allows the mother cell to nurture the developing forespore and sustain transcription in the 
forespore. We show here that conserved components of this structure in C. difficile are 
dispensable for forespore transcription, although they are important for completing 
forespore engulfment and retaining the protective spore coat around the forespore, in 
contrast with B. subtilis. The results of our study suggest that targeting these conserved 
proteins could prevent C. difficile spore formation and thus disease transmission.  
 
3.3. Introduction 
A small subset of bacteria can survive adverse environmental conditions by 
forming a metabolically dormant cell-type known as an endospore (referred to as a 
“spore” hereafter) [1-3]. Spore formation allows bacteria to survive harsh environmental 
conditions, such as heat, desiccation, oxygen-rich environments, disinfectants, and 
antibiotic treatment, since they can “reawaken” when favorable conditions return [1-4]. 
While spore formation is an ancient and adaptive mechanism for members of the 
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Firmicutes, this developmental process is essential for the survival of many obligate 
anaerobes that inhabit or transiently live in the gut [5,6].  
Clostridium difficile is a spore-forming obligate anaerobe that is a leading cause 
of nosocomial diarrhea and a major threat to healthcare systems around the world [7-10]. 
When C. difficile spores are ingested by susceptible hosts, they germinate in the gut and 
outgrow to form toxin-secreting vegetative cells [7,11,12]. While the toxins produced by 
C. difficile are responsible for the disease infection symptoms, spores are essential for 
this obligate anaerobe to transmit disease [6]. Accordingly, during growth in the 
gastrointestinal tract, C. difficile strongly induces sporulation in order to survive exit from 
the host [6,13]. Spores complicate C. difficile infection clearance because they are 
resistant to many disinfectants and inert to antibiotics [4]. As a result, they can persist in 
the environment for long periods of time and facilitate C. difficile disease recurrence 
[12,14,15]. Recurrent C. difficile infections are particularly problematic because they can 
lead to severe complications such as pseudomembranous colitis, toxic megacolon, and 
death [14-16]. However, despite the importance of spores to the pathogenesis of C. 
difficile, the molecular mechanisms underlying infectious spore formation remain largely 
uncharacterized. 
Transmission electron microscopy analyses of several spore-forming organisms 
including C. difficile have shown that sporulation is defined by a series of morphological 
events starting with the formation of a polar septum, which generates a larger mother cell 
and smaller forespore [1-3,17]. The mother cell engulfs the forespore to create a 
protoplast surrounded by two lipid bilayer membranes suspended within the mother cell 
cytosol. The germ cell wall between the two membranes serves as the template for the 
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synthesis of a thick protective layer of modified peptidoglycan called the cortex, while a 
series of protective proteinaceous shells called the spore coat is deposited on the outer 
forespore membrane [2,18]. Once forespore maturation is complete, the mother cell lyses 
to liberate a highly resistant spore.   
Our knowledge of how these morphological events occur derives primarily from 
studies of the organism Bacillus subtilis. These analyses have revealed that 
morphological changes during sporulation are coupled to compartment-specific 
transcriptional changes [1-3]. In particular, the sequential and compartment-specific 
activation of four conserved sporulation-specific sigma factors, σF, σE, σG, and σK, leads 
to the activation of transcriptional programs that allow key morphological stages to be 
completed [1-3,17]. Following asymmetric division, σF and σE are activated early in the 
forespore and mother cell, respectively; following forespore engulfment, σG and σK are 
activated in the forespore and mother cell, respectively. These activation events depend 
upon coordinated intercompartmental signaling events. σF- and σG-dependent signaling in 
the forespore activates σE and σK in the mother cell, respectively, via regulated 
intramembrane proteolysis. σF and σE control σG activation in the forespore following 
engulfment completion by inducing the formation of a channel, also known as the 
“feeding tube” [19,20]. This channel physically connects the mother cell to the forespore 
and transports unknown substrates that are required for σG activity in the forespore [19-
21]. The “feeding tube” also controls forespore integrity [20], since the forespore 
collapses and eventually lyses in mutants lacking channel components [20,22]. σG 
activity may be further regulated by its apparent dependence on engulfment completion 
 144 
[23-25]. 
Analyses of sporulation-specific sigma factor function in C. difficile have 
revealed important differences in the regulatory architecture controlling sporulation 
[17,26]. While the sigma factors are controlled in a similar compartment-specific manner, 
σE activation only partially depends on σF; σG activation does not require σE; and σK 
activation does not depend on σG [27-29]. Since a C. difficile sigE mutant, which is 
stalled at asymmetric division, still activates σG in the forespore [28], C. difficile σG 
activity does not appear to be coupled to engulfment completion, in contrast with B. 
subtilis [23]. In general, activation of C. difficile sporulation-specific sigma factors 
appears to depend less on intercompartmental signaling and morphological changes than 
B. subtilis [17,26].  
Since genome-wide transcriptional profiling has shown that σG regulon genes are 
expressed at wildtype levels in a C. difficile sigE– mutant [27,29], the mother cell-to-
forespore channel shown to regulate B. subtilis σG activity appears to be dispensable for 
C. difficile σG activity, at least at early stages of sporulation [30]. Intriguingly, however, 
the genes encoding B. subtilis channel components, spoIIQ and the eight gene spoIIIA 
operon, are conserved across all spore-forming bacteria [31,32] and are induced during 
sporulation in a manner analogous to B. subtilis, with σF activating spoIIQ transcription 
and σE activating spoIIIA transcription [27,29]. These observations suggest that the 
mother cell-to-forespore channel may play important but possibly distinct roles during C. 
difficile spore formation relative to B. subtilis [30]. 
SpoIIQ has homology to Zn2+-dependent M23 peptidases (LytM domain, [33,34]) 
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and forms a multimeric ring in the inner forespore membrane of B. subtilis [35-38]. The 
SpoIIIA proteins, SpoIIIAA-SpoIIIAH [39], have homology to secretion system 
components [19-21,40]. SpoIIIAA functions as an ATPase that likely powers the 
transport of metabolites across the “feeding tube” during B. subtilis sporulation [20]. 
SpoIIIAH forms a multimeric ring in the mother cell-derived outer forespore membrane 
that directly binds the SpoIIQ multimeric ring formed in the inner forespore membrane 
[34,35,37,38]. The SpoIIQ-SpoIIIAH complex alone can drive “zipper-like” engulfment 
in sporulating B. subtilis lacking a cell wall [41]. Based on these observations, this 
complex has been proposed to function as a Brownian “ratchet” that helps power 
engulfment. Consistent with this model, a spoIIQ mutant fails to complete engulfment 
[33] when sporulation is induced by nutrient starvation, even though “feeding tube” 
mutants can complete engulfment when sporulation is induced by resuspension [20]. 
C. difficile SpoIIIAA and SpoIIIAH exhibit 57% and 38% similarity, respectively, 
to their orthologs in B. subtilis (Figs. S1 and S2), while C. difficile SpoIIQ (CD0125) 
exhibits only 28% similarity despite also encoding a C-terminal LytM domain ([32], Fig. 
S3). In contrast with the degenerate active site of B. subtilis SpoIIQ [34], C. difficile 
SpoIIQ has an intact active site ([30], Fig. S3), suggesting that it may have peptidoglycan 
endopeptidase activity and thus function differently in C. difficile relative to B. subtilis. 
Furthermore, residues that directly mediate binding between B. subtilis SpoIIQ and 
SpoIIIAH are not well conserved in C. difficile (Figs. S1 and S2), raising the question as 
to whether these proteins interact in C. difficile. Indeed, whether SpoIIQ and/or SpoIIIA 
proteins regulate forespore integrity and/or have additional functions during C. difficile 
sporulation remain unknown [30].   
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To address these questions, we constructed gene disruptions of C. difficile spoIIQ, 
spoIIIAA, and spoIIIAH and determined their effects on spore formation using 
microscopic and cell biological assays. We also tested whether C. difficile SpoIIQ and 
SpoIIIAH interact and whether the predicted ATPase and endopeptidase activities of C. 
difficile SpoIIIAA and SpoIIQ are required for spore formation. These analyses revealed 
that SpoIIQ, SpoIIIAA, and SpoIIIAH regulate multiple stages of C. difficile spore 
formation, including engulfment, proper coat localization around the forespore, and 
maintenance of the forespore. 
   
3.4. Materials and Methods 
3.4.1. Bacterial strains and growth conditions 
 All C. difficile strains are listed in Table 1 and derive from the parent strain 
JIR8094, an erythromycin-sensitive derivative [70] of the sequenced clinical isolate 630 
[71]. C. difficile strains were grown on solid brain heart infusion media supplemented 
with yeast extract (BHIS: 37 g brain heart infusion, 5 g yeast extract, 0.1% (w/v) L-
cysteine, 15 g agar per liter) [72]. Taurocholate (TA; 0.1% w/v), thiamphenicol (5-10 
µg/mL), kanamycin (50 µg/mL), cefoxitin (16 µg/mL), FeSO4 (50 µM), and/or 
erythromycin (10 µg/mL) were used to supplement the BHIS media as indicated. 
Cultures were grown at 37˚C, under anaerobic conditions using a gas mixture containing 
85% N2, 5% CO2, and 10% H2. 
Sporulation was induced on media containing BHIS and SMC (90 g 
BactoPeptone, 5 g protease peptone, 1 g NH4SO4, 1.5 g Tris base, 15 g agar per liter) 
[73], at 70% SMC and 30% BHIS (70:30 media, 63 g BactoPeptone, 3.5 g Protease 
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Peptone, 11.1 g BHI, 1.5 g yeast extract, 1.06 g Tris base, 0.7 g NH4SO4, 15 g agar per 
liter) [45]. 70:30 agar (supplemented as appropriate with thiamphenicol at 10 µg/mL) was 
inoculated from a starter culture grown on solid media. 70:30 broth was made as stated 
above omitting the agar.  
HB101/pK424 strains were used for conjugations and BL21(DE3) strains were 
used for protein expression. E. coli strains were routinely grown at 37˚C, shaking at 225 
rpm in Luria-Bertani broth (LB). Media was supplemented with chloramphenicol (20 
µg/mL), ampicillin (100 µg/mL), or kanamycin (30 µg/mL) as indicated.  
 
3.4.2. E. coli strain construction 
All strains are listed in Table S1; all plasmids are listed in Table S2; and all 
primers used are listed in Table S3. For disruption of spoIIQ, spoIIIAA, and spoIIIAH, a 
modified plasmid containing the retargeting group II intron, pCE245 (a gift from C. 
Ellermeier, University of Iowa), was used as the template. Primers used to amplify the 
targeting sequence from the template carried flanking regions specific for each gene 
target and are listed as follows: spoIIQ (#1052, 1053, 1054 and 532, the EBS Universal 
primer as specified by the manufacturer (Sigma Aldrich)), spoIIIAA (#1049, 1050, 1051 
and 532), and spoIIIAH (#1264, 1265, 1266, and 532). The resulting retargeting 
sequences were digested with BsrGI and HindIII and cloned into pJS107 (a gift from J. 
Sorg, University of Texas A&M), a derivative of pJIR750ai (Sigma Aldrich). The 
ligations were transformed into DH5α and confirmed by sequencing. The resulting 
plasmids were used to transform HB101/pK424. 
 148 
To construct the spoIIQ complementation construct, primers #1177 and 1178 
were used to amplify spoIIQ containing 106 bp of the upstream region using 630 
genomic DNA as the template. To construct the spoIIQ H120A complementation 
construct, SOE primers #1177 and #1851 were used to generate a 5’ fragment (590 bp) 
containing the H120A mutation; primers #1850 and #1178 were used for the 3’ SOE 
product using the IIQ complementation construct as a template. To construct the spoIIIA 
operon complementation construct, primers #1174 and 1175 were used to amplify 211 bp 
upstream of spoIIIAA and 9 bp downstream of spoIIIAH using 630 genomic DNA as the 
template. The spoIIIAH complementation construct was made using PCR splicing by 
overlap extension (SOE, [74]). Primer pair #1174 and 1618 was used to amplify the 5’ 
SOE product, while primer pair #1617 and 1239 was used to amplify the 3’ SOE product. 
The resulting fragments were mixed together, and flanking primers #1174 and #1239 
were used to generate a fragment corresponding to 211 bp of the spoIIIA upstream region 
fused to the spoIIIAH gene (PspoIIIA-spoIIIAH). To construct the spoIIIA operon K167A 
complementation construct, SOE primers #1174 and #1432 were used to generate a 5’ 
fragment (590 bp) containing the K167A mutation; primers #1431 and #1175 were used 
for the 3’ SOE product. The flanking primers #1174 and #1175 were used to amplify the 
K167A IIIA complementation construct. To construct the spoIIIA operon D244A 
complementation construct, SOE primers #1174 and #1853 were used to generate a 5’ 
fragment (590 bp) containing the D244A mutation; primers #1852 and #1854 were used 
for the 3’ SOE product using the IIIA complementation construct as a template. The 
flanking primers #1174 and #1854 were used to amplify the D244A IIIA mutation insert, 
digested with NotI and SalI. The plasmid carrying the IIIA complementation construct 
 149 
was also digested with NotI/SalI and then gel purified to separate the plasmid backbone 
from the wildtype fragment. The D244A IIIA NotI/SalI fragment was ligated to the gel-
purified cut vector. To construct the spoIIIA operon K167A/D244A complementation 
construct, SOE primers #1174 and #1853 were used to generate a 5’ fragment (590 bp) 
containing the D244A mutation; primers #1852 and #1854 were used for the 3’ SOE 
product using the K167A complementation construct as a template. The flanking primers 
#1174 and #1854 were used to amplify the D244A IIIA mutation insert, digested with 
NotI and SalI, and ligated to the IIIA complementation construct digested with NotI/SalI 
as described earlier. All complementation constructs except for the D244A and 
K167A/D244A were digested with NotI and XhoI and ligated into pMTL83151 [44] 
digested with the same enzymes. 
To construct strains producing recombinant N-terminally truncated SpoIIQ and 
N-terminally truncated SpoIIIAH for antibody production, primer pairs #1568 and 1569 
and #1566 and 1567, respectively were used to amplify codon optimized spoIIQ and 
spoIIIAH genes lacking stop codons off template synthesized by Genscript. The spoIIQ 
expression construct deletes the sequence encoding the first 30 amino acids of SpoIIQ, 
while the spoIIIAH expression construct deletes the sequence encoding the first 33 amino 
acids of SpoIIIAH, which removes the membrane-tethering domains and improves the 
solubility of the proteins in E. coli. The resulting PCR products were digested with NdeI 
and XhoI, ligated to pET22b, and transformed into DH5α. The resulting pET22b-spoIIQ 
and pET22b-spoIIIAH plasmids were used to transform BL21(DE3) for protein 
expression.  
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To construct the pET28a-HA-spoIIIAH construct for the affinity co-purification 
studies, primer pair #1665 and 1614 was used on the codon-optimized spoIIIAH template 
synthesized by Genscript. To construct the pET28a-HA-spoVT construct for the affinity 
co-purification studies, primer pair #1691 and 1313 was used to amplify spoVT encoding 
an N-terminal HA-tag using C. difficile genomic DNA as the template. The resulting 
PCR products were digested with NcoI and XhoI, ligated to pET28a digested with the 
same enzymes, and transformed into DH5α. The pET28a-HA-spoIIIAH construct was 
transformed into BL21(DE3) to construct strain #1378. The pET28a-HA-spoIIIAH 
construct was transformed into BL21(DE3) to construct strain #1404. 
To construct the σG-dependent transcriptional reporter, the σG-regulated promoter 
of sspA (PsspA) was fused to a C. difficile codon optimized SNAP-tag [75] to generate 
PsspA-SNAP (Genscript) with flanking restriction sites. This promoter region has 
previously been described [28]. The plasmid was transformed into E. coli DH5α, isolated, 
and digested with NotI and XhoI then cloned into the complementation plasmid 
pMTL84151, transformed into E. coli HB101 (Table S1) and subsequently conjugated 
into C. difficile strains.   
 
3.4.3. C. difficile strain construction 
C. difficile strains were constructed using TargeTron-based gene disruption as 
described previously (Fig. S4, [27]). TargeTron constructs in pJS107 were conjugated 
into C. difficile using an E. coli HB101/pK424 donor strain. HB101/pK424 strains 
containing the appropriate pJS107 construct were grown aerobically to exponential phase 
in 2 mL of LB supplemented with ampicillin (50 µg/mL) and chloramphenicol (10 
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µg/mL). Cultures were pelleted, transferred into the anaerobic chamber, and resuspended 
in 1.5 mL of late-exponential phase C. difficile JIR8094 cultures (grown anaerobically in 
BHIS broth). The resulting cell mixture was plated as seven 100 µL spots onto pre-dried, 
pre-reduced BHIS agar plates. After overnight incubation, all growth was harvested from 
the BHIS plates, resuspended in 2.5 mL pre-reduced BHIS, and twenty-one 100 µL spots 
per strain were plated onto three BHIS agar plates supplemented with thiamphenicol (10 
µg/mL), kanamycin (50 µg/mL), and cefoxitin (16 µg/mL) to select for C. difficile 
containing the pJS407 plasmid. After 24-48 hrs of anaerobic growth, single colonies were 
patched onto BHIS agar supplemented with thiamphenicol (10 µg/mL), kanamycin (50 
µg/mL), and FeSO5 (50 µM) to induce the ferredoxin promoter of the group II intron 
system. After overnight growth, patches were transferred to BHIS agar plates 
supplemented with erythromycin (10 µg/mL) for 24-72 hrs to select for cells with 
activated group II intron systems. Erythromycin-resistant patches were struck out for 
isolation onto the same media and individual colonies were screened by colony PCR for a 
2 kb increase in the size of spoIIQ (primer pair #1074 and 1075), spoIIIAA (primer pair 
#1302 and 1176), and spoIIIAH (primer pair #1301 and 1239) (Fig. S4).  
 
3.4.4. C. difficile complementation 
HB101/pK424 donor strains carrying the appropriate complementation construct 
were grown in LB containing ampicillin (50 µg/mL) and chloramphenicol (20 µg/mL) at 
37˚C, 225 rpm, under aerobic conditions, for 6 hrs. C. difficile recipient strains spoIIQ–, 
spoIIIAA–, and spoIIIAH– containing group II intron disruptions, were grown 
anaerobically in BHIS broth at 37˚C with gentle shaking for 6 hrs. HB101/pK424 
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cultures were pelleted at 2500 rpm for 5 min and the supernatant was removed. Pellets 
were transferred to the anaerobic chamber and gently resuspended in 1.5 mL of the 
appropriate C. difficile culture. The resulting mixture was inoculated onto pre-dried, pre-
reduced BHIS agar plates, as seven 100 µL spots for 12 hrs. All spots were collected 
anaerobically and resuspended in 1 mL PBS. The resulting suspension was spread onto 
pre-dried, pre-reduced BHIS agar plates supplemented with thiamphenicol (10 µg/mL), 
kanamycin (50 µg/mL), and cefoxitin (10 µg/mL) at 100 µL per plate, five plates per 
conjugation. Plates were monitored for colony growth for 24-72 hrs. Individual colonies 
were struck out for isolation and analyzed for complementation by phase contrast 
microscopy, Western blot analysis and transmission electron microscopy. A minimum of 
two independent clones from each complementation strain was phenotypically 
characterized. 
For the SNAP-tag expression constructs, a pMTL84151 [44] or pMTL84121 [28] 
plasmid backbone was used. The complementation protocol was followed as described 
except that after spots were collected from overnight growth on BHIS plates, 100 µL of 
the resulting PBS suspension was spotted 7 times onto a BHIS agar plate supplemented 
with thiamphenicol (10 µg/mL), kanamycin (50 µg/mL), and cefoxitin (16 µg/mL). This 
procedure was repeated for three plates. 
 
3.4.5. Sporulation assay 
C. difficile strains were grown from glycerol stocks on BHIS plates supplemented 
with TA (0.1% w/v), or with both TA and thiamphenicol (5-10 µg/mL) for strains with 
pMTL83151-derived or pMTL84151-derived plasmids (as previously described [27]). 
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Cultures grown on BHIS agar plates were then used to inoculate 70:30 agar plates (with 
thiamphenicol at 5-10 µg/mL as appropriate) for 17-24 hrs depending on the assay. 
Sporulation induced lawns were harvested in PBS, washed once, resuspended in PBS, 
visualized by phase contrast microscopy, and/or further processed for analysis by 
transmission electron microscopy, Western blotting, or fluorescence microscopy. 
 
3.4.7. Heat resistance Assay 
C. difficile strains were induced to sporulate as described above, and cells were 
harvested in 1.0 mL PBS, and split into two tubes. One tube was heat shocked at 60-65˚C 
for 25 minutes. Both heat-shocked and non-heat shocked cells were serially diluted, and 
cells were plated on pre-reduced BHIS-TA plates. After 20 hrs on BHIS-TA, colonies 
were counted, and cell counts were determined. The percent of heat-resistant spores was 
determined based on the ratio of heat-resistant cells to total cells, and sporulation 
efficiencies were determined based on the ratio of heat-resistant cells for a strain 
compared to wild type. Results are based on a minimum of three biological replicates. 
 
3.4.8. Electron microscopy 
 One hundred microliters of bacterial cell suspension samples from sporulation 
assays were prepared as previously described [45]. 
 
3.4.9. Antibody production  
The anti-SpoIIQ and anti-SpoIIIAH antibodies used in this study were raised in 
rabbits by Cocalico Biologicals (Reamstown, PA). The antigens SpoIIQ-His6 and 
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SpoIIIAH-His6 were purified on Ni2+-affinity resin from E. coli strains #1301 and 1302 
as described above. Cultures were grown and protein expression was analyzed as 
previously described [27]. 
 
3.4.10. Western blot analyses 
Sporulation assay C. difficile cells (50 µL of PBS suspension) were freeze-thawed 
three times, diluted in 100 µL EBB buffer (8 M urea, 2 M thiourea, 4% (w/v) SDS, 2% 
(v/v) β-mercaptoethanol), and incubated at 95˚C for 20 min with vortexing every 5 min. 
Samples were centrifuged for 5 min at 15,000 rpm, and 7 µL of 4X sample buffer (40% 
(v/v) glycerol, 1 M Tris pH 6.8, 20% (v/v) β-mercaptoethanol, 8% (w/v) SDS, and 0.04% 
(w/v) bromophenol blue), was added. Protein samples were incubated again at 95˚C for 
15 minutes with vortexing followed by centrifugation for 5 min at 15,000 rpm. SDS-
PAGE gels (12% - 15%) were loaded with 5 µL of the sample. Gels were transferred to 
Bio-Rad PVDF membrane and blocked in 50% PBS:50% Odyssey® Blocking Buffer 
with 0.1% (v/v) Tween for 30 min at RT. Polyclonal rabbit anti-SpoVT ([27] anti-SpoIIQ 
and anti-SpoIIIAH, antibodies were used at a 1:1,000 dilution. Monoclonal mouse anti-
Spo0A [27] was used at a 1:10,000 dilution. Monoclonal mouse anti-SNAP (NEB) was 
used at a 1:2,000 dilution. IRDye 680CW and 800CW infrared dye-conjugated secondary 
antibodies were used at a 1:20,000 dilutions. The Odyssey LiCor CLx was used to detect 
secondary antibody fluorescent emissions for Western blots. 
 
3.4.11. RNA processing 
RNA from WT, spo0A–, sigF–, spoIIQ–, sigE–, spoIIIA–, spoIIIAH–, and sigG– 
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strains grown for 17 hrs on 70:30 sporulation media was extracted for qRT-PCR analyses 
of spoIIIAA transcript. RNA from WT, spo0A–, sigF–, spoIIQ–, sigE–, spoIIIA–, and sigG– 
strains grown for 25 hr on 70:30 sporulation media was extracted for qRT-PCR analyses 
of spoVT, CD1430, and spoVAD transcripts. RNA from WT/EV, spo0A–/EV, spoIIIAA–
/EV, spoIIIA–/spoIIIA operon, and spoIIIA–/spoIIIAK167A operon complementation 
strains grown for 17 hr on 70:30 sporulation media was extracted for qRT-PCR analyses 
of spoIIIAA transcript. RNA was extracted using a FastRNA Pro Blue Kit (MP 
Biomedical) and a FastPrep-24 automated homogenizer (MP Biomedical). Contaminating 
genomic DNA was depleted using three successive DNase treatments and mRNA 
enrichment was done using an Ambion MICROBExpress Bacterial mRNA Enrichment 
Kit (Invitrogen). Samples were tested for genomic DNA contamination using quantitative 
PCR for rpoB. Enriched RNA was reverse transcribed using Super Script® First Strand 
cDNA Synthesis Kit (Invitrogen) with random hexamer primers. 
 
3.4.12. Quantitative RT-PCR 
 Transcript levels of spoIIIAA and rpoB (housekeeping gene) were determined 
from cDNA templates prepared from 3 biological replicates of WT, spo0A–, sigF–, 
spoIIQ–, sigE–, spoIIIA–, spoIIIAH–, and sigG– and three biological replicates of WT/EV, 
spo0A–/EV, spoIIIA–/EV, spoIIIA–/spoIIIA operon, and spoIIIA–/spoIIIAK167A operon. 
Gene-specific primer pairs for spoIIIAA and rpoB have been previously described 
[29,75]. Transcript levels of spoVT, CD1430, spoVAD, and rpoB were determined from 
cDNA templates prepared from three biological replicates of WT, spo0A–, sigE–, spoIIIA–
, and sigG–. Transcript levels of CD1430 and spoVAD were analyzed using gene-specific 
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primer pairs #1458 and 1459, #1708 and 1709, respectively. Gene-specific primers for 
measuring spoVT transcript levels have been previously described [27]. Quantitative real-
time PCR was performed (as described by [75]). Briefly, using SYBR Green JumpStart 
Taq Ready Mix (Sigma), 50 nM of gene specific primers, and an ABI PRISM 7900HT 
Sequence Detection System (Applied Biosystems). Transcript levels were normalized to 
the housekeeping gene rpoB using the standard curve method and calculated relative to 
either the spo0A– strain or spo0A– strain carrying empty pMTL83151 vector.  
 
3.4.13. SNAP-tag reporter construction 
The CotE-SNAP previously described by Pereira et al. [28] was transformed into 
E. coli HB101/ pK424 and conjugated into the indicated C. difficile strains to analyze 
coat localization in spoIIQ and spoIIIA mutants.  
 C. difficile strains containing SNAP-tag reporters were grown on 70:30 media to 
induce sporulation. Cells were grown as a lawn for 21 hours on solid 70:30 media and 
harvested as described by Pereira et al. [28]. Briefly, cells were harvested in PBS and 
pelleted (4,000 rpm for 3 min), washed once with PBS, reconstituted in 100 µL of PBS. 
TMR-star SNAP substrate (NEB) was added to a final concentration of 3 µM to each 
tube and cells were incubated for 30 min at 37°C. Cells were pelleted, washed 3 times 
with PBS, and resuspended in PBS. Hoechst 33342 (10 mg/ml) was added to a final 
concentration of 15 µg/ml and FM4-64 (200 µg/ml) was added to a final concentration of 
1 µg/mL.  
 
3.4.14. Peptidoglycan Labeling Assay 
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Strains were harvested from 70:30 plates after 14 hours of growth as a bacterial 
lawn and re-suspended in 3 mL of 70:30 liquid media. For each strain used, the culture 
was split into 2 tubes for two conditions, each containing 1.5 mL of culture. Alkyne D-
alanine or D-alanine (ACROS Organics) was added to each tube, respectively, at a final 
concentration of 2.5 mM and incubated at 37°C for 30 min. with mild shaking. After 
incubation, cells were pelleted (8000 rpm for 3 min.) and washed 3x with PBS. Cells 
were resuspended in 0.7 mL of 2% formaldehyde diluted in PBS and incubated for 10 
min on the nutator.  Cells were then pelleted and washed 2x with 1 mL PBS. Cells were 
incubated with 5 mg/mL lysozyme, 37°C, 45 min., pelleted, washed 2x with 1 mL PBS, 
and washed once with 3% BSA (in PBS). For the click chemistry reaction, a Click-iT 
Plus Alexa Fluor 488 Picolyl Azide Toolkit (Molecular Probes) was used according to 
the manufacturer’s instructions. After incubation with Click-iT reagents, samples were 
pelleted and washed 1x with 3% BSA and 1x with PBS. Samples were resuspended and 
Hoechst 33342 (10 mg/ml) was added to a final concentration of 15 µg/ml.  
For the peptidoglycan labeling timecourse, cells were harvested into 5.5 ml of 
70:30 broth after 14 hours of growth on 70:30 plates, and either alkyne D-alanine or D-
alanine (ACROS Organics) was added to each tube. One mL samples of each culture was 
taken at every timepoint (0, 10, 20, 30, and 40 min) and processed as described above. 
For evaluation of peptidoglycan labeling after treatment with antibiotics, 1 ml of 
WT cells in BHIS broth were harvested at late exponential phase for each treatment 
condition. 2X MIC of antibiotics (2 µg/ml vancomycin and 8 µg/ml imipenem) was 
added to designated cells and mixed with mild shaking. Dala and alkDala was added 
immediately after to designated cells and incubated for 30 minutes with mild shaking in 
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the anaerobic chamber. Cells were processed for peptidoglycan labeling as described 
above.  
 
3.4.15. Flow Cytometry 
 The median fluorescent intensity (MFI) of alkDala incorporation was determined 
using a MACSQuant VYB flow cytometer. MACSQuantify™ software was used for data 
collection and FlowJo V.10.0.8 was used for data analysis. Cells that incorporated 
Hoechst dye 33342 (Molecular Probes) were evaluated for alkDala staining based on 
fluorescence in the FITC channel.  
 
3.4.16. His6-tag pulldowns 
E. coli BL21(DE3) strains were grown to mid-log phase in 2YT (5 g NaCl, 10 g 
yeast extract, and 15 g tryptone per liter), 225 rpm, at 37°C. 250 µM isopropyl-β-D-1-
thiogalactopyranoside (IPTG) was added to induce the cells followed by an overnight 
incubation at 18°C. Cultures were pelleted, resuspended in low-imidazole buffer (500 
mM NaCl, 50 mM Tris [pH 7.5], 15 mM imidazole, 10% [vol/vol] glycerol), and lysed 
by freeze-thawing and sonication. The insoluble material was pelleted, and the soluble 
fraction (Input) was batch affinity purified using Ni2+ affinity resin and eluted with high-
imidazole buffer (500 mM NaCl, 50 mM Tris [pH 7.5], 150 mM imidazole, 10% 
[vol/vol] glycerol). The resulting eluates were run on SDS-PAGE gels (12%) and 
transferred onto a PVDF membrane for Western blot analysis, as described above. 
 
3.4.17. Fluorescence Microscopy 
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For live cell fluorescence microscopy studies, C. difficile strains were harvested in 
PBS, pelleted, and resuspended in PBS. For initial characterization of mutant phenotypes, 
cells were resuspended in PBS containing 1 µg/mL FM4-64 (Molecular Probes) and 15 
µg/mL Hoechst 33342 (Molecular Probes). All live bacterial suspensions (4 µL) were 
added to a freshly prepared 1% agarose pad on a microscope slide, covered with a 22 x 
22 mm #1 coverslip and sealed with VALAB (1:1:1 of vaseline, lanolin, and beeswax) as 
previously described [27].  
DIC and fluorescence microscopy was performed using a Nikon PlanApo Vc 
100x oil immersion objective (1.4 NA) on a Nikon Eclipse Ti2000 epifluorescence 
microscope. Multiple fields for each sample were acquired with an EXi Blue Mono 
camera (QImaging) with a hardware gain setting of 1.0 and driven by NIS-Elements 
software (Nikon). Images were subsequently imported into Adobe Photoshop CS6 for 
minimal adjustments in brightness/contrast levels and pseudocoloring.  
DIC and fluorescence microscopy for cells that were processed for peptidoglycan 
labeling experiments were performed and processed with the same equipment as 
described above with the following differences: a Nikon PlanApo Vc 60x oil immersion 
objective (1.4 NA) was utilized, hardware gain setting 2.0, and fields were imaged with 
Z-spacing of 0.15 µm followed by deconvolution using AutoQuant 3x software 
(MediaCybernetics). 
Quantification of total cells undergoing sporulation was determined by analyzing 
multiple fields for each strain at random. At least 50 cells were enumerated for each 
strain. Sporulating cells were identified as either having a polar septum with or without 
DNA staining in the forespore, a DIC-dark forespore with or without DNA staining in the 
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forespore compartment, a DIC-bright forespore without DNA staining, or a free spore (no 
mother cell compartment).  
 
3.5. Results 
3.5.1. SpoIIQ, SpoIIIAA, and SpoIIIAH are required for spore formation. 
To first determine if C. difficile spore development depends on the SpoIIQ and 
SpoIIIA proteins, we constructed targeted gene disruptions in the σF-regulated spoIIQ 
and σE-regulated spoIIIAA and spoIIIAH genes using the ClosTron gene knockout system 
(Fig. S4, [42]). Since targetron insertion into the spoIIIAA gene likely causes polar effects 
on the spoIIIA operon, which includes spoIIIAA-spoIIIAH (Fig. S4), the spoIIIAA 
mutation will be referred to as a spoIIIA mutant from hereon. However, since a second 
promoter within the spoIIIA operon has been shown to drive expression of spoIIIAG and 
spoIIIAH ([29], Fig. S4), the spoIIIA mutant likely still produces SpoIIIAH. Microscopic 
analysis of spoIIQ, spoIIIA, and spoIIIAH mutants during sporulation using the 
membrane dye FM4-64 and the nucleoid dye Hoechst revealed that these mutants are 
defective in engulfment (Fig. 1). The percentage of cells captured at (i) asymmetric 
division, (ii) pre-engulfment with FM4-64 staining and Hoechst staining, (iii) post 
engulfment with FM4-64 staining and Hoechst staining, (iv) post engulfment with FM4-
64 staining and Hoechst exclusion, (v) post engulfment with DIC-bright, FM4-64 
exclusion and Hoechst exclusion, and (vi) free spore was quantified based on analyses of 
100 sporulating cells. Whereas uniform staining of FM4-64 around the entire forespore or 
the presence of DIC-bright spore compartments was observed in wildtype sporulating 
cells 73% of the time (blue, green, white, and pink arrows), FM4-64 staining of 
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sporulating spoIIQ and spoIIIAH mutants was restricted to the curved membrane at the 
mother cell-forespore interface (yellow arrows), and no DIC-bright forespore 
compartments were observed in these mutants, indicative of an engulfment defect. While 
the spoIIQ and spoIIIAH mutants both failed to complete engulfment, the spoIIIA and 
sigG mutants completed engulfment 10% and 24% of the time, respectively, although 
they did not mature to a stage that excluded Hoechst or FM4-64 (Fig. 1). Taken together, 
these results suggest that SpoIIQ and SpoIIIAH are required for C. difficile forespore 
engulfment, while the SpoIIIAA-AF complex may be only partially required for 
engulfment.  
Disruption of C. difficile spoIIQ, spoIIIA, and spoIIIAH resulted in a significant 
decrease in heat-resistant spore formation relative to wild type. Interestingly, while the C. 
difficile spoIIQ mutant did not show evidence of mature spore formation by fluorescence 
microscopy, we observed only a 200-fold defect in heat resistance relative to wild type 
(Fig. 1). Since this defect was not as severe as the ~4-6 log defect reported for B. subtilis 
spoIIQ mutants [19], we investigated the possibility that the heat-resistant C. difficile 
spoIIQ mutant cells might arise from a heritable change by testing the heat resistance of 
subcultured spoIIQ– colonies that arose following heat treatment. The same frequency of 
heat resistance was observed, indicating that the production of heat-resistant spoIIQ– 
spores is a stochastic event. In contrast with the C. difficile spoIIQ mutant, no heat-
resistant spores were observed for the C. difficile spoIIIA– and spoIIIAH– strains within 
the limits of detection of our assay (<10-6, Fig. 1). The heat resistance defect of the C. 
difficile spoIIIA– mutant was similar to the defect reported for a B. subtilis ∆spoIIIAA 
mutant [20], although the C. difficile spoIIIAH– mutant was at least 4-logs more severe 
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than the defect of a B. subtilis ∆spoIIIAH mutant [20].  
To confirm that the spoIIQ, spoIIIA, and spoIIIAH gene disruptions abrogated 
protein production, we analyzed sporulating cell lysates prepared from spoIIQ, spoIIIA, 
and spoIIIAH mutants by Western blotting using antibodies raised against SpoIIQ and 
SpoIIIAH. As expected, SpoIIQ and SpoIIIAH were not detected in the spoIIQ and 
spoIIIAH mutants, respectively, and both proteins were absent in the spo0A mutant, 
which fails to initiate sporulation altogether (Fig. 2A). Consistent with spoIIQ and 
spoIIIAH regulation by σF and σE, respectively [27,29], SpoIIQ was absent from the sigF 
mutant, and SpoIIIAH was absent in the sigE mutant. SpoIIIAH was nevertheless 
detected at wildtype levels in the spoIIIA mutant, since an internal promoter drives 
expression of spoIIIAG-AH ([29], Fig. S4A) similar to the regulation of the B. subtilis 
spoIIIA operon [43]. Wildtype levels of SpoIIQ were observed in the spoIIIAH mutant, 
and vice versa, suggesting that loss of the predicted interaction between SpoIIQ and 
SpoIIIAH did not affect their steady state levels. Wildtype levels of SpoIIQ and 
SpoIIIAH were also observed in the sigG mutant, suggesting that this mutant’s 
engulfment defect did not result from the absence of these components. The small 
amount of SpoIIIAH that was detected in a sigF mutant (Fig. 2A) is consistent with the 
partial activation of σE in a sigF mutant [27,29].  
Since we were unable to generate a working antibody for detecting SpoIIIAA, we 
measured spoIIIAA transcript levels in the same strains. Consistent with the previously 
reported regulation of spoIIIAA by σE [27,29], statistically significant decreased levels of 
spoIIIAA transcripts were observed in spo0A, sigF, and sigE mutants relative to wild type 
(Fig. 2B, p < 0.01). spoIIIAA transcript levels were unaffected in the spoIIQ, spoIIIAH, 
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and sigG mutants (Fig. 2B), indicating that loss of SpoIIQ or SpoIIIAH does not alter 
spoIIIAA expression. spoIIIAA transcripts could not be accurately measured in the 
spoIIIA mutant, since the amplification product is downstream of the targetron insertion. 
 
3.5.2. Plasmid complementation rescues the sporulation defects of spoIIQ, spoIIIA, 
and spoIIIAH mutants. 
To validate that the observed mutant phenotypes were due to the targeted 
insertions, we attempted to complement the mutant strains with a wildtype copy of the 
disrupted gene(s) expressed from their native promoter using the pMTL83151 multicopy 
plasmid [44]. The spoIIIA mutant was complemented with the full spoIIIA operon, and 
the spoIIIAH mutant was complemented with either the full spoIIIA operon, or the 
spoIIIAH gene alone (Fig. S5). The spoIIQ and spoIIIA complementation constructs all 
restored production of heat-resistant, DIC-bright spores to their respective mutant 
backgrounds (Fig. S5). While complementation of the spoIIIAH mutant with either the 
spoIIIA operon or spoIIIAH gene under the control of the spoIIIA promoter restored heat-
resistant spore production, the spoIIIA operon conferred ~8-fold higher heat-resistance to 
the spoIIIAH mutant relative to complementation with the spoIIIAH gene alone. Western 
blot analysis revealed that SpoIIIAH levels were elevated in the spoIIIA operon 
complementation strain relative to spoIIIAH complementation strain and wildtype 
carrying empty vector (Fig. S6). Complementation of spoIIQ– resulted in ~4-fold greater 
heat-resistant spore formation than wildtype carrying empty vector. Western blot analysis 
indicated that SpoIIQ levels were slightly elevated in the spoIIQ complementation strain 
relative to wildtype carrying empty vector (Fig. S6).  
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Fluorescence microscopy analyses of the spoIIQ, spoIIIA, and spoIIIAH strains 
carrying empty vector confirmed that the majority of mutant cells failed to complete 
engulfment (Fig. S5, yellow arrows). On rare occasions, we observed that the spoIIIA 
mutant carrying empty vector completed engulfment (Fig. S5, blue arrow), similar to our 
observations with the spoIIIA mutant alone (Fig. 1). Regardless, these results indicate that 
the gene disruptions in the spoIIQ, spoIIIAA and spoIIIAH genes are responsible for the 
observed engulfment and heat-resistance defects. 
 
3.5.3. Engulfment defects in the spoIIQ, spoIIIA, and spoIIIAH mutants.  
To gain further insight into the nature of the engulfment defect in the spoIIQ, 
spoIIIA, and spoIIIAH mutants, we analyzed each mutant using transmission electron 
microscopy (TEM). We failed to observe engulfment of spoIIQ and spoIIIAH mutants 
based on analyses of over 50 cells that had progressed beyond asymmetric division for 
each mutant, with engulfment being defined as the mother cell-derived membrane 
surrounding the entire forespore (Fig. 3). The spoIIIA mutant was observed to complete 
engulfment in ~20% of cells analyzed by TEM, even though this mutant failed to produce 
heat-resistant spores (Fig. 1). In contrast, none of the spoIIQ and spoIIIAH mutant cells 
strains completed engulfment. However, since heat-resistant spoIIQ– spores could be 
detected at a frequency of 1 in 200 (Fig. 1), we extensively analyzed the TEM grids and 
identified a single spoIIQ– cell that had completed engulfment (Fig. S7A). Taken 
together, these results confirm the live cell microscopy analyses (Fig. 1): loss of SpoIIQ 
and SpoIIIAH causes a severe defect in forespore engulfment, while the apparent loss of 
SpoIIIAA-AF in the spoIIIA mutant still permits engulfment in 10-20% of cells.  
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3.5.4. spoIIQ, spoIIIA, and spoIIIAH mutants exhibit defects in adhering coat to the 
forespore and maintaining forespore integrity. 
In addition to the engulfment defects observed in the spoIIQ, spoIIIA, and 
spoIIIAH mutants by TEM, a second “compartment” was often observed to extend from 
the forespore of the spoIIQ, spoIIIA, and spoIIIAH mutants (Fig. 3, white arrows). Closer 
inspection of these extensions revealed multiple striated lines that were consistent with 
coat. The mutant coat-like structures appeared to anchor to the leading edge of the 
engulfing membrane but were not adhered to the mother cell-forespore interface in the 
majority of cells with engulfment defects. Coat-like structures were present 100% of the 
time in spoIIQ–, spoIIIA–, and spoIIIAH– strains that had begun engulfment; these 
structures appeared anchored to the leading edge of the engulfing membrane 94%, 96%, 
and 66% of the time in spoIIQ–, spoIIIA–, and spoIIIAH– strains, respectively. A similar 
phenotype was observed in the sigG– strain (Fig. 3, [27]). In some instances, the coat-like 
structures were not associated with the forespore at all and were instead mislocalized to 
the mother cell cytosol, similar to the previously described coat mislocalization 
phenotype of a spoIVA mutant ([45], Fig. 3, yellow arrows). In particular, mislocalized 
cytosolic coat was observed with high frequency in the spoIIIAH mutant (51%), 
regardless of whether the coat was anchored to the leading edge. For the spoIIQ–, 
spoIIIA–, and spoIIIAH– cells that had coat anchored to the leading edge of the engulfing 
membrane, 98%, 89%, and 94%, respectively, did not have coat intimately associated 
with the forespore interface (Fig. 3, white arrows). Notably, the rare spoIIIA and spoIIQ 
mutants that completed engulfment had visible coat surrounding the forespore 
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compartment by TEM (Fig. S7A, black arrows). Furthermore, in wildtype cells, coat was 
only observed after engulfment was complete.  
To confirm that the coat-like assemblages observed in the spoIIQ, spoIIIA, 
spoIIIAH, and sigG mutants were indeed coat, we analyzed the localization of a known 
coat protein in these mutant backgrounds. In particular, we correlated the localization of 
the previously reported surface-exposed coat protein CotE fused to a SNAP imaging tag 
[28] with FM4-64 and Hoechst staining. The CotE-SNAP protein fusion was detected 
concentrated at both poles of the developing forespore in wild type, with a weaker signal 
surrounding the forespore (Fig. 4) similar to the previously reported localization of this 
protein fusion around the forespore [28]. Faint CotE-SNAP staining was observed around 
free spores of wild type, consistent with the surface localization of CotE [46,47]. In 
contrast, in the spoIIQ, spoIIIA, and spoIIIAH mutants, CotE-SNAP signal was 
frequently offset from FM4-64 staining of the forespore membrane. The CotE-SNAP 
signal was also observed mislocalized to the mother cell cytosol in these mutants (Fig. 4), 
similar to the displacement of the CotE-SNAP signal to the mother cell cytosol of the 
spoIVA mutant, which has previously been shown to mislocalize coat [45]. While the 
FM4-64 readily stained forespore membranes, it also appeared to associate with 
mislocalized coat in the spoIVA, spoIIQ, spoIIIA, and spoIIIAH mutants (Fig. 4, yellow 
arrows), making it difficult to assess by light microscopy whether CotE-SNAP was 
adhered to the forespore membrane. Nevertheless, combined with our TEM data, the 
CotE-SNAP localization experiments strongly suggest that coat detaches from the 
forespore and/or completely mislocalizes to the mother cell cytosol in the absence of 
SpoIIQ and SpoIIIA proteins.  
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While the dominant phenotypes observed by TEM for spoIIQ, spoIIIA, and 
spoIIIAH mutants are shown in Fig. 3, 13%, 14%, and 27% of spoIIQ, spoIIIA, and 
spoIIIAH mutant cells, respectively, harbored forespores that were undergoing forespore 
collapse. In particular, large invaginations of the forespore membrane were observed in 
these mutants (Fig. S7B, blue arrows), similar to the phenotypes previously described for 
B. subtilis mutants lacking SpoIIQ or SpoIIIA complex components [20]. These results 
indicate that these proteins in C. difficile are also required to maintain forespore integrity, 
similar to B. subtilis [20].  
 
3.5.5. C. difficile σG activity does not depend on SpoIIQ, SpoIIIAA, and SpoIIIAH. 
In addition to maintaining forespore integrity in B. subtilis, the feeding tube is 
required to sustain transcription in the forespore [19] and thus is necessary for σG activity 
[19,20,25,40]. However, previous transcriptional analyses in C. difficile suggested that 
the “feeding tube” components were dispensable for σG activity, since a C. difficile σG-
dependent transcriptional reporter is produced in the forespore of a sigE mutant [28], and 
the σG regulon is expressed at wildtype levels in the sigE mutant [27,29].  To test whether 
C. difficile spoIIQ, spoIIIA, and spoIIIAH are required for σG activity, we measured σG-
dependent transcript levels in wild type, spoIIQ, spoIIIA and sporulation sigma factor 
mutants using quantitative RT-PCR. As expected, no statistically significant difference in 
σG-dependent transcripts spoVT, spoVAD, and CD1430 [27,29], were observed in the 
feeding tube mutants (Fig. S8). Consistent with the dependence of σG activity on Spo0A 
and σF, spoVT was significantly decreased in spo0A, sigF, and sigG mutants (p < 
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0.0005), CD1430 was significantly decreased in spo0A, sigF, and sigG mutants (p < 
0.05) and spoVAD was significantly decreased in spo0A, sigF, and sigG mutants (p < 
0.01, 0.01, and 0.05, respectively).  
Since it is possible that the wildtype levels of σG activity detected in spoIIQ and 
spoIIIA mutants by qRT-PCR may derive from improper σG activation in the mother cell, 
we used the σG-dependent SNAP-tag transcriptional reporter to visualize σG activation in 
spoIIQ and spoIIIA mutants. The promoter region of the σG-dependent sspA gene 
previously described by Pereira et al. [28] was fused to a codon-optimized SNAP gene 
and conjugated into wildtype, sigF–, spoIIQ–, sigE–, spoIIIA–, spoIIIAH–, and sigG– 
strains. Similar to the previous reports [28], SNAP labeling with the TMR-Star substrate 
(i.e. σG activity) was restricted to the forespore of cells that had completed asymmetric 
division or engulfment (Fig. 5A). No SNAP signal was detectable in either the sigF or 
sigG mutants (Fig. 5A, black arrows), as expected. In contrast, σG-dependent SNAP 
labeling was detectable in the forespores of cells undergoing sporulation in the spoIIQ–, 
sigE–, spoIIIA–, and spoIIIAH– strains (Fig. 5A, yellow arrows). The prevalence of σG-
dependent transcription in cells undergoing sporulation (based on the presence of an 
asymmetric septum, engulfment initiated, or engulfment completed phenotype) was 
determined by counting the number of cells exhibiting SNAP labeling. The σG-dependent 
transcriptional reporter was produced in the forespore of spoIIQ–, spoIIIA–, and 
spoIIIAH– cells 58%, 57%, and 50%, respectively, of sporulating cells, which was similar 
to the frequency observed in wild type (57%, Fig. 5A). The SNAP signal was observed in 
the forespore of the sigE mutant in 28% of sporulating cells. Western blot analyses 
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confirmed that wildtype levels of SNAP protein were observed in spoIIQ, sigE, spoIIIA, 
and spoIIIAH mutants (Fig. 5B). Taken together, these results demonstrate that the C. 
difficile SpoIIQ and SpoIIIA components are dispensable for maintaining transcription in 
the forespore, in contrast with B. subtilis [19]. 
 
3.5.6. SpoIIQ and SpoIIIAH interact 
Since these analyses indicated that the C. difficile SpoIIQ and SpoIIIA proteins 
regulate different cellular processes during sporulation than in B. subtilis, namely σG 
activity and forespore engulfment, we next sought to investigate how these components 
regulated these processes. We first tested whether the C. difficile feeding tube 
components assemble into a complex as has been shown in B. subtilis [34], since the 
interaction between SpoIIQ and SpoIIIAH is necessary for feeding tube function in B. 
subtilis [35]. Using a co-affinity purification assay, we determined whether C. difficile 
SpoIIQ and SpoIIIAH directly interact through their extracellular domains. To this end, 
we co-expressed His6-tagged SpoIIQ and HA-tagged SpoIIIAH, both lacking their 
transmembrane domains, in E. coli. Affinity purification of His6-tagged SpoIIQ resulted 
in the co-purification of HA-tagged SpoIIIAH, whereas HA-tagged SpoVT, which was 
used as a specificity control, did not co-purify with His6-tagged SpoIIQ when co-
expressed (Fig. 6). Thus, despite the low degree of sequence homology between B. 
subtilis and C. difficile SpoIIQ orthologs (Fig. S3), C. difficile SpoIIQ and SpoIIIAH 
directly interact in vitro through their extracellular domains, consistent with the 
hypothesis that these proteins form a complex that bridges the intercompartmental space 
between the mother cell and forespore [34,41]. 
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3.5.7. Mutation of the SpoIIQ LytM catalytic triad does not strongly impact 
sporulation. 
 Based on these findings, we next tested whether the predicted catalytic activities 
of SpoIIQ and SpoIIIAA were required for their function. The LytM domain of C. 
difficile SpoIIQ carries an intact catalytic triad consisting of two conserved motifs: 
HxxxD and HxH [30]. These motifs coordinate a metal ion (commonly zinc) that is 
essential for endopeptidase activity, which degrades the peptide linkages that crosslink 
the glycan strands of peptidoglycan [48]. To determine if C. difficile SpoIIQ’s 
endopeptidase activity is necessary for sporulation, we complemented the spoIIQ mutant 
with a spoIIQ variant encoding a histidine 120 to alanine mutation (spoIIQ–/H120A, Fig. 
S3), which should inactive its predicted endopeptidase activity. Analysis of this strain in 
the heat resistance assay indicated that the H120A mutation caused an ~50% reduction in 
heat-resistant spore formation relative to wildtype carrying empty vector (Fig. S9). TEM 
analyses revealed that 52% of spoIIQ–/H120A cells completed engulfment compared to 
88% of the wildtype complementation strain (spoIIQ–/spoIIQ) and 96% of wildtype 
carrying empty vector (Fig. S9). These results indicate that the endopeptidase activity of 
SpoIIQ plays a minor role in regulating C. difficile sporulation under the conditions 
tested. 
 
3.5.8. The Walker A motif of SpoIIIAA is important for C. difficile sporulation.  
SpoIIIAA is predicted to function as an ATPase, since strains carrying mutations 
of conserved residues in the Walker A and B boxes (Fig. S1, [49]) in B. subtilis resemble 
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a ∆spoIIIAA mutant [20]. Disruption of the Walker A motif typically prevents ATP 
binding [50], while disruption of the Walker B motif typically prevents ATP hydrolysis 
without affecting ATP binding [51,52]. To determine whether the ATPase activity of C. 
difficile SpoIIIAA is also required for spore formation, we constructed complementation 
strains encoding SpoIIIAA carrying a Walker A lysine mutation, K167A, a Walker B 
aspartate mutation, D244A, and a Walker A/Walker B double mutation K167A/D244A 
(Fig. S1), and tested their ability to complement the heat resistance defect of a spoIIIA 
mutant. The K167A mutant, expressed from a spoIIIA operon complementation plasmid 
exhibited ~300-fold defect relative to wildtype carrying empty vector (Fig. 7). 
Interestingly, only 6% of sporulating K167A cells completed engulfment when analyzed 
by TEM compared to 20% of the parent spoIIIA– strain carrying empty vector (Fig. 7), 
and similar results were observed by FM4-64 and Hoechst staining (Fig. S10).  The 
D244A mutant exhibited close to wildtype levels of heat resistance (~3-fold decrease), 
consistent with its ability to complete engulfment 35% of the time (Fig. 7).  The 
K167A/D244A double mutant resembled the K167A single mutant in exhibiting a three-
log decrease in heat resistance and ~4% engulfment efficiency relative to wild type. In 
contrast, the wildtype complementation strain (spoIIIA–/spoIIIA) exhibited wildtype 
levels of heat resistance and engulfment completion (Fig. 7).  
Since we could not test whether the K167A, D244A, or K167A/D244A 
mutation(s) affected SpoIIIAA protein levels due to the absence of a working antibody, 
we compared spoIIIAA transcript levels in the K167A mutant, whose heat resistance and 
engulfment defect was more severe than the D244A mutant and equivalent to the double 
mutant (Fig. 7), relative to wildtype carrying empty vector and the spoIIIA 
 172 
complementation strain. These analyses indicated that spoIIIAA transcript levels in the 
K167A complementation strain were similar to the spoIIIA complementation strain and 
wildtype carrying empty vector (Fig. S6B). Since the Walker A K167A mutation was 
considerably more severe than the Walker B D244A mutation, our results suggest that 
SpoIIIAA function likely depends on its ability to bind, but not necessarily hydrolyze, 
ATP. Given that B. subtilis SpoIIIAA function completely depends on the presence of 
intact Walker A and Walker B boxes [20], C. difficile SpoIIIAA appears to have 
differential requirements for its function relative to B. subtilis.  
 
3.5.9. spoIIQ, spoIIIA, and spoIIIAH mutants actively transform peptidoglycan 
around the forespore despite their engulfment defects. 
The engulfment defects of the C. difficile spoIIQ, spoIIIA, and spoIIIAH mutants 
prompted us to investigate the mechanisms underlying this engulfment defect. In B. 
subtilis, peptidoglycan hydrolase enzymes that degrade the peptidoglycan layer between 
the mother cell and forespore drive engulfment [53-55]. Subsequent transformations of 
this peptidoglycan layer, which involve both the making and breaking of peptide and 
glycan bonds, essentially “cut” the forespore free of the mother cell until engulfment is 
complete [56]. Since transpeptidases and/or ligases can incorporate D-alanine into the 
stem peptide that is conjugated to the glycan strand of peptidoglycan [57], newly 
remodeled and/or synthesized peptidoglycan can be metabolically labeled using unnatural 
D-alanine derivatives conjugated to bioorthogonal functional groups [58,59]. To 
determine if peptidoglycan remodeling and/or synthesis is active during C. difficile 
forespore engulfment, we incubated sporulating C. difficile cultures with D-alanine 
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bearing an alkyne group and visualized its incorporation into peptidoglycan over time 
using copper-catalyzed click chemistry [59]. Alkyne D-alanine, referred to as “alkDala,” 
was labeled through the azide-alkyne cycloaddition of an azide group conjugated to a 
fluorescein-derivative [60]. 
Analysis of wildtype sporulating cells using this metabolic labeling assay revealed 
that fluorescent peptidoglycan signal (PG) was detectable within 10 min of incubating the 
culture with alkDala (Fig. 8 and S11). After 30 min of incubation with alkDala, the 
peptidoglycan signal was observed surrounding the forespore and, to a lesser extent, the 
mother cell (Fig. 8). In contrast, when the spoIIQ mutant was incubated with alkDala for 
10 min or longer, peptidoglycan remodeling and/or synthesis was localized primarily at 
the curved septa at the mother cell-forespore interface (Fig. 8), consistent with the spoIIQ 
mutant’s engulfment defect (Fig. 1). Incubation of the sigE mutant with alkDala resulted 
in labeling of the polar septa and mother cell peptidoglycan after 20 min of incubation 
with alkDala. For comparison, B. subtilis engulfment requires ~45 min to complete 
[61,62], and sporulation occurs more slowly in C. difficile than in B. subtilis [27,28]. 
To determine the optimal length of time for measuring alkDala incorporation 
during sporulation, we analyzed the distribution of the alkDala label in sporulating wild 
type cells 10’, 20’, 30’, and 40’ after alkDala addition. Sporulating wildtype cells with 
visible peptidoglycan labeling were binned into the following categories: (i) no staining 
of the forespore, (ii) labeling of the polar septum, (iii) partial labeling of the forespore on 
the mother cell distal side (i.e. labeling after engulfment has initiated), (iv) partial 
labeling around the middle of the forespore, (v) partial labeling of the forespore on the 
mother cell proximal side, (vi) labeling around the entire forespore (Fig. S11). Based on 
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these analyses, we chose to label cells after a 30 minute incubation with alkDala, since 
this was the earliest time point at which full labeling of the forespore was detected in the 
majority of wildtype sporulating cells (Fig. S11). 
As expected, the alkDala probe labeled division septa in all strains (Fig. S12A), 
and fluorescent labeling was not observed in wildtype cells incubated with D-alanine, 
which cannot undergo cycloaddition (Fig. S12B), or at time 0 min, even though the 
samples were exposed to the azido-fluorophore probe (Fig. 9). To ensure that alkDala 
specifically labeled newly transformed PG, we incubated WT cells with the cell wall 
synthesis inhibitors vancomycin and imipenem prior to addition of alkDala and evaluated 
alkDala incorporation by flow cytometry. Vancomycin inhibits cell wall synthesis by 
preventing both transpeptidation and transglycosylation [63], and imipenem covalently 
inhibits the penicillin binding proteins required for transpeptidation [64]. Incubation of 
wildtype cells with alkDala resulted in a statistically significant increase in median 
fluorescent intensity (MFI) relative to the MFI of WT cells incubated with Dala (Fig. 
S13; p < 0.0001). While vancomycin treatment did not reduce alkDala labeling relative to 
the positive control in a statistically significant manner, imipenem treatment decreased 
alkDala label incorporation ~5-fold relative to the positive control (p < 0.0001). Taken 
together, these results suggest that the alkDala probe specifically labels newly 
synthesized and/or remodeled peptidoglycan, and peptidoglycan continuously surrounds 
the C. difficile forespore throughout engulfment as previously observed in B. subtilis 
[65]. 
Since the metabolic labeling time course demonstrated that the fluorescent signal 
was maximal after 30 min of alkDala incorporation, we used this labeling period to assess 
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whether C. difficile mutants defective in engulfment could remodel and/or synthesize 
peptidoglycan around the forespore. Although the metabolic label was evenly distributed 
around the entire perimeter of wildtype forespores, the label was only partially distributed 
around the mother cell proximal side of the forespore in engulfment-defective spoIIQ, 
spoIIIA, spoIIIAH, and sigG mutants (Fig. 9). These results suggest that the engulfment 
defect of the spoIIQ, spoIIIA, spoIIIAH, and sigG mutants is not due to a failure to 
activate peptidoglycan remodeling and/or synthesis. Instead, the active peptidoglycan 
transformations observed in the spoIIQ, spoIIIA, and spoIIIAH mutants appear to be 
insufficient to drive engulfment to completion. 
 
3.6. Discussion 
Since the SpoIIIAA-AH components of the B. subtilis “feeding tube” channel are 
universally conserved in spore-forming organisms [31,32], and a SpoIIQ-like ortholog is 
conserved in the Clostridia [32], we hypothesized that these proteins would play a critical 
role in regulating C. difficile spore formation. In this study, we have demonstrated that C. 
difficile SpoIIQ and SpoIIIA proteins control forespore engulfment and integrity and the 
intimate association of the coat with the forespore (Figs. 3, 4 and S7). Although SpoIIQ 
and SpoIIIAH are strongly required for engulfment, the SpoIIIAA-AF proteins appear to 
be only partially required for engulfment completion in C. difficile, since the spoIIIA 
mutant completes engulfment ~10-20% of the time (Figs. 1, 7, and S7). Given that this 
mutant produces wildtype levels of SpoIIQ and SpoIIIAH (Fig. 2), and SpoIIQ and 
SpoIIIAH directly interact at least in vitro (Fig. 6) similar to their B. subtilis counterparts 
[34], C. difficile SpoIIQ and SpoIIIAH would appear to be sufficient to complete 
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engulfment in some spoIIIA mutant cells.  
While it remains possible that SpoIIIAG also regulates C. difficile forespore 
engulfment in the spoIIIA mutant, our observations are nevertheless consistent with the 
proposal that SpoIIQ-SpoIIIAH complex functions like a “Brownian” ratchet to allow for 
“zipper-like” engulfment [41]. Indeed, the finding that the SpoIIQ H120A mutant 
exhibits only a partial defect in engulfment completion and heat-resistant spore formation 
relative to wild type (~50%, Fig. S9) implies that SpoIIQ-SpoIIIAH complex formation is 
more important for engulfment completion than the putative endopeptidase activity of C. 
difficile SpoIIQ. In contrast, B. subtilis SpoIIQ lacks endopeptidase activity, and the 
SpoIIQ-SpoIIIAH complex is dispensable for engulfment when sporulation is induced by 
the re-suspension method [20,41,66]. However, when sporulation is induced by nutrient 
exhaustion, B. subtilis SpoIIQ is required to complete engulfment [22,33,41]. This 
observation suggests that media composition causes changes within sporulating cells such 
that some sporulation proteins are differentially required for engulfment. Since the 70:30 
media used to induce C. difficile sporulation in this study resembles the nutrient 
exhaustion media used in B. subtilis [67], it will be interesting to test whether differences 
in media compositions and sporulation conditions (e.g. broth vs. plate-based induction) 
will lead to differential requirements for C. difficile SpoIIQ and SpoIIIAH during 
engulfment. Indeed, C. difficile sigG mutants appear to exhibit differences in engulfment 
completion when sporulation is induced in broth vs. on plates, although slight differences 
in strain background could be responsible for this difference [27,28]. Regardless, the 
engulfment defects of C. difficile spoIIQ and spoIIIAH mutants suggest that the ancestral 
function of the SpoIIQ-SpoIIIAH complex is to control engulfment during sporulation 
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[68].  
Even though SpoIIQ and SpoIIIAH appear to be sufficient to mediate engulfment 
in ~15% of C. difficile spoIIIA– cells, the spoIIIA– mutant nevertheless failed to produce 
heat-resistant spores. Since the spoIIIA– mutant is likely defective in producing the 
SpoIIIAA-AF proteins (Fig. S4), these proteins would appear to regulate steps beyond 
engulfment during C. difficile sporulation (Fig. 1). Indeed, our mutational analyses 
implicate SpoIIIAA’s predicted ability to bind ATP as being critical for engulfment 
completion, since mutation of the Walker A ATP binding motif (K167A) results in an 
~300-fold defect in heat-resistant spore formation relative to wild type (Fig. 7). 
Interestingly, ATP hydrolysis would appear to be less important for SpoIIIAA’s function 
during spore formation, since the Walker B mutant (D244A) exhibits only a 3-fold defect 
in engulfment and heat-resistant spore formation (Fig. 7). Given that the phenotype of the 
K167A/D244A double mutant resembles that of the K167A single mutant, nucleotide 
binding by SpoIIIAA may induce a conformational change within the protein that is 
necessary for its function. Consistent with this hypothesis, B. subtilis SpoIVA Walker A 
ATP binding mutants exhibit different phenotypes from Walker B ATPase mutants [52]. 
Alternatively, a different aspartate residue may substitute for the predicted role of D244 
in catalyzing C. difficile SpoIIIAA’s ATPase activity. While this functional redundancy 
is formally possible, we note that the equivalent Walker B mutation in B. subtilis 
SpoIIIAA (D224A) causes a heat-resistant spore formation defect equivalent to a 
∆spoIIIAA mutant [20]. It will be important in future studies to determine whether C. 
difficile SpoIIIAA binds and hydrolyzes ATP, and whether these activities are necessary 
to power transport of proteins and/or metabolites from the mother cell to the forespore 
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similar to B. subtilis SpoIIIAA [19-21]. 
While the C. difficile spoIIIA mutant completed engulfment in ~10-20% of cells 
yet failed to produce heat-resistant spores, the C. difficile spoIIQ mutant exhibited a 
severe engulfment defect and produced heat-resistant spores 0.5% of the time relative to 
wild type. The mechanism by which spoIIQ– cells form functional spores remains 
mysterious given that SpoIIIAH likely binds SpoIIQ during C. difficile sporulation (Fig. 
6) and is required for heat-resistant spore formation. Interestingly, a differential 
requirement for SpoIIIAH is observed in B. subtilis, since a spoIIIAH mutant has a 1000-
fold less severe phenotype relative to other spoIIIA mutants [20]. While a mechanism 
underlying these differential phenotypes remains unclear for both C. difficile and B. 
subtilis, functionally redundant mechanisms appear to exist in both organisms. Testing 
this hypothesis in C. difficile would be greatly aided by analyses of C. difficile SpoIIQ 
and SpoIIIA protein complex formation during sporulation. 
Although the SpoIIQ and SpoIIIA proteins regulate C. difficile forespore 
engulfment, these proteins appear dispensable for σG activity in the forespore (Figs. 5 and 
S8) as predicted [27,29]. Despite these observations, it nevertheless remains possible that 
these proteins are needed to sustain σG activity after engulfment is complete. Contrary to 
this model, the number of spoIIIA– cells that activated σG was identical to wild type (Fig. 
5). Nevertheless, since we cannot assess the duration of σG activity in the forespore due 
to the inability to synchronize sporulation in C. difficile [27,28,45], it remains possible 
that the forespore may require resources from the mother cell in a SpoIIQ- and SpoIIIA-
dependent manner during late stages of sporulation.  
 Our analyses also uncovered a surprising role for C. difficile SpoIIQ and SpoIIIA 
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proteins in regulating the adherence of the spore coat to the engulfing forespore. TEM 
analyses revealed that the spore coat appears to localize and anchor to the leading edge of 
the engulfing membrane but sometimes sloughs away from the mother cell-forespore 
interface (Fig. 3). Unfortunately, little is known about the mechanisms by which the 
spore coat localizes around the forespore in C. difficile, since few coat morphogenetic 
proteins are conserved between C. difficile and B. subtilis [18]. SpoIVA and the 
clostridial-specific SipL have been shown to function as coat morphogenetic proteins by 
localizing the coat to the forespore in C. difficile [45], but how these proteins are 
recruited to the forespore membrane is unclear. Our results suggest an intriguing link 
between engulfment completion and adhering coat around the forespore, since the 
minority of spoIIIA– and spoIIQ– cells that completed engulfment produced coat 
surrounding the forespore (Fig. S7). Perhaps proteins localized to the leading edge of the 
engulfing membrane recruit C. difficile coat proteins but are insufficient to adhere the 
coat to the forespore in the absence of engulfment completion, or mechanical forces that 
drive engulfment to completion are also required to intimately associate the coat with the 
forespore. 
A link between SpoIIQ and coat localization around the forespore has been 
described in B. subtilis, since SpoIIQ is required for many coat proteins, including the σE-
dependent coat protein CotE (unrelated to C. difficile CotE [47]), to surround the 
forespore in a process known as “encasement” [69]. Since B. subtilis CotE localizes 
properly in a sigG mutant [69], the B. subtilis spoIIQ mutant’s ~30-fold encasement 
defect suggests that components of the coat indirectly interact with the forespore-
localized SpoIIQ. It should be noted, however, that CotE in a B. subtilis spoIIQ mutant 
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appears to track along the mother cell-forespore interface [69], in contrast with C. 
difficile spoIIQ, spoIIIA, and spoIIIAH mutants in which coat is located some distance 
from this interface due to an apparent defect in adhering to the forespore (Figs. 3 and 4). 
Furthermore, the B. subtilis ∆spoIIQ mutant completes engulfment in the conditions used 
for the coat localization studies, whereas the C. difficile spoIIQ mutant largely fails to 
complete engulfment (Figs. 3, S7 and S9). Since B. subtilis CotE localization around the 
forespore depends upon earlier morphogenetic proteins SpoVM, SpoIVA, and SpoVID 
[69], it would be interesting to determine whether B. subtilis “feeding tube” components 
affect the localization of these earlier morphogenetic proteins, and vice versa. Similarly, 
C. difficile CotE is a σK-regulated protein that appears to localize to the outermost layers 
of C. difficile spores [46], so determining the localization patterns of SpoIVA and/or SipL 
in the spoIIQ, spoIIIA, and spoIIIAH mutants may provide insight into whether SpoIIQ 
and/or SpoIIIAA-AH regulate the localization of these coat morphogenetic proteins. 
Future studies evaluating whether these proteins form a channel in C. difficile, why these 
proteins are important for forespore integrity, and how these proteins regulate engulfment 
and coat association with the forespore will provide much-needed insight into how these 
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Table 1. C. difficile strains used in this study. 
Strain  C. difficile strain Relevant genotype or features 
11 JIR8094 erm-sensitive derivative of 630 [71] 
13 630 Clinical isolate 630 [72] 
35 spo0A– JIR8094 spo0A::ermB 
50 sigE– JIR8094 sigE::ermB 
67 sigK– JIR8094 sigK::ermB 
71 JIR8094/pMTL84151 JIR8094/pMTL84151 
99 sigG– JIR8094 sigG::ermB 
106 sigF– JIR8094 sigF::ermB 
111 JIR8094/pMTL83151 JIR8094/pMTL83151 
218 JIR8094 spo0A–/pMTL83151 JIR8094 spo0A::ermB/pMTL83151 
251 spoIIIA– JIR8094 spoIIIAA::ermB 
253 spoIIQ– JIR8094 spoIIQ::ermB 
295 spoIIQ–/pMTL83151-spoIIQ JIR8094 spoIIQ::ermB/pMTL83151-spoIIQ 
297 spoIIIA–/pMTL83151-spoIIIA JIR8094 spoIIIAA::ermB/pMTL83151-spoIIIA operon 
307 spoIIIA–/pMTL83151 JIR8094 spoIIIAH::ermB/pMTL83151 
331 spoIIQ–/pMTL83151 JIR8094 spoIIQ::ermB/pMTL83151 
415 spoIIIAH– JIR8094 spoIIIAH::ermB 
433 spoIIIAH–/pMTL83151-spoIIIA JIR8094 spoIIIAH::ermB/pMTL83151-spoIIIA operon 
441 spoIIIA–/pMTL83151-spoIIIA K167A JIR8094 spoIIIAA::ermB/pMTL83151-spoIIIA operon K167A 
449 spoIIIAH–/pMTL83151 JIR8094 spoIIIAH::ermB 
525 spoIIIAH–/pMTL83151-spoIIIAH JIR8094 spoIIIAH::ermB/pMTL83151-spoIIIAH 
540 sigG–/pMTL84121-cotE-SNAP JIR8094 sigG::ermB/pMTL84121-cotE-SNAP 
542 spoIIQ–/pMTL84121-cotE-SNAP JIR8094 spoIIQ::ermB/pMTL84121-cotE-SNAP 
546 spoIIIA–/pMTL84121-cotE-SNAP JIR8094 spoIIIAA::ermB/pMTL84121-cotE-SNAP 
570 JIR8094/pMTL84121-cotE-SNAP JIR8094/pMTL84121-cotE-SNAP 
591 spoIVA–/pMTL84121-cotE-SNAP JIR8094 spoIVA::ermB/pMTL84121-cotE-SNAP 




















649 spoIIIAH–/pMTL84121-cotE-SNAP JIR8094 spoIIIAH::ermB/pMTL84121-cotE-SNAP 
752 spoIIQ–/pMTL83151-spoIIQ H120A JIR8094 spoIIQ::ermB/pMTL83151-spoIIQ H120A 





spoIIIA operon K167A/D244A 
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Table S1. E. coli strains used in this study. 
 
Strain  
Relevant genotype or features Source or 
reference 
DH5α 
F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 
hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
D. 
Cameron 
BL21(DE3) F– ompT hsdSB(rB–, mB–) gal dcm (DE3) Novagen 
HB101 
F- mcrB mrr hsdS20(rB- mB-) recA13 leuB6 ara-13 
proA2 lavYI galK2 xyl-6 mtl-1 rpsL20 
C. 
Ellermeier 
7 pET22b in DH5α D. Higgins 
269 pET28a in DH5α M. Bogyo 
556 pJS107 in DH5α J. Sorg 
655 pMTL83151 in DH5α This study 
686 pMTL83151 in HB101/pK424 This study 
701 pMTL84151 in DH5α This study 
703 pMTL84151 in HB101/pK424 This study 
908 pJS107-spoIIIAA targeting bp 166 in HB101/pK424 This study 
909 pJS107-spoIIQ targeting bp 456 in HB101/pK424 This study 
1058 pMTL83151-spoIIQ in HB101/pK424 This study 
1080 pMTL83151-spoIIIA in HB101/pK424 This study 
1197 pJS107-spoIIIAH targeting bp 75 in HB101/pK424 This study 
1301 pET22b-spoIIQ 91-669 (E. coli codon optimized) in BL21(DE3) This study 
1302 pET22b-spoIIIAH 100-691 (E. coli codon optimized) in BL21(DE3) This study 
1303 pMTL83151-spoIIIA operon K167A in HB101/pK424 This study 
1370 pMTL84121-CotE-SNAP in HB101/pK424 
A. 
Henriques 
1378 pET28a-HA-SpoIIIAH in BL21(DE3) This study 
1380 pMTL83151-PspoIIIAA-spoIIIAH in HB101/pK424 This study 
1385 pET22b + pET28a-HA-SpoIIIAH in BL21(DE3) This study 
1386 pET22b-His-SpoIIQ + pET28a-HA-SpoIIIAH in BL21(DE3) This study 
1387 pET22b-His-SpoIIQ + pET28aEV in BL21(DE3) This study 
1404 pET28a-HA-SpoVT in BL21(DE3) This study 
1405 pET22b-His-SpoIIQ + pET28a-HA-SpoVT in BL21(DE3) This study 
1433 pMTL84151-PsspA-SNAP in HB101/pK424 This study 
1531 pMTL83151-spoIIQ H120A in HB101/pK424 This study 
1533 pMTL83151-spoIIIA operon D244A in HB101/pK424 This study 
1534 pMTL83151-spoIIIA operon K167A/D244A in HB101/pK424 This study 
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Table S2. Plasmids used in this study. 
Plasmids Relevant features 
Source or 
reference 
pET22b bla Novagen 
pET28a kan Novagen 
pRSFduet1 kan Novagen 




TargeTron construct based on pJIR750ai (group II intron 
ermB::RAM, ltrA); catP J. Sorg 
pCE245 
TargeTron construct based on pJIR750ai (group II intron 
ermB::RAM, ltrA); catP 
C. 
Ellermeier 

















Table S3. Primers used in this study. 
Primer Name Sequence 
532 3' Universal EBS CGAAATTAGAAACTTGCGTTCAGTAAAC 
1049 5' IBS1.2 spoIIIAA 166 
AAAAAAGCTTATAATTATCCTTACAAGTCTC
ATAGGTGCGCCCAGATAGGGTG 
1050 3' EBS1d spoIIIAA 166 
CAGATTGTACAAATGTGGTGATAACAGATA
AGTCTCATAGTTTAACTTACCTTTCTTTGT 
1051 5' EBS2 spoIIIAA 166 
TGAACGCAAGTTTCTAATTTCGGTTACTTGT
CGATAGAGGAAAGTGTCT 
1052 5' IBS1.2 spoIIQ 456 AAAAAAGCTTATAATTATCCTTAGAATACGGACAAGTGCGCCCAGATAGGGTG 
1053 3' EBS1d spoIIQ 456 CAGATTGTACAAATGTGGTGATAACAGATAAGTCGGACAATCTAACTTACCTTTCTTTGT 
1054 5' EBS2 spoIIQ 456 
TGAACGCAAGTTTCTAATTTCGATTTATTCT
CGATAGAGGAAAGTGTCT 
1074 5' NdeI spoIIQ AGAATCATATGAAGAAAAAGCTGTTAG 
1075 3' XhoI spoIIQ  AATACTCGAGCTTAATTAGACTCATTGGGTC 
1174 5' NotI spoIIIA operon  
AGAATGCGGCCGCCACTTCATGATTGAAGT
GTC 
1175 3' XhoI spoIIIA operon  AATACTCGAGGTTTATACTTTAC 
1176 3' XhoI spoIIIAA  AATACTCGAGCTACTTCCTATCAAGAAAGC 
1177 5' NotI spoIIQ with promoter 
AGAATGCGGCCGCCCACATTACTACACAGA
TAC 
1178 3' XhoI spoIIQ 
AATACTCGAGGTTATACTATTACTTAATTAG
ACTC 
1239 3' XhoI spoIIIAH 
AATACTCGAGCTTATTACTATTATTATTTGT
AAG 
1264 5' IBS1 spoIIIAH 75 
AAAAAAGCTTATAATTATCCTTACTGTTCCT
ACTAGTGCGCCCAGATAGGGTG 
1265 3' EBS1d spoIIIAH 75 
CAGATTGTACAAATGTGGTGATAACAGATA
AGTCCTACTACCTAACTTACCTTTCTTTGT 
1266 5' EBS2 spoIIIAH 75 
TGAACGCAAGTTTCTAATTTCGATTAACAGT
CGATAGAGGAAAGTGTCT 
1277 3’ XhoI C. difficile SNAP 
AAAGCTCGAGTTAACCAGCTGGACCAAGAC
C 
1301 5’ NheI spoIIIAH TATGGCTAGCATGAAGTTTAATTATAAGGG 
1302 5' NheI spoIIIAA TATGGCTAGCATGAATAAACTTTCTGATGA 
1303 3' XhoI spoIIIAA no stop 
AATACTCGAGATTTGCAAAATACCATCTCTT
TTC 
1313 3' XhoI spoVT AATACTCGAGTTATTGAACTTGTTTTCC 
1431 5' spoIIIAA K167A SOE CAATGTGGAGCAACAACTTTAATAAGAG 
1432 3' spoIIIAA K167A SOE CTCTTATTAAAGTTGTTGCTCCACATTG 
1458 5' NdeI cd1430  
ATACATATGAAAAAAGATAGCCTAAAAAAA
TACATTATGATAGG 









3' XhoI spoIIIAH (100-691) codon 
opt ACAAGCTCGAGTTTGTTTGAGTTATTGTTCG 
1568 5' NdeI spoIIQ (91-669) no stop AGAATCATATGAACAATAATGTGGATAAAC
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codon opt TG 
1569 
3' XhoI spoIIQ (91-669) no stop 
codon opt ACAAGCTCGAGTTTGATCAGGCTCATCGG 
1614 




1617 5' spoIIIA operon SOE to spoIIIAH 
CAAAGGAGGAGGACAAGAGATGAAGTTTA
ATTATAAGGG 
1618 3' spoIIIA operon SOE to spoIIIAH 
CCCTTATAATTAAACTTCATCTCTTGTCCTC
CTCCTTTG 
1662 5' NdeI 6xHis-spoIIQ codon opt 
AAACATATGCACCACCACCACCACCACAAC
AATAATGTGGATAAACTG 
1665 5’ NcoI HA-spoIIIAH codon opt 
CCCATGGGATACCCGTACGACGTCCCGGAT
TATGCCCTGCTGGAAACCTCAAAAGAA 
1691 5' NcoI HA-spoVT 
CCCATGGGATACCCGTACGACGTCCCGGAC
TACGCGAAAGCAACAGGTATAGTTAG 
1708 5' NdeI spoVAD  
AATCATATGAAAAATAAAAGAATTGGAAAA
AGAACAGTC 
1709 3' XhoI spoVAD no stop 
AATCTCGAGCTCATTTACTATTACTACTGCA
TG 
1850 5’ spoIIQ H120A SOE 
TCTAAAACACTTGATGTTTGGGAAACTGCT
AAAGGTGTAGATATTAGTTGTACTAAAG 
1851 3’ spoIIQ H120A rev eos 
CTTTAGTACAACTAATATCTACACCTTTAGC
AGTTTCCCAAACATCAAGTGTTTTAGA 
1852 5’ spoIIIAA D244A SOE 
ATGTCACCAAATGTTATTGTGACAGCTGAA
ATTGGAAGTGAAAAAGAAATAAAGGC 
1853 3’ spoIIIAA D244A ev oes 
GCCTTTATTTCTTTTTCACTTCCAATTTCAGC
TGTCACAATAACATTTGGTGACAT 
1854 3’ SalI spoIIIAA 2844  GGATTCAAAGTAGTCGACGTTATTGGG 
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3.9. Figure Legends  
Fig. 1. C. difficile spoIIQ, spoIIIA, and spoIIIAH mutants are defective in 
engulfment and mature spore formation. C. difficile strains wild type (WT), spoIIQ– 
(IIQ–), spoIIIA– (IIIA–), spoIIIAH– (IIIAH–), and sigG– were grown on sporulation media 
for 20 hrs and evaluated by live differential interference contrast (DIC) and fluorescence 
microscopy. The nucleoid was stained with Hoechst (blue) and membranes were stained 
with FM4-64 (red). Hoechst appears to be excluded after coat surrounds the forespore 
[76], while FM4-64 is excluded after membrane fission has occurred at least in B. subtilis 
[77]. Brown arrows designate cells at asymmetric division (flat polar septa); yellow 
arrows designate forespores that have not completed engulfment, although they stain with 
Hoechst and FM4-64; blue arrows designate cells that have completed engulfment and 
stain with both Hoechst and FM4-64; green arrows designate forespore compartments 
that have completed engulfment and exclude Hoechst but stain with FM4-64; white 
arrows designate forespores that have completed engulfment and exclude Hoechst and 
FM4-64; pink arrows designate free spores. Free spores were not observed in any of the 
mutant strains. Cell phenotype percentages (%CP) were determined from analyzing 100 
sporulating cells. The efficiency of heat-resistant spore formation (HR) was determined 
for each strain relative to WT across three biological replicates. Scale bars represent 5 
µm.  
 
Fig. 2. Levels of SpoIIQ and SpoIIIAH in C. difficile sporulation mutants. (A) 
Western blot analyses of SpoIIQ and SpoIIIAH levels in cell lysates prepared from WT, 
spo0A–, sigF–, spoIIQ– (IIQ–), sigE–, spoIIIA– (IIIA–), spoIIIAH– (IIIAH–), and sigG– 
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strains grown for 17 hr on sporulation media. The anti-Spo0A antibody serves as a 
control for the extent of sporulation [45]. (B) qRT analysis of spoIIIAA transcripts in WT, 
spo0A-, sigE-, spoIIIA-, and sigG- strains grown for 17 hr on sporulation media. Transcript 
levels were calculated relative to the spo0A– strain after normalization to the 
housekeeping gene rpoB using the standard curve method. Data shown represents the 
averages of three biological replicates. Error bars indicate the standard error of the mean. 
Statistically significant changes in transcript levels were determined relative to WT and 
are represented by adjusted p-values determined by a one-way ANOVA and Dunnett’s 
test. **p ≤ 0.001. n.a. indicates not applicable since the region amplified is downstream 
of the disrupted spoIIIAA gene.  
 
Fig. 3. Morphological defects of spoIIQ, spoIIIA, and spoIIIAH mutants. 
Transmission electron microscopy (TEM) of WT, spoIIQ– (IIQ–), spoIIIA– (IIIA–), 
spoIIIAH– (IIIAH–), sigG–, and spoIVA– (IVA–) strains grown for 24 hrs on sporulation 
media. The forespore region of these strains is shown on the right. Black arrows indicate 
regions that resemble coat layers surrounding the forespore. White arrows indicate coat 
that appears anchored to the leading edge of the engulfing membrane but is not intimately 
associated with the mother cell-forespore interface. Yellow arrows highlight coat that 
appears to be mislocalized away from the forespore region to the mother cell cytosol. 
Scale bars represent 500 nm.  
 
Fig. 4. Coat mislocalization in the absence of SpoIIQ and SpoIIIA proteins. DIC and 
fluorescence microscopy of WT, spoIIQ– (IIQ–), spoIIIA– (IIIA–), spoIIIAH– (IIIAH–), 
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sigG–, and spoIVA– (IVA–) strains producing CotE-SNAP fusions. Cells were collected 
after 24 hrs on sporulation media and labeled with the SNAP substrate TMR-Star (green), 
the lipophilic dye FM4-64 (red), and the Hoechst nucleoid dye (blue). Yellow arrows 
indicate where the SNAP signal (green) overlaps with FM4-64 staining (red). Scale bars 
represent 2 µm.  
 
Fig. 5. σG activity is localized to the forespore in spoIIQ, spoIIIAA, and spoIIIAH 
mutants. (A) Fluorescence microscopy analyses of the indicated strains carrying the σG-
dependent PsspA-SNAP transcriptional reporter. Cells were collected after growth on 
sporulation media for 22 hr and stained with TMR-Star to monitor σG activity (green), the 
lipophilic dye FM4-64 (red), and Hoechst nucleoid dye (blue). Yellow arrows denote 
forespores where σG-activity is detectable by TMR-Star staining. Black arrows mark 
sporulating cells where σG activity was not observed. The percentage of cells for each 
strain producing visible SNAP for each strain is shown (at least 50 sporulating cells per 
strain were counted). (B) Western blot analyses of strains carrying the σG-dependent 
PsspA-SNAP transcriptional reporter using an anti-SNAP antibody. The anti-Spo0A 
antibody serves as a control for the extent of sporulation [45]. Scale bars represent 3 µm.  
 
Fig. 6. C. difficile SpoIIQ and SpoIIIAH directly interact in vitro. Western blot 
analyses of co-affinity purifications of His6-tagged SpoIIQ with either empty vector 
(EV), HA-SpoVT, and HA-SpoIIIAH. The indicated constructs were produced in E. coli 
upon induction with IPTG. Input represents the soluble fraction of cell lysates prepared 
from the co-expression strains prior to Ni2+-affinity purification, while eluate represents 
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the fractions eluted from the Ni2+-affinity beads following incubation with the soluble 
fraction. Dual western blot detection was performed using anti-HA (red) and anti-His 
(green). 
 
Fig. 7. Mutation of the Walker A motif but not the Walker B motif of SpoIIIAA 
leads to defects in spore formation. TEM analyses of wildtype carrying empty vector 
(WT/EV) and spoIIIA– (IIIA–) strains carrying empty vector (EV), or spoIIIA 
complementation constructs encoding the wildtype operon (IIIA), a K167A Walker A 
mutation (K167A), D244A Walker B mutation (D244A), and K167A/D244A double 
mutation (K167A/D244A). The forespore region of these strains is shown on the right. 
Black arrows indicate regions that resemble coat layers surrounding the forespore. White 
arrows indicate coat that appears anchored to the leading edge of the engulfing membrane 
but is not intimately associated with the mother cell-forespore interface. Scale bars 
represent 500 nm. The efficiency of heat-resistant (HR) spore formation was determined 
for each strain relative to WT for at least three biological replicates. Engulfment complete 
(EC) cells designates the number of cells in the population that completed engulfment out 
of at least 50 sporulating cells that had initiated engulfment or progressed beyond this 
stage.  
 
Fig. 8.  Metabolic labeling of peptidoglycan transformations in WT, spoIIQ–, and 
sigE– strains during sporulation. Strains were induced to sporulate on solid media for 
14 hrs then resuspended in liquid sporulation media. Alkyne D-alanine (alkDala) was 
incubated with the cells for 0’, 10’, 20’, 30’, or 40’. After fixation, permeabilization, and 
 197 
copper-catalyzed cycloaddition of an azide-conjugated fluorophore, Hoechst nucleoid 
dye was added, and cells were visualized by light microscopy. Scale bars represent 2 µm.  
 
Fig. 9. Engulfment defective mutants actively remodel peptidoglycan around the 
forespore. Strains were induced to sporulate on solid media for 14 hrs then resuspended 
in liquid sporulation media and incubated with alkyne D-alanine (alkDala). After 
fixation, permeabilization, and copper-catalyzed cycloaddition of an azide-conjugated 
fluorophore, Hoechst nucleoid dye was added, and cells were visualized by light 
microscopy. Scale bars represent 2 µm.  
 
3.10. Supplemental Figure Legends  
Fig. S1. ClustalW sequence alignment of SpoIIIAA. Completely conserved, identical 
residues are blocked in blue, conserved identical residues are blocked in green, and 
conserved similar residues in yellow. The conserved motifs (boxes) found in all secretion 
NTPases are highlighted [20]. The conserved lysine in the Walker A motif that was 
mutated (K167 in C. difficile SpoIIIAH) and conserved aspartate in the Walker B motif 
(D244 in C. difficile SpoIIIAH) are shown boxed in orange. SpoIIIAA sequences are 
from B. subtilis serovar subtilis str. 168 (CAA43959) B. cereus serovar anthracis 
(YP_003793897), C. botulinum ATCC 3502 (CAL83436), C. acetobutylicum ATCC 824 
(AE007711_9), C. perfringens str. 13 (NP_562749), C. bartlettii CAG 1329 
(WP_022072529), C. bifermentans ATCC 19299 (EQK45222), C. sordellii VPI 9048 
(EPZ57018), and C. difficile 630 (YP_001087685). C. bartlettii, C. bifermentans, C. 
sordellii and C. difficile are part of the Peptoclostridium spp. [78]. 
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Fig. S2. ClustalW sequence alignment of SpoIIIAH. Completely conserved, identical 
residues are blocked in blue, conserved identical residues are blocked in green, and 
conserved similar residues in yellow. α-helices and β-sheets in the B. subtilis SpoIIIAH 
(NP_390316) extracellular domain (determined from the SpoIIQ-SpoIIIAH complex, 
[37,38]) are indicated as a helix or black arrow above the sequence alignment, 
respectively, with the first and last α-helices and β-sheets being labeled. Purple asterisks 
identify B. subtilis SpoIIIAH residues that directly interact with SpoIIQ as determined by 
both Levdikov et al. and Meisner et al. [37,38]. Orange asterisks indicate B. subtilis 
SpoIIIAH residues that directly interact with SpoIIQ as determined by Levdikov et al. 
[37]. The remaining sequences are from B. cereus serovar anthracis (YP_003793890), C. 
botulinum ATCC 3502 (YP_001254390), C. acetobutylicum ATCC 824 (AE007711_2), 
C. perfringens str. 13 (NP_562742), C. bartlettii CAG 128 (CDA09218), C. bifermentans 
ATCC 19299 (EQK45176), C. sordellii VPI 9048 (EPZ57011), and C. difficile 630 
(YP_001087692). C. bartlettii, C. bifermentans, C. sordellii and C. difficile are part of the 
Peptoclostridium genus [78].  
 
Fig. S3. ClustalW sequence alignment of SpoIIQ orthologs of CD0125. Orthologs 
were identified based on a Hidden Markov Model search using HHMER [79]. 
Completely conserved, identical residues are blocked in blue, conserved identical 
residues are blocked in green, and conserved similar residues in yellow. A red triangle 
demarcates active site residues (boxed in red), with phosphate binding residues in the 
active site being marked with a blue triangle (boxed in blue) [32]. The intact active site 
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His in the HxxxD motif of the metallopeptidase found in C. difficile CD0125 is shown in 
red; the active site His has been mutated to Ser in B. subtilis SpoIIQ. Residue numbering 
is based on B. subtilis SpoIIQ (NP_391536). α-helices and β-sheets in the B. subtilis 
SpoIIQ extracellular domain (determined from the SpoIIQ-SpoIIIAH complex, [37,38]) 
are indicated as a helix or black arrow above the sequence alignment, respectively, with 
the first and last α-helices and β-sheets being labeled. Asterisks indicate B. subtilis 
SpoIIQ residues that directly interact with SpoIIIAH. The remaining SpoIIQs are from B. 
cereus serovar anthracis (YP_003794960), C. botulinum Loch Maree Type A3 
(ACA54665), C. acetobutylicum ATCC 824 (NP_349463), C. perfringens str. 13 
(BAB81888), C. bartlettii CAG 1329 (CDA09218), C. bifermentans ATCC 19299 
(EQK48677), C. sordellii VPI 9048 (EPZ61518), and C. difficile 630 (YP_001086594). 
C. bartlettii, C. bifermentans, C. sordellii and C. difficile are part of the Peptoclostridium 
spp. [78]. 
 
Fig. S4. Construction of spoIIQ, spoIIIA, and spoIIIAH mutants in C. difficile. (A) 
Schematic of C. difficile spoIIIA operon structure. The percent similarity between C. 
difficile and B. subtilis SpoIIIAA-AH proteins is shown. Bent arrows indicate promoters 
identified by Saujet et al. through global transcriptional start-site mapping [29]. (B) 
Schematic of the group II intron targeted gene disruption system. (C) Colony PCR 
analysis of spoIIQ–, spoIIIA–, and spoIIIAH– strains compared to wild type (WT) using 
primers that flank the gene of interest. The group II intron insertion is ~2 kb.   
 
Fig. S5. Plasmid complementation rescues spore formation in C. difficile spoIIQ–, 
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spoIIIA–, and spoIIIAH– strains. Fluorescence microscopy of spoIIQ– (IIQ–), spoIIIA– 
(IIIA–), and spoIIIAH– (IIIAH–) complementation strains grown on sporulation media for 
21 hrs using the lipophilic dye FM4-64 (red) and Hoechst nucleoid stain (blue). The 
strains carry empty vector (EV), or the spoIIQ (IIQ), or spoIIIA operon (IIIA), or 
spoIIIAH (IIIAH) complementation constructs. Yellow arrows designate forespores that 
have not completed engulfment, although they stain with Hoechst and FM4-64; blue 
arrows designate cells that have completed engulfment and stain with both Hoechst and 
FM4-64; green arrows designate forespore compartments that have completed 
engulfment and exclude Hoechst but stain with FM4-64; white arrows designate 
forespores that have completed engulfment and exclude Hoechst and FM4-64; pink 
arrows designate free spores. The efficiency of heat-resistant spore formation was 
determined for each strain relative to WT from three biological replicates. Scale bars 
represent 5 µm.  
 
Fig. S6. Analysis of spoIIQ–, spoIIIA–, and spoIIIAH– complementation strains. (A) 
Western blot analyses of wildtype (WT), spo0A-, spoIIQ– (IIQ–), spoIIIA– (IIIA–), or 
spoIIIAH– (IIIAH–) strains carrying empty vector (EV) or spoIIQ (IIQ), spoIIIA operon 
(IIIA), spoIIIAH (IIIA), or spoIIIAH (IIIAH) complementation constructs. Spo0A levels 
serve as a loading control for sporulation induction. (B) qRT-PCR analysis of spoIIIAA 
transcripts of wildtype, spo0A–, or spoIIIA– (IIIA–) carrying empty vector (EV), K167A 
spoIIIA operon (K167A), or spoIIIA operon (IIIA) complementation constructs. 
Transcript levels were calculated relative to the spo0A– strain after normalization to the 
housekeeping gene rpoB using the standard curve method. Error bars indicate the 
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standard error of the mean. Data represents the average of three biological replicates. 
Error bars indicate the standard error of the mean. Statistically significant changes in 
transcript levels were determined relative to WT and are represented by adjusted p-values 
determined by a one-way ANOVA and Dunnett’s test. *p < 0.05. n.a. indicates not 
applicable since the region amplified is downstream of the disrupted spoIIIAA gene. 
  
Fig. S7. Variable sporulation phenotypes of C. difficile spoIIQ–, spoIIIA–, and 
spoIIIAH– strains. Transmission electron microscopy (TEM) of spoIIQ–, spoIIIA–, and 
spoIIIAH– grown for 24 hrs on sporulation media. (A) Rare example of spoIIQ– and 
spoIIIA– cells that have completed engulfment (green arrows). Black arrows designate 
coat localized around the forespore compartment. The spoIIIAH mutant was not observed 
to complete engulfment. (B) The forespore regions of spoIIQ–, spoIIIA–, and spoIIIAH– 
cells exhibiting forespore collapse (blue arrows), which occurred in 13%, 14%, and 27% 
of cells, respectively. Scale bars represent 500 nm. 
 
Fig. S8. σG activity is unaffected in spoIIQ, spoIIIA, and spoIIIAH mutants. 
Transcript levels of the σG regulon genes spoVT, CD1430, and spoVAD in wild type 
(WT), spo0A–, sigF–, spoIIQ– (IIQ–), sigE–, spoIIIA– (IIIA–), spoIIIAH– (IIIAH–), and 
sigG– induced to sporulate for 25 hrs as measured by qRT-PCR. Transcript levels were 
calculated relative to the spo0A– strain after normalization to the housekeeping gene rpoB 
using the standard curve method. Data represents the average of three biological 
replicates. Error bars indicate the standard error of the mean. Statistically significant 
changes in transcript levels were determined relative to WT and are represented by 
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adjusted p-values determined by a one-way ANOVA and Dunnett’s test. ***p < 0.0005, 
**p < 0.01, *p < 0.05.  
 
Fig. S9. Mutation of the SpoIIQ LytM catalytic histidine 120 leads to a defect in 
spore formation. TEM analyses of wildtype (WT) and spoIIQ– (IIQ–) strains carrying 
empty vector (EV), the spoIIQ H120A LytM mutation (H120A) complementation 
construct, and the wildtype spoIIQ complementation construct (IIQ). The forespore 
region of these strains is shown on the right. Black arrows indicate regions that resemble 
coat layers surrounding the forespore. White arrows indicate coat that appears anchored 
to the leading edge of the engulfing membrane but is not intimately associated with the 
mother cell-forespore interface. Yellow arrows demarcate coat that has mislocalized to 
the cytosol. Scale bars represent 500 nm. The efficiency of heat-resistant (HR) spore 
formation was determined for each strain relative to WT across four biological replicates. 
Engulfment complete (EC) cells designates the number of cells in the population that 
completed engulfment out of at least 50 sporulating cells that had initiated engulfment or 
progressed beyond. Two representative phenotypes for the H120A mutant are shown; A 
designates engulfment complete, B designates engulfment incomplete. 
 
Fig. S10. The Walker A motif is critical for spore formation. Wild type carrying 
empty vector (WT/EV) and spoIIIA– (IIIA–) strains carrying either empty vector (EV), the 
IIIA K167A complementation construct (K167A), or wildtype IIIA complementation 
construct (IIIA) were grown on sporulation media for 22 hrs and evaluated by live 
differential interference contrast (DIC) and fluorescence microscopy using the Hoechst 
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nucleoid stain (blue) and lipophilic dye FM4-64 (red). Yellow arrows designate 
forespores that have not completed engulfment, although they stain with Hoechst and 
FM4-64; green arrows designate forespore compartments that have completed 
engulfment and exclude Hoechst but stain with FM4-64; white arrows designate 
forespores that have completed engulfment and exclude Hoechst and FM4-64; pink 
arrows designate free spores. Scale bars represent 5 µm. 
 
Fig. S11. Timecourse of peptidoglycan labeling of sporulating cells. Cells induced to 
sporulate were incubated with alkDala and analyzed over the course of 40 minutes at 10 
minute intervals. Sporulating cells were surveyed for sporulation based on DIC, Hoechst 
incorporation, and alkDala labeling (Shown in Fig. 8). alkDala incorporation was scored 
based on no incorporation at the forespore compartment (black bars), labeling of a polar 
septum (designating a cell undergoing asymmetric division, gray bars), labeling at the 
forespore side of the forespore compartment (yellow bars), labeling of the middle section 
of the forespore compartment (red bars), labeling at the mother cell side of the forespore 
compartment (blue bars), and full labeling of the spore (green bars). At least 50 cells per 
time point were analyzed.  
 
Fig. S12. Fluorescent labeling of peptidoglycan transformations during cell division 
and sporulation of wildtype, spoIIQ–, and sigE– strains. (A) Examples of cells 
undergoing vegetative cell division (yellow arrows). Strains were induced to sporulate on 
solid media for 14 hrs then resuspended in liquid sporulation media. Alkyne D-alanine 
(alkDala) or D-alanine (background control shown in (B)) was incubated with the cells 
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for 30’. After fixation, permeabilization, and copper-catalyzed cycloaddition of an azide-
conjugated fluorophore, Hoechst nucleoid dye was added, and cells were visualized by 
light microscopy. Scale bars represent 2 µm. 
 
Fig. S13. Imipenem inhibition of peptidoglycan transformations in C. difficile. 
AlkDala incorporation during peptidoglycan transformations after treatment with cell 
wall inhibitors vancomycin and imipenem was evaluated by flow cytometry. Mean 
fluorescence intensities (MFIs) were determined for WT cells incubated with Dala or 
alkDala after treatment with 2X MIC determined for vancomycin or imipenem or no 
treatment controls. MFIs are based on three biological replicates, and statistically 
significant changes were determined by an ordinary one-way ANOVA and Tukey’s test. 
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Clostridium difficile is a Gram-positive spore-forming pathogen and a leading cause of 
nosocomial diarrhea. C. difficile infections are transmitted when ingested spores 
germinate in the gastrointestinal tract and transform into vegetative cells. Germination 
begins when the germination receptor CspC detects bile salts in the gut. CspC is a 
subtilisin-like serine pseudoprotease that activates the related CspB serine protease 
through an unknown mechanism. Activated CspB cleaves the pro-SleC zymogen, which 
allows the activated SleC cortex hydrolase to degrade the protective cortex layer. While 
these regulators are essential for C. difficile spores to outgrow and form toxin-secreting 
vegetative cells, the mechanisms controlling their function have only been partially 
characterized. In this study, we identify the lipoprotein GerS as a novel regulator of C. 
difficile spore germination using targeted mutagenesis. A gerS mutant has a severe 
germination defect and fails to degrade cortex even though it processes SleC at wildtype 
levels. Using complementation analyses, we demonstrate that GerS secretion, but not 
lipidation, is necessary for GerS to activate SleC. Importantly, loss of GerS attenuates C. 
difficile spores to cause infection in a hamster model. Since GerS appears to be conserved 
exclusively in related Peptostreptococcaeace family members, our results contribute to a 
growing body of work indicating that C. difficile has evolved distinct mechanisms for 




4.2. Author Summary 
Clostridium difficile is a spore-forming bacterium capable of causing severe 
diarrhea. The dormant spore-form of C. difficile is necessary to cause infection, since 
vegetative cells of this organism cannot survive in the presence of oxygen. Spores are 
difficult to eradicate because they can withstand extreme environmental conditions and 
chemical insults including antibiotics. However, since spores cannot grow, they must 
transform back into actively replicating cells once the appropriate environmental 
conditions are sensed through a process called germination. A key step during 
germination is the break-down of a specialized cell wall layer in the spore known as 
cortex by the SleC hydrolase. In this paper, we identify GerS as a novel lipid-modified 
protein that is important for C. difficile germination to occur. GerS is made at high levels 
during spore formation and gets packaged into mature spores. We show that GerS is 
required for the cortex hydrolase SleC to degrade the protective cortex layer, since a 
strain lacking GerS does not lose its cortex layer. Loss of GerS prevents C. difficile from 
causing infection in a hamster model of infection, suggesting that GerS is a novel target 





Clostridium difficile is a Gram-positive spore-former capable of causing diarrheal 
disease that can lead to fatal colitis. Disease symptoms are caused by the production of 
two toxins, TcdA and TcdB, which are secreted when C. difficile establishes infection in 
the gastrointestinal tract of mammals [1-3]. C. difficile infections have primarily been 
associated with individuals undergoing antibiotic therapy, but long hospitalizations, 
underlying comorbidities, community-acquired infections, and age-related risk factors 
have also been documented [4-6]. These complications lead to C. difficile disease 
treatment costs between $1-5 billion per year in the United States [7,8]. Of the 0.5 million 
C. difficile infections in the United States each year, approximately 30,000 lead to death 
[9]. These deaths are primarily due to recurrent C. difficile infections, which occur in 
~20-30% of people that clear the first infection [9,10]. 
Since C. difficile is an obligate anaerobe, its endospore, or spore form, is 
responsible for initiating infection and mediating disease recurrence [11]. Spores are 
highly resistant, oxygen-tolerant, multi-layered structures composed of a tightly packed, 
dehydrated inner core surrounded by the inner forespore membrane, a germ cell wall, a 
thick modified peptidoglycan layer known as cortex, an outer forespore membrane, a 
series of proteinaceous layers known as the coat, and, in some spore formers, an 
outermost exosporium layer [12,13]. The specialized packaging of spores confers 
resistance to many chemical and physical insults and allows them to persist in the 
environment, and potentially an infected human, for long periods of time [1,14]. The 
dehydrated core renders spores metabolically dormant and is achieved by the 
displacement of water by calcium dipicolinic acid (Ca-DPA) in late stages of spore 
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formation [15,16]. The thick cortex layer surrounding the core physically constrains its 
expansion and prevents hydration [17]. 
C. difficile infections begin when spores are ingested by a susceptible host and 
transit to the gastrointestinal (GI) tract [18-20]. In the small intestine, C. difficile spores 
sense specific bile salts, which induce them to transform into vegetative cells in a process 
known as germination [18,21]. While germination has been primarily characterized in the 
model organism Bacillus subtilis and in C. perfringens [13,22], recent studies in C. 
difficile have revealed that C. difficile uses a unique mechanism to regulate the initiation 
of spore germination [21,23-26] .  
While B. subtilis and C. perfringens employ highly conserved inner membrane 
germinant receptors to sense small molecule nutrients (germinants), such as amino acids, 
sugars, and potassium ions [13], C. difficile and related Peptostreptococcaceae family 
members do not encode inner membrane germinant receptors [22,27]. Instead, C. difficile 
uses the subtilisin-like serine protease CspC as a germinant receptor [21] to sense bile salt 
germinants such as taurocholate [18,20,28-30]. Although C. perfringens encodes a CspC 
homolog and the related Csp family serine proteases, CspA and CspB [25,26], CspC is 
dispensable for germination in C. perfringens [25] in contrast with C. difficile [21]. 
Furthermore, C. perfringens CspC is catalytically competent and undergoes 
autoprocessing similar to other subtilisin-like serine proteases [26], whereas C. difficile 
CspC carries two mutations in its catalytic triad and lacks autoprocessing activity [21,23]. 
Unlike the catalytically competent C. perfringens CspA, C. difficile CspA is produced as 
a pseudoprotease that is fused to a catalytically competent CspB protease [23]. During 
spore formation, the C. difficile CspBA fusion protein undergoes interdomain processing, 
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and the CspB domain is incorporated into mature spores [23].  
Despite these differences, CspB in both C. perfringens and C. difficile functions 
to process the cortex lytic enzyme (CLE) SleC, which is found in dormant spores as the 
pro-SleC zymogen [21,23-26,31]. SleC degrades the cortex layer, which is essential for 
spore germination to proceed [32]. In the Clostridia, SleC targets the cortex-specific 
modification muramic-δ-lactam (MAL), which allows SleC to avoid degrading the germ 
cell wall of the outgrowing cell [33,34]. In B. subtilis, the cortex lytic enzymes CwlJ and 
SleB target MAL [16,35], although these enzymes exhibit little primary sequence 
homology to clostridial SleC. Cortex hydrolysis in C. difficile was recently shown to be 
required for Ca-DPA to be released from the core [36,37], whereas in B. subtilis, Ca-DPA 
is released before the cortex is hydrolyzed and actually activates CwlJ [38,39]. These 
observations indicate that different regulatory factors and mechanisms control 
germination in C. difficile relative to B. subtilis and even C. perfringens.   
In this report, we describe the identification of a novel regulator of C. difficile 
spore germination, CD3464 in strain 630, herein referred to as GerS, which is conserved 
among sequenced Peptostreptococcaceae family members. Using a series of biochemical, 
genetic, and cell biological assays, we characterize the gerS– phenotype and identify the 
stage at which spore germination is arrested. We also demonstrate that GerS is essential 
for virulence in hamsters.  
 
4.4. Materials and Methods 
 
4.4.1. Bacterial strains and growth conditions 
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C. difficile strains are listed in Table 1 and derive from the parent strain JIR8094, 
an erythromycin-sensitive derivative of the sequenced clinical isolate 630. C. difficile 
strains were grown on solid BHIS media, which consists of brain heart infusion media 
supplemented with yeast extract and 0.1% (w/v) L-cysteine [76]. BHIS media was 
supplemented with taurocholate (TA; 0.1% w/v), thiamphenicol (5-10 µg/mL), 
kanamycin (50 µg/mL), cefoxitin (16 µg/mL), FeSO4 (50 µM), and/or erythromycin (10 
µg/mL) as indicated. Cultures were grown at 37˚C, under anaerobic conditions using a 
gas mixture containing 85% N2, 5% CO2, and 10% H2. 
Sporulation was induced on solid media containing 70% BHIS and 30% SMC (90 
g BactoPeptone, 5 g protease peptone, 1 g NH4SO4, 1.5 g Tris base, 15 g agar per liter) 
[77], as previously described. For strains carrying pMTL83151 derivatives, sporulation 
was induced on 70:30 media containing 5 µg/mL thiamphenicol.  
HB101/pRK24 strains were used for conjugations and BL21(DE3) strains were 
used for protein production. E. coli strains (Table 1) were routinely grown at 37˚C, 
shaking at 225 rpm in Luria-Bertani broth (LB). Media was supplemented with 
chloramphenicol (20 µg/mL), ampicillin (50 µg/mL), or kanamycin (30 µg/mL) as 
indicated.  
 
4.4.2. E. coli strain construction 
E. coli strains are listed in Table 1; all primers are listed in Table S1. For 
disruption of gerS and alr2, a modified plasmid containing the retargeting group II intron, 
pCE245 (a gift from C. Ellermeier, University of Iowa), was used as the template. 
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Primers for amplifying the targeting sequence from the template carried flanking regions 
specific for each gene target and are listed as follows: gerS (#1122, 1123, 1124 and 532, 
the EBS Universal primer (Sigma Aldrich) and alr2 (#1385, 1386, 1385 and 532). The 
resulting retargeting sequences were digested with BsrGI and HindIII and cloned into 
pJS107 [21], which is a derivative of pJIR750ai (Sigma Aldrich). The ligations were 
transformed into DH5α and confirmed by sequencing. The resulting plasmids were used 
to transform HB101/pRK24. 
To construct the dual promoter complementation construct (Figure S4), primers 
#1464 and 1466 were used to amplify an ~1.8 kB construct containing acpS, CD3465, 
gerS, and 360 bp upstream of acpS using 630 genomic DNA as the template. To 
construct the single promoter complementation construct, primers #1667 and 1466 were 
used to amplify gerS containing 367 bp upstream of gerS using 630 genomic DNA as the 
template. The gerS C22S and ∆SP complementation constructs were made using PCR 
splicing by overlap extension (SOE). For C22S, primer pair #1464 and 1734 was used to 
amplify the 5’ SOE product (containing the C22S mutation), while primer pair #1733 and 
1466 was used to amplify the 3’ SOE product (containing the C22S mutation). The 
resulting fragments were mixed together, and flanking primers #1464 and 1466 were 
used to generate the dual promoter complementation construct that encodes the C22S 
mutation. To construct the ∆SP complementation construct, SOE primers #1464 and 
1727 were used to generate a 5’ fragment; primers #1726 and 1466 were used for the 3’ 
SOE product. The flanking primers #1464 and 1466 were used to amplify the ∆SP 
complementation construct, which deletes the region encoding residues 2-22. All 
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complementation constructs were digested with NotI and XhoI and ligated into 
pMTL83151 digested with the same enzymes. 
To construct a strain producing GerS for antibody production, primer pairs #1278 
and 1173 were used to amplify gerS lacking the signal peptide sequence using genomic 
DNA as the template. The resulting PCR products were digested with NdeI and XhoI, 
ligated to pET28a, and transformed into DH5α. The resulting pET28a-gerS plasmid was 
used to transform BL21(DE3) for protein production. To construct a strain for generating 
mouse anti-CspC antibodies, primer pairs #1128 and 1166 were used to amplify codon-
optimized cspC using pJS148 as the template. The resulting PCR products were digested 
with NdeI and SacI, ligated to pET22b-CPDSacI [78], and transformed into DH5a. The 
resulting pET22b-cspC_opt-CPD was transformed into BL21(DE3) for protein 
production. 
 
4.4.3. Bioinformatic analyses  
Homologs of C. difficile 630 GerS (CD3464) were identified using NCBI psi-
blast. Homologs identified in Peptostreptococcaceae family members gave an e-value < 
e-52, whereas the next closest homolog in a Clostridium spp. gave an e-value > e-27. When 
GerS lacking its N-terminal signal peptide was used in the psi-blast search, the difference 
in e-value cut-offs was < e-52 for Peptostreptococcaceae family members and the next 
closest homolog in a Clostridium spp. gave an e-value > e-23.  
 
4.4.4. C. difficile strain construction 
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C. difficile strains were constructed using TargeTron-based gene disruption as 
described previously (Figure S2, [40,79]). TargeTron constructs in pJS107 were 
conjugated into C. difficile using E. coli HB101/pRK24 as the donor strain. 
HB101/pRK24 strains containing the appropriate pJS107 construct were grown 
aerobically to exponential phase in 2.5 mL of LB supplemented with ampicillin (50 
µg/mL) and chloramphenicol (10 µg/mL). Cultures were pelleted, transferred into the 
anaerobic chamber, and resuspended with 1.5 mL of late-exponential phase C. difficile 
JIR8094 cultures (grown anaerobically in BHIS broth). The resulting cell mixture was 
plated as seven 100 µL spots onto pre-dried, pre-reduced BHIS agar plates. After 
overnight incubation, all growth was harvested from the BHIS plates, resuspended in 2.5 
mL pre-reduced BHIS, and twenty-one 100 µL spots per strain were plated onto three 
BHIS agar plates supplemented with thiamphenicol (10 µg/mL), kanamycin (50 µg/mL), 
and cefoxitin (16 µg/mL) to select for C. difficile containing the pJS107 plasmid. After 
24-48 hrs of anaerobic growth, single colonies were patched onto BHIS agar 
supplemented with thiamphenicol (10 µg/mL), kanamycin (50 µg/mL), and FeSO4 (50 
µM) to induce the ferredoxin promoter of the group II intron system. After overnight 
growth, patches were transferred to BHIS agar plates supplemented with erythromycin 
(10 µg/mL) for 24-72 hrs to select for cells with activated group II intron systems. 
Erythromycin-resistant patches were struck out for isolation onto the same media and 
individual colonies were screened by colony PCR for a 2 kb increase in the size of gerS 
(primer pair #1212 and 1173) and alr2 (primer pair #1352 and 1359) (Figure S2). 
 
4.4.5. C. difficile complementation 
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HB101/pRK24 donor strains carrying the appropriate complementation construct 
were grown in LB containing ampicillin (50 µg/mL) and chloramphenicol (20 µg/mL) at 
37˚C, 225 rpm, under aerobic conditions, for 6 hrs. C. difficile recipient strains gerS– and 
alr2– containing group II intron disruptions, were grown anaerobically in BHIS broth at 
37˚C with gentle shaking for 6 hrs. HB101/pRK24 cultures were pelleted at 2500 rpm for 
5 min and the supernatant was removed. Pellets were transferred to the anaerobic 
chamber and gently resuspended in 1.5 mL of the appropriate C. difficile culture. The 
resulting mixture was inoculated onto pre-dried, pre-reduced BHIS agar plates, as seven 
100 µL spots for 12 hrs. All spots were collected anaerobically and resuspended in 1 mL 
PBS. One hundred microliters of the resulting suspension was spread onto pre-dried, pre-
reduced BHIS agar plates supplemented with thiamphenicol (10 µg/mL), kanamycin (50 
µg/mL), and cefoxitin (10 µg/mL), five plates per conjugation. Plates were monitored for 
colony growth for 24-72 hrs. Individual colonies were struck out for isolation and 
analyzed for complementation using the heat resistance assay to test for functional spore 
formation and Western blot analysis. A minimum of two independent clones from each 
complementation strain was phenotypically characterized. 
 
4.4.6. Sporulation  
 C. difficile strains were grown from glycerol stocks on BHIS plates supplemented 
with TA (0.1% w/v), or with TA and thiamphenicol (5 µg/mL) for strains carrying 
pMTL83151-derived vectors. Colonies that arose on BHIS agar plates were then used to 
inoculate 70:30 agar plates containing 5 µg/mL thiamphenicol for 17-24 hrs depending 
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on the assay. Sporulating cells were harvested into PBS, pelleted, and resuspended in 
PBS for visualization by phase contrast microscopy and further processing as needed. 
 
4.4.7. Heat Resistance Assay 
C. difficile strains were induced to sporulate as described above and functional 
(heat-resistant) spore formation was measured as previously described [41] with the 
following exceptions. After 24 hrs of growth, cells were harvested into 600 µL of pre-
reduced PBS. The sample was divided into two tubes. One tube was exposed to 60˚C for 
25-30 minutes. Heat-treated and untreated cells were serially diluted, and dilutions were 
plated on pre-reduced BHIS-TA plates. After ~20 hrs colonies were counted, and cell 
counts were determined. The percent of heat-resistant spores was determined based on 
the ratio of heat-resistant cells to total cells, and heat-resistance efficiencies were 
determined based on the ratio of heat-resistant cells for a strain compared to wildtype. 
Results are based on a minimum of three biological replicates. The raw data for the heat 
resistance assay is provided in Table S2. 
 
4.4.8. Spore Purification 
 Sporulation was induced by growing C. difficile strains on 70:30 plates (with 5 
µg/mL thiamphenicol when appropriate for 2-3 days, and spores were harvested in ice-
cold water as previously described [23,76] with the following modifications. Spores were 
incubated on ice overnight following multiple water washes. The following day, they 
were pelleted and treated with DNase (New England Biolabs) at 37°C for 30 minutes. 
Following DNAse treatment, the spores were purified on a HistoDenz (Sigma Aldrich) 
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gradient, evaluated for purity by phase contrast microscopy, and the optical density of the 
suspension was measured at OD600. Spores were stored in water at 4˚C. 
 
4.4.9. Germination Assay 
 Approximately 1 x 107 spores (equivalent of 0.35 OD600 units) were re-suspended 
in 100 µL of water. Ten microliters of the suspension was serially diluted in PBS, and 
dilutions were plated onto pre-reduced BHIS-TA. After ~22 hrs, colonies arising from 
germinated spores were counted. Germination efficiency represents the number of CFUs 
produced by germinating spores of a given strain relative to wild type. Results are based 
on a minimum of three biological replicates. The remaining 90 µL of the spores were 
pelleted and resuspended in EBB buffer for Western blot analyses.  
 To assess the effect of heat treatment on spore viability, the procedure above was 
followed, with the exception that 2 x 107 spores were re-suspended in 200 µL of water 
(equivalent of 0.7 OD600 units) and the sample was divided into two. One half was 
incubated at 60˚C for 30 min, while the other half was left untreated.  
The effect of taurocholate concentration on spore germination efficiency was 
determined by re-suspending ~4 x 107 spores (~1.4 OD600 units) in 160 µL of water in 
triplicate. Two hundred microliters of BHIS was added to each spore suspension. Ninety 
microliters of this suspension was added to either 10 µL of water, 0.1% TA, 1% TA, or 
10% TA (to give a final concentration of 0.01% TA, 0.1% TA, or 1% TA). The samples 
were incubated for 20 min at 37˚C, and a 10 µL aliquot was removed for 10-fold serial 
dilutions into PBS. Ten microliters of the serial dilutions were plated on BHIS to 
determine the number of spores that had initiated germination. The serial dilutions for 
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untreated and 1% TA-treated spores were also plated on BHIS-TA plates to determine the 
maximum level of spore germination. Spore germination was maximal following 
exposure to 1% TA. The remaining samples were pelleted for Western blot analysis. 
 
4.4.10. Antibody production  
The anti-GerS used in this study was raised against GerS-His6 lacking its signal 
peptide in rabbits by Cocalico Biologicals (Reamstown, PA). The anti-CspC mouse 
antibodies were raised against recombinant untagged CspC in mice by Cocalico 
Biologicals (Reamstown, PA). GerS-His6 was purified from E. coli strains #1112 using 
Ni2+-affinity resin as previously described [23]. Recombinant, untagged CspC was 
purified using the autoprocessing CPD tag as previously described [78] followed by gel 
filtration [23]. 
 
4.4.11. Western blot analyses 
C. difficile cell pellets were processed as previously described [40,60]. Briefly, 
pellets were freeze-thawed three times, diluted in EBB buffer (8 M urea, 2 M thiourea, 
4% (w/v) SDS, 2% (v/v) β-mercaptoethanol), and incubated at 95˚C for 20 min with 
vortexing every 5 min. C. difficile spores (~1 x 106) were resuspended in EBB buffer, 
which can extract proteins in all layers of the spore including the core. Samples were 
centrifuged for 5 min at 15,000 rpm and 4X sample buffer (40% (v/v) glycerol, 1 M Tris 
pH 6.8, 20% (v/v) β-mercaptoethanol, 8% (w/v) SDS, and 0.04% (w/v) bromophenol 
blue), was added. Samples were incubated again at 95˚C for 5-15 minutes with vortexing 
followed by centrifugation for 5 min at 15,000 rpm. The samples were resolved by SDS-
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PAGE and transferred to Millipore Immobilon-FL membrane. The membranes were 
blocked in  Odyssey Blocking Buffer. Rabbit polyclonal rabbit anti-GerS or anti-GPR 
[40] antibodies were used at a 1:1,000 dilution; anti-CspB [23] antibodies were used at a 
1:2,500 dilution, and the anti-SleC [23] antibody was used at a 1:5,000 dilution. 
Polyclonal mouse anti-SpoIVA [80] and anti-CspC antibodies were used at  1:2,500 
dilutions. IRDye 680CW and 800CW infrared dye-conjugated secondary antibodies were 
used at 1:20,000 dilutions. The Odyssey LiCor CLx was used to detect secondary 
antibody infrared fluorescence emissions. 
 
4.4.12. RNA processing 
RNA from WT/EV, gerS–/EV, gerS–/gerS, gerS–/C22S, and gerS–/∆SP strains grown for 
24 hrs on 70:30 sporulation media containing thiamphenicol (5 µg/mL) was extracted for 
qRT-PCR analyses of the gerS transcript. RNA was extracted using a FastRNA Pro Blue 
Kit (MP Biomedical) and a FastPrep-24 automated homogenizer (MP Biomedical). 
Contaminating genomic DNA was depleted using three successive DNase treatments, and 
mRNA enrichment was done using an Ambion MICROBExpress Bacterial mRNA 
Enrichment Kit (Invitrogen). Samples were tested for genomic DNA contamination using 
quantitative PCR for rpoB. Enriched RNA was reverse transcribed using Super Script 
First Strand cDNA Synthesis Kit (Invitrogen) with random hexamer primers. 
 
4.4.13. Quantitative RT-PCR 
 Transcript levels of gerS and rpoB (housekeeping gene) were determined from 
cDNA templates prepared from 3 biological replicates of WT/EV, spo0A–/EV, gerS–/EV, 
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gerS–/gerS, gerS–/C22S, and gerS–/∆SP strains. Gene-specific primer pairs for gerS 
(#1278 and #1173), alr2 (#1668 and #1356), and rpoB [40] were used. Quantitative real-
time PCR was performed (as described by [41]. Briefly, using MaximaTM SYBRTM Green 
qPCR Master Mix (Thermo Scientific), 50 nM of gene specific primers, and an ABI 
PRISM 7900HT Sequence Detection System (Applied Biosystems). Transcript levels 
were normalized to the housekeeping gene rpoB using the standard curve method. 
 
4.4.14. Fluorescence Microscopy 
For live cell fluorescence microscopy studies, C. difficile strains were harvested in 
PBS, pelleted, and resuspended in PBS. For characterization of mutant phenotypes, cells 
were resuspended in PBS containing 1 µg/mL FM4-64 (Molecular Probes) and 15 µg/mL 
Hoechst 33342 (Molecular Probes). All live bacterial suspensions (4 µL) were added to a 
freshly prepared 1% agarose pad on a microscope slide, covered with a 22 x 22 mm #1 
coverslip and sealed with VALAB (1:1:1 of vaseline, lanolin, and beeswax) as previously 
described [41,81].  
DIC and fluorescence microscopy was performed using a Nikon PlanApo Vc 
100x oil immersion objective (1.4 NA) or a Nikon PlanApo Vc 60x oil immersion 
objective (1.4 NA) on a Nikon Eclipse Ti2000 epifluorescence microscope. Multiple 
fields for each sample were acquired with an EXi Blue Mono camera (QImaging) with a 
hardware gain setting of 1.0 and driven by NIS-Elements software (Nikon). Images were 
subsequently imported into Adobe Photoshop CS6 for minimal adjustments in 
brightness/contrast levels and pseudocoloring.  
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4.4.15. Artificial Germination Assay 
Artificial germination was determined using thioglycollate and lysozyme 
treatment. About 1 x 106 spores were pelleted at 8,000 RPM for 3 min, resuspended in 
250mM thioglycollate, and incubated at 50°C for 30 min based on previously methods 
developed [21,58]. Spores were washed with 150 µL of PBS, pelleted, resuspended in 
150 µL (2 mg/mL) lysozyme and incubated at 37°C for 15 min. Equivalent numbers of 
spores for each strain were incubated at the indicated temperatures without thioglycollate 
or lysozyme treatment for the untreated sample. The spore samples were plated on either 
BHIS or BHIS-TA. Natural germination represents the number of spores in the untreated 
sample that outgrew to form colonies on BHIS-TA media. Artificial Germination 
represents the number of thioglycollate/lysozyme-treated spores that germinated and 
outgrew to form colonies on BHIS media.  
 
4.4.16. Decoating Assay.  
About 1 x 107 spores (~0.35 OD600) were pelleted and resuspended in 30 µL of 
decoat buffer (0.1 M H3BO3 pH 10.0, 1% SDS, 2% β-ME) [57]. The sample was 
incubated for 30 min at 37˚C and then pelleted. The supernatant, representing the “coat-
extractable” (CE) fraction, was removed, and the pellet was washed in 20 µL decoat 
buffer and incubated for 10 min. The sample was re-pelleted, and the supernatant was 
added to the CE; 40 µL of EBB was added to the pooled fractions. The decoated spores 
were re-suspended in 90 µL EBB to produce the cell lysate (pellet) fraction. For the input 
fraction, representing whole spore lysate, equal numbers of spores were pelleted and 
resuspended in 90 µL EBB. All samples were boiled for a minimum of 15 min, followed 
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by centrifugation and sample resuspension. Fractions were pelleted one more time before 
the samples were resolved by SDS-PAGE and analyzed by Western blotting as described 
above. 
 
4.4.17. Cortex hydrolysis assay 
Cortex hydrolysis was analyzed by transmission electron microscopy for 
untreated spores (0’) and 15’ and 45’ after germinant addition. About 4 x 107 spores (1.4 
OD600 units) were resuspended in 160 µL of water in triplicate. Two hundred microliters 
of BHIS was added to each spore suspension. Forty microliters of water was added to one 
sample, while 40 µL of 10% taurocholate (w/v) was added to the remaining samples. The 
spores were incubated under anaerobic conditions for the indicated time point after which 
a small sample was removed for visualizing by phase-contrast microscopy and plating on 
BHIS and BHIS-TA. The remainder of the sample was pelleted and re-suspended in 
osmium tetroxide fixative for TEM analysis as previously described [60]. TEM grids for 
each sample analyzed were prepared as previously described [41]. A minimum of 50 
spore pictures chosen at random were analyzed for each strain observed. To account for 
asymmetrical spore shapes, two orthologous cortex lengths were measured such that a 
minimum and maximum cortex thickness was obtained for every spore. Cortex length 
was defined as the distance between the outer most germ cell wall and the cortex outer 
edge. The minimum and maximum measurements were averaged for each spore and the 
upper and lower values were discarded. The cortex length reported represents the average 
of these measurements. 
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4.4.18. Ca-DPA Release Assay 
To evaluate the amount of Ca-DPA released in response to germinant relative to 
the total amount of Ca-DPA observed in the spore core, a modified Ca-DPA release assay 
was adopted from [21]. About 2x107 spores from each strain were re-suspended in (i) 1 
mL of germination buffer (0.3 m M (NH4)2SO4, 6.6 mM KH2PO4, 15 mM NaCl, 59.5 
mM NaHCO3, and 35.2 mM Na2HPO4) and incubated at 37°C for 30 min (background); 
(ii) 1 mL of germination buffer containing 10% freshly prepared taurocholate and 10 mM 
glycine and incubated at 37°C for 30 min (DPA release); (iii) 1 mL of germination buffer 
and incubated at 100°C for 1 hr (total DPA). After incubation, samples were spun down 
at 15,000 RPM for 2 min. 700 µL was transferred to UV clear cuvettes, and the A270 was 
determined. The % Ca-DPA release was determined by subtracting the background DPA 
release value from the germinant containing DPA release value and dividing by total 
DPA. Total DPA measured in wild type was set as 100% total DPA. 
 
4.4.19. O.D. kinetics assay 
 Approximately 1 x 107 spores (0.48 OD600 units) were resuspended in BHIS to a 
total volume of 1100. The sample was divided into two: 540 µL was added to a cuvette 
containing 60 µL of water, while the other sample was added to a cuvette containing 60 
µL of 10% taurocholate. The samples were mixed, and the OD600 was measured every 3-
6 mins for 45 min. 
 
4.4.20. Virulence Studies 
 All animal studies were performed with prior approval from the Texas A&M 
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University Institutional Animal Care and Use Committee. Female Syrian golden hamsters 
(80-120 g) were housed and tested for C. difficile susceptibility as previously described 
[21,82]. To induce C. difficile infection, hamsters were gavaged with 30 mg/kg 
clindamycin prior to C. difficile spore inoculum. After 5 days, 10 hamsters per C. difficile 
strain tested were gavaged with 1,000 spores and monitored for signs of disease. 
Hamsters showing disease symptoms (wet tail, poor fur coat and lethargy) were 
euthanized by CO2 asphyxia followed by thoracotomy as a secondary means of death.  
 
4.5. Results 
4.5.1. Identification of GerS as a novel regulator of C. difficile spore germination  
We previously conducted RNA-Seq analyses of C. difficile sporulation-specific 
sigma factor mutants to identify gene products that might be required for spore formation 
and/or germination [40,41]. We hypothesized that highly expressed genes induced during 
sporulation would likely encode proteins that regulate spore formation and/or 
germination. gerS (CD3464) and alr2 are the second and sixth most highly expressed, 
sporulation-induced genes [40,41], respectively, and their gene products have not been 
previously characterized. Interestingly, alr2 is encoded downstream of gerS (Figure 1A), 
and these genes are part of a σE-activated operon (Figure S1, [42]). alr2 encodes a 
putative alanine racemase that in Bacillus. spp. converts L-alanine to D-alanine and 
reduces the sensitivity of spores to L-alanine germinant [43-45]. gerS is predicted to 
encode a lipoprotein that appears to be unique to the Peptostreptococcaceae family 
(Figure 1B).  
To test whether Alr2 or GerS regulate C. difficile sporulation and/or spore 
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germination, we constructed TargeTron gene disruption mutants in alr2 and gerS (Figure 
S2). Analysis of the alr2 and gerS mutants by phase contrast microscopy revealed that 
both strains produced phase-bright spores (Figure 1C). Fluorescence microscopy analyses 
indicated that alr2– and gerS– forespores appeared to develop similar to wild type (Figure 
S3). However, when the alr2– and gerS– strains were tested for functional spore 
formation, the gerS mutant failed to produce detectable heat-resistant spores, while the 
alr2 mutant produced wildtype levels of heat-resistant spores (Figure 1C). Western blot 
analysis confirmed that the gerS mutant was defective in producing GerS, while the alr2 
mutant produced wildtype levels of GerS (Fig. 1D).  
The inability of the gerS mutant to produce heat-resistant spores could be due to 
heat sensitivity [17,46] or a general defect in spore germination. To distinguish between 
these possibilities, we isolated spores from wild type and the gerS and alr2 mutants and 
tested their ability to germinate following heat-treatment using a plate-based assay. No 
obvious defect in spore morphology was apparent when gerS– and alr2– spores were 
visualized by phase contrast microscopy (Figure 2A). However, alr2– spores germinated 
at wildtype levels, whereas gerS– spores exhibited an ~5-log defect in spore germination 
relative to wild type (Figure 2B). Heating wildtype and alr2– spores to 60˚C for 30 min 
had no impact on spore germination, whereas heat treatment reduced the germination 
efficiency of gerS– spores by three-fold  (p < 0.05, Figure 2B). Although a similar heat 
treatment potentiates Bacillus sp. spore germination [47-49], this effect has not been 
observed in C. difficile [37,50]. Western blot analyses verified that GerS is packaged into 
wildtype and alr2– mutant spores but not gerS– spores (Figure 2C). Taken together, these 
results strongly suggest that gerS– spores have a significant germination defect that is 
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slightly heat sensitive. Furthermore, the germination defect of gerS mutant spores is 
unlikely to be caused by polar effects on alr2 expression, since Alr2 itself is dispensable 
for heat-resistant spore formation. 
 
4.5.2. Complementation of the gerS mutant 
To validate that the gerS mutant phenotype was due to absence of GerS, we 
complemented the mutant in trans by ectopically expressing gerS from its native 
promoter(s). Since gerS transcription originates from the proximal promoter (P1) directly 
upstream of gerS [42] and possibly the distal promoter upstream of acpS (P2, Figure S4), 
we constructed gerS complementation constructs in which gerS transcription originates 
from the proximal promoter (P1, single) or from both P1 and P2 promoters (dual, 
including the two genes upstream of gerS). Heat resistance analyses revealed that the 
single and dual promoter complementation constructs both restored heat-resistant spore 
formation to wildtype levels (Figure S4). Western blot analyses indicated that the dual 
and single promoter gerS complementation constructs restored GerS production to 
wildtype levels in the gerS– background (Figure S4). We chose to use the dual promoter 
complementation construct, since it produced GerS levels that were most similar to 
wildtype carrying empty vector. 
 
4.5.3. GerS regulates cortex hydrolysis 
We next sought to determine why gerS mutant spores exhibit such a strong 
germination defect. We first considered that GerS could affect the rate of spore 
germination, since a lipoprotein, GerD, controls the speed of germination in B. subtilis 
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[51,52]. Loss of B. subtilis GerD results in an ~20-fold germination defect after a 15 hr 
incubation with germinant; however, after 48 hr, it resembles wild type [52]. Although B. 
subtilis GerD exhibits no homology to C. difficile GerS, we assessed whether gerS 
mutants germinated after prolonged incubation. After 48 hrs of germination on BHIS 
plates containing taurocholate, the change in number of colonies formed following gerS– 
spore germination was minimal and appeared to arise from spontaneous germination [53]. 
We next wondered whether GerS regulates germinant accessibility in C. difficile 
spores, since GerP in B. subtilis and B. anthracis facilitates the interaction of germinants 
to inner membrane germination receptors, potentially by altering coat permeability [54-
56]. Bacillus spp. gerP mutants exhibit slower germination and require higher levels of 
germinant in order to achieve equivalent levels of germination as wild type. To test 
whether C. difficile gerS mutant spores are differentially sensitive to germinant, we 
compared the effect of increasing concentrations of taurocholate germinant on gerS– 
spores carrying empty vector (gerS–/EV) relative to wildtype carrying empty vector 
(WT/EV) and gerS– spores carrying the wildtype complementation construct (gerS–
/gerS). gerS– spores exhibited a similar dose-dependent germination response to 
taurocholate as wild type and the gerS complementation spores, although gerS– spores 
still had an ~5-log defect in spore germination in the presence of 1% taurocholate (Figure 
3A), which leads to germination levels equivalent to those obtained by plating on BHIS 
plates containing 0.1% taurocholate.  
This result suggested that gerS– spores can sense germinant similar to wildtype 
spores. Consistent with this finding, no difference in the levels of CspC germinant 
receptor and CspB germination protease were observed between the strains by Western 
 250 
blotting (Figure 3B), and no difference in CspB-mediated processing of SleC in response 
to increasing amounts of germinant was observed. Since CspB-mediated processing of C. 
perfringens SleC activates its cortex hydrolase function [26], and CspB-mediated 
processing of C. difficile SleC is required for optimal spore germination [23], these 
results suggested that GerS acts after SleC-mediated cortex hydrolysis.  
In order to test this hypothesis, we developed a transmission electron microscopy 
(TEM) assay to visualize and quantify cortex hydrolysis. Although cortex hydrolysis can 
be measured biochemically [24,36,57], it is difficult to obtain the amount of spores 
required for these analyses using the JIR8094 strain background. For the TEM assay, 
wildtype, gerS–, and sleC– spores were exposed to germinant for 45 min, and cortex 
thickness was measured over time for a minimum of 50 spores per time point (Figure 4). 
Within 15 min of exposure to germinant, cortex thinning was visible in wildtype spores 
(Figure 4A), and the average thickness decreased by 3-fold (p < 0.0001, Figure 4B). 
Cortex thickness decreased even further at 45 min. In contrast with wild type, no change 
in cortex thickness was observed in either sleC– or gerS– spores even after 45 min of 
incubation with germinant (Figure 4B). Thus, even though taurocholate induces CspB-
mediated pro-peptide removal from the pro-SleC zymogen in gerS– spores (Figure 3), 
SleC does not appear to be active (Figure 4). These results suggest that GerS may 
regulate SleC activity through an unknown post-translational mechanism or by altering 
the availability of the SleC substrate, MAL, in the cortex layer.  
If SleC activity is indeed dependent on the presence of GerS, it should be possible 
to bypass the need for SleC-mediated cortex hydrolysis by artificially germinating gerS– 
spores. During artificial germination, a reducing agent, thioglycollate, is added to 
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permeabilize the coat layers followed by lysozyme addition to degrade the cortex layer 
[13,58]. Treatment of wildtype, gerS–, and sleC– spores with thioglycollate and lysozyme 
restored outgrowth to gerS– and sleC– spores (Figure 5); no statistically significant 
difference in artificial germination between wildtype, gerS–, sleC– spores was observed. 
In contrast, wildtype spores germinated much more efficiently than the mutants upon 
“natural” exposure to taurocholate. The small amount of germination observed in sleC– 
spores is likely due to spontaneous germination [37,46], which can occur even in the 
absence of the germinant receptor [21].  
 
4.5.4. Ca-DPA release does not occur in the absence of GerS 
Since recent studies have shown that Ca-DPA release immediately follows cortex 
hydrolysis [36,37], we next tested whether the gerS mutant releases Ca-DPA in response 
to germinant (Figure S5). Whereas wildtype spores released ~80% of their Ca-DPA 
stores in response to germinant, gerS– spores released <5% of their Ca-DPA stores. Since 
wildtype and gerS– spores contained similar amounts of Ca-DPA (88%, Figure S5), Ca-
DPA storage does not appear to be affected by the gerS mutation, consistent with the 
recent observation that Ca-DPA release depends on cortex hydrolysis in C. difficile 
[36,37] in contrast with B. subtilis [13,38]. 
 
4.5.5. GerS localizes to a “coat-extractable” (CE) fraction 
Having shown that GerS is important for SleC activity, we next wanted to 
understand how GerS carries out its function. We first tested whether GerS and SleC 
were present in the “coat-extractable” (CE) fraction. To this end, we subjected wildtype 
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and gerS– mutant spores to a mild boric acid decoating treatment [57] to generate a CE 
supernatant fraction and a pellet fraction. Western blotting of these fractions revealed that 
both SleC and GerS co-localized to the CE fraction in wildtype spores but not to the 
pellet fraction, which consists of decoated spore lysate (Figure 6). Analysis of 
germination regulators CspC and CspB revealed that they also are concentrated in the CE 
fraction of wildtype and gerS– spores. These results indicate that the germination 
regulators GerS, SleC, CspB, and CspC are located in a similar cellular fraction. Since C. 
perfringens SleC has been shown to localize to the cortex using immunoelectron 
microscopy [59], and CspB and SleC were recently reported to localize to a CE fraction 
in C. perfringens [31], these results imply that the CE fraction includes cortex and outer 
forespore membrane proteins in C. perfringens and likely in C. difficile (although it 
remains formally possible that SleC does not localize to the cortex region in C. difficile). 
Importantly, the coat morphogenetic protein SpoIVA [60] localized exclusively to the CE 
fraction of wildtype and gerS– mutant spores, whereas the forespore-localized 
germination protease (GPR) [40,61,62] was found exclusively in the pellet fraction of 
these spores.   
 
4.5.6. Secretion, but not lipidation, of GerS is required for its function 
Since GerS is predicted to be a lipoprotein based on the presence of a putative N-
terminal signal peptide containing a lipobox [63-65], we tested whether GerS undergoes 
lipidation and whether its function depends on lipidation and/or secretion. The signal 
peptide of lipoproteins directs their transport across membranes after which Lgt, a 
prolipoprotein diacylglyerol transferase, adds a diacylglycerol group to the lipobox 
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cysteine via a thioether bond. Following lipidation, the lipoprotein signal peptidase (Lsp) 
cleaves off the signal peptide, and the lipoprotein inserts into the plasma membrane in 
Gram-positive bacteria [63]. Since mutation of the conserved cysteine residue in the 
lipobox to serine is sufficient to prevent lipidation [63-65], we complemented the gerS 
mutant with a construct that produces GerS carrying a cysteine 22 to serine (C22S) 
mutation. We also complemented the gerS mutant with a construct that deletes the GerS 
signal peptide sequence to prevent secretion (∆SP, Figures 1B and 7A). The C22S 
complementation strain produced heat-resistant spores at levels comparable to wild type, 
whereas the ΔSP complementation strain exhibited a >4-log decrease in functional (heat-
resistant) spore formation relative to wildtype (H.R., Figure 7B). These results suggest 
that secretion but not lipidation is required for GerS to activate cortex hydrolysis. 
Western blot analyses of the complementation strains revealed that only full-length GerS 
was detectable in the C22S strain, whereas both full-length and cleaved GerS were 
observed in wild type and the wildtype gerS complementation strain. These observations 
strongly suggest that Cysteine 22 is important for cleavage of the signal peptide, similar 
to other lipoproteins [63-65]. Neither full-length nor cleaved GerS could be detected in 
∆SP sporulating cells, implying that loss of the signal peptide leads to destabilization of 
GerS (Figure 7B). To test this hypothesis, we measured gerS transcript levels in the 
complementation strains by qRT-PCR relative to wildtype carrying empty vector. The 
gerS– complementation strains all produced an excess of gerS transcripts relative to 
wildtype carrying empty vector; this over-expression is likely due to the multi-copy 
nature of the pMTL83151 plasmid used for complementation (Figure S6). Thus, GerS 
lacking its signal peptide appears to be unstable in the mother cell cytosol of sporulating 
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cells. 
Consistent with our analyses of sporulating cells, purified spores from the C22S 
strain germinated at wildtype levels, while ΔSP spores exhibited an ~4-log defect in 
germination relative to wild type (Figure 7B). Only full-length GerS was detected in 
C22S spores, whereas only cleaved GerS was detected in wildtype spores carrying empty 
vector and gerS– spores carrying the wildtype complementation construct. GerS was 
undetectable in ∆SP spores. Taken together, these analyses suggest that GerS secretion 
across the mother cell-derived membrane is necessary for GerS function, while lipidation 
and signal peptide removal are dispensable for GerS to activate cortex hydrolysis. 
To test whether alterations to the signal peptide affected the heat sensitivity of gerS– 
mutant spores, we heated spores for 30 min at 60˚C prior to plating on media containing 
taurocholate germinant. As expected, heat treatment had no impact on the germination of 
wildtype spores carrying empty vector or wildtype complementation spores (Figure S7). 
No difference in spore germination between untreated and heat-treated C22S or ∆SP 
spores was observed. In contrast, gerS– mutant spores carrying empty vector showed a 
statistically significant decrease in the number of germinating spores following heat 
treatment (p < 0.01), similar to results with gerS– spores (Figure 2B). 
 
4.5.7. GerS is necessary to cause disease in hamsters 
Since bile acid-mediated germination has previously been shown to be important 
for C. difficile pathogenesis [21], we tested whether gerS– could cause disease in the 
hamster model of C. difficile infection (CDI). Hamsters inoculated with gerS– spores 
carrying empty vector had a 100% survival 7 days post inoculation, whereas wildtype 
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spores carrying empty vector resulted in 50% survival at the same time point (Figure 8). 
Inoculation with the gerS–/gerS construct resulted in 100% of the hamsters being 
euthanized by day 5 after inoculation. These results indicate that the gerS mutant’s in 
vitro germination defect correlates with an inability to cause disease in a hamster model 
of CDI.  
Since a possible explanation for the greater lethality of the gerS–/gerS strain might 
be a faster rate of spore germination relative to wildtype spores carrying empty vector, 
we analyzed the rate of germination initiation by measuring the decrease in optical 
density at 600 nm when spores form thecomplementation strains were exposed to 
taurocholate germinant (Figure S8). This assay revealed that the C22S and gerS–/gerS 
strains germinated with similar kinetics as wild type, albeit slightly less efficiently, 




Recent studies of C. difficile spore germination have uncovered a unique signaling 
pathway for sensing bile salt germinants and initiating spore outgrowth relative to 
previously studied organisms [12]. Although the germination regulators SleC and the Csp 
family proteases are conserved between C. difficile and C. perfringens [22], they can 
have different functions and/or activities in these organisms [21,23-26]. In this study, we 
identified a novel protein specific to C. difficile and related Peptostreptococcaceae family 
members that functions as a critical regulator of SleC cortex hydrolase activity and is 
essential for germination in vivo in a hamster model of infection under the conditions 
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tested. While C. difficile strain JIR8094 contains mutations in the flagellar operon that 
impacts motility and toxin gene expression, a gerS mutant nevertheless causes 
significantly less disease than wild type JIR8094.  
In particular, we showed that GerS regulates SleC activity downstream of CspB-
mediated processing of SleC. This processing event had previously been thought to be 
sufficient to activate SleC’s cortex hydrolase activity, since studies in C. perfringens 
showed that CspB-mediated cleavage of the pro-SleC zymogen was necessary for SleC to 
degrade cortex fragments in vitro [26,57], and loss of C. difficile CspB protease activity 
markedly reduced SleC processing and spore germination [23]. However, unlike C. 
perfringens SleC, full-length C. difficile SleC can degrade cortex fragments in vitro [33], 
calling into question why SleC does not automatically degrade cortex in dormant spores. 
It will be important in future studies to precisely determine the impact of pro-peptide 
removal in activating SleC function in vitro and in C. difficile.  
How then does GerS regulate SleC activity? Our results indicate that gerS is 
under the control of the mother cell-specific sigma factor σE (Figure 1A) and thus should 
be produced in the mother cell cytosol [40,41,61]. Deletion of the signal peptide from 
GerS destabilizes GerS in sporulating cells (Figures 7 and S6). This observation is 
consistent with the notion that GerS is transported across the outer forespore membrane 
into the cortex region during sporulation (Figure 9); more evidence is nevertheless 
needed to test this hypothesis. Since mutation of the invariant cysteine in the GerS 
lipobox prevents signal peptide removal but does not affect GerS function (Figure 7), the 
signal peptide of GerS C22S may insert into the outer forespore membrane where it can 
apparently function like lipidated wildtype GerS (Figure 7). Although mutation of the 
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invariant lipobox cysteine frequently disrupts lipoprotein function [51,66,67], lipidation 
of some bacterial lipoproteins can be dispensable for their activity because they remain 
embedded in the plasma membrane through their signal peptide [63,68]. These 
observations suggest that GerS may exert its function on the surface of the outer 
forespore membrane facing the cortex (Figure 9). Notably, SleC activity also appears to 
be localized to this region, since TEM analyses of germinating wildtype spores revealed 
that cortex thinning initiates at the outer forespore membrane and radiates inward in C. 
difficile (Figure 4). While more studies are clearly needed to determine the exact 
locations of SleC and GerS in mature spores, our results suggest that these germination 
regulators may be localized to the outer forespore membrane, which likely fractionates 
with the coat (Figure 9), raising the intriguing possibility that GerS retains SleC at this 
site. It will be interesting to determine in future work whether GerS acts as a direct or 
indirect activator of SleC and/or whether GerS is necessary for SleC to recognize its 
cortex substrate, for example by controlling the predicted modification of NAM residues 
to muramic acid δ-lactam in the cortex [34,35], particularly since GerS lacks homology 
to other proteins aside from its lipobox.  
Although GerS carries a signal peptide that directs its secretion across mother 
cell-derived membranes (Figure 9), SleC lacks a canonical N-terminal signal sequence. 
Thus, it is unclear how SleC is transported across the outer forespore membrane so that it 
can bind its cortex substrate. Similarly, how CspB is transported across this mother cell-
derived membrane to cleave pro-SleC, and how CspC is presumably translocated across 
this membrane to activate CspB, remains unknown, since both CspB and CspC lack a 
canonical signal sequence. 
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 Intriguingly, all the known germinant regulators in C. difficile, CspC, CspBA, 
SleC, and GerS, are produced under the control of mother cell-specific sigma factors 
[40,42,61]. In contrast, the germination regulators of B. subtilis, the GerAA-AC complex 
and GerD, are all under the control of the forespore-specific sigma factor σG [69]. These 
observations suggest that the topology of germination signaling differs significantly 
between C. difficile and B. subtilis. In B. subtilis, the germinant receptors are located in 
the inner forespore membrane [70-72], since decoated spores germinate efficiently [73]. 
Germinant sensing stimulates release of Ca-DPA from the core through the inner 
forespore membrane-localized channel SpoVAC [13]; Ca-DPA then activates the CwlJ 
cortex lytic enzyme [46].  In C. difficile, the germinant receptor CspC, the germination 
protease CspB, the cortex hydrolase SleC, and the lipoprotein GerS, all localize to the CE 
fraction (Figure 5). Thus, these regulators are unlikely to be associated with the inner 
forespore membrane in contrast with B. subtilis. Since SleC cortex hydrolase activation 
precedes Ca-DPA release in C. difficile (Figure S5, [21,37]), the germinant signal appears 
to travel from the outside-in, whereas in B. subtilis the signal appears to travel from the 
inside-out. 
 While our genetic analyses demonstrated that GerS is a key germination regulator 
in C. difficile, they also showed that Alr2, a putative alanine racemase, is dispensable for 
germination (Figure 2). It should be noted that this observation does not exclude the 
possibility that Alr2 could alter the sensitivity of C. difficile spores to L-alanine, which 
has been shown to function as a co-germinant for C. difficle in vitro [74]. In B. anthracis 
and B. cereus, the Alr2 homolog alanine racemase converts L-alanine, a known 
germinant, to D-alanine to reduce the sensitivity of spores to L-alanine germinant 
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[43,44,75]. Whether Alr2 modulates C. difficile spore germination remains to be 
determined, in particular whether it functions in suppressing germination. However, 
Howerton and Abel-Santos have shown that D-alanine is not an inhibitor of C. difficile 
spore germination [74], suggesting that Alr2 plays little role in C. difficile spore 
germination or has an as-yet-unknown function. 
 In summary, in identifying a novel germination regulator conserved in C. difficile 
and other Peptostreptococcaceae family members, our study reveals yet another 
difference between the regulation of spore germination in C. difficile relative to B. 
subtilis and C. perfringens. While many unanswered questions remain, cortex hydrolysis 
in C. difficile appears to be subject to an additional level of regulation during germination 
by GerS. Thus, GerS could be a potential target for inhibiting C. difficile disease 
transmission, especially given its limited conservation in spore-forming organisms.  
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Table 1: Strains and Plasmids used in this study 
Strain 
# 
Strain name Relevant genotype or features Source or 
reference 
C. difficile strains 
11 JIR8094 erm-sensitive derivate of 630 [81] 
35 spo0A– JIR8094 spo0A::ermB [40] 
47 sleC– JIR8094 sleC::ermB [23] 
278 gerS– JIR8094 gerS::ermB This study 
111 JIR8094/EV JIR8094 carrying pMTL83151 empty vector [23] 
330 gerS–/EV JIR8094 gerS::ermB/pMTL83151 This study 
425 alr2– JIR8094 alr2::ermB This study 
520 gerS–/gerS JIR8094 gerS::ermB/pMTL83151-acpS-CD3465-gerS This study 
574 gerS–/single JIR8094 gerS::ermB/pMTL83151-gerS This study 
630 gerS–/ΔSP JIR8094 gerS::ermB/pMTL83151-acpS-CD3465-ΔSPgerS This study 
632 gerS–/C22S JIR8094 gerS::ermB/pMTL83151-acpS-CD3465-gerS(C22S) This study 
    





F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 
endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 
gyrA96 relA1 D. Cameron 
269 pET28a  pET28a in DH5α M. Bogyo 
373 pET22b-CPDSacI 
pET22b-CPD encoding MARTXVc toxin 3442-
3650 aa [76] 
531 HB101/pRK24 
F- mcrB mrr hsdS20(rB- mB-) recA13 leuB6 ara-
13 proA2 lavYI galK2 xyl-6 mtl-1 rpsL20 carrying 
pRK24 C. Ellermeier 
556 DH5α/pJS107 pJS107 in DH5α [21] 
686 pMTL83151 pMTL83151 in HB101/pK424 [23] 
892 BL21(DE3) F– ompT hsdSB(rB–, mB–) gal dcm (DE3) Novagen 
951 pJS107/gerS pJS107-gerS targeting bp 177 in HB101/pK424 This study 





pET22b-cspC codon optimized fused to CPD 
 This study 
1112 pET28a-gerS 
pET28a-gerS encoding 66-591 aa (no signal 
peptide) This study 













pMTL83151-Proximal promoter-gerS in 












gerS(ΔSP) in HB101/pK424 This study 
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Plasmids 
 pET28a IPTG-inducible expression plasmid, KanR Novagen 




TargeTron construct based on pJIR750ai (group II 











TargeTron construct based on pJIR750ai (group II 
intron ermB::RAM, ltrA); catP 
C. Ellermeier 
 








   
 
  
Primer Name Sequence 
532 3’ Universal EBS CGAAATTAGAAACTTGCGTTCAGTAAAC 




















3' SacI cspC 
codon opt  no 
TAA AAATGAGCTCAAGGGTGTTGGCAATCTGCTG 
1173 
3’ XhoI gerS no 
stop AATACTCGAGGTTTCTGTATTCAAAATC 
1212 5’ NdeI gerS AATACATATGAGAAAAAAGTGGACCATAG 
1278 


















1387 5’ EBS2 alr2 666 
TGAACGCAAGTTTCTAATTTCGATTAAATCTCGATAG
AGGAAAGTGTCT 
1464 5’ NotI gerS operon promoter AAAAGCGGCCGCAGTTTTTAGTGATAATAAATTC 
1466 3’ XhoI gerS AAAACTCGAGGTCTTTAGTCCCCCTTAGTTTCTG 
1667 5’ NotI gerS-CD3463 operon AAAGCGGCCGCCAGTTGTAGATTCAGAGAATAG 
1726 5’ trunc gerS SOE to CD3465 
CTGAAGTAGGAGGTGTGATGTGCAAAAACGACAGTC
CAC 
1727 3’ CD3465 SOE to trunc gerS 
GTGGACTGTCGTTTTTGCACATCACACCTCCTACTTC
AG 
1733 5’ C22S gerS SOE 
GCACTGGTTATAATTGTAATAGGATCCCAAAAACGA
CAGTCCACAAAAG 
1734 3’ C22S gerS rev oes 
CTTTTGTGGACTGTCGTTTTTGGGATCCTATTACAATT
ATAACCAGTGC 
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4.10. Figure Legends 
Figure 1. C. difficile gerS is highly induced during sporulation and encodes a protein 
important for heat-resistant spore formation. (A) Schematic of C. difficile gerS and 
alr2 genomic loci. gerS and alr2 are predicted to be part of an operon where transcription 
initiates from a P1 promoter immediately upstream of gerS (mapped by RNA-Seq 
transcriptional start site mapping, [42]) and potentially from the P2 promoter upstream of 
acpS. Fold-change represents the difference in gene expression between wild type and the 
sigE– mutant [41]. Base mean refers to the number of transcripts detected for the 
respective gene normalized to the length of that gene. (B) ClustalW alignment of GerS. 
Completely conserved, identical residues are blocked in blue, conserved identical 
residues are blocked in green, and conserved similar residues in yellow. The predicted 
signal peptide is bracketed in black, and the lipobox is bracketed in red. The lipobox 
cysteine predicted to be lipidated is designated by a red asterisk. The following sequences 
from Peptostreptococcaceae family members [27] were analyzed: Peptostreptococcaceae 
bacterium VA2 (WP_026902346), Intestini bartlettii (WP_007287647), C. bifermentans 
(WP_021430359), C. glycolicum (WP_018591922), C. mangenotii (WP_027700975), C. 
sordellii (CEK32529), and C. difficile (YP_001089984). (C) Phase contrast microscopy 
of the indicated C. difficile strains grown on sporulation media for 20 hrs. The spo0A– 
mutant cannot initiate sporulation [85]. The efficiency of heat-resistant spore formation 
(H.R.) was determined for each strain relative to wild type for three biological replicates. 
Scale bars represent 5 µm. (D) Western blot analysis of sporulating WT, spo0A–, gerS–, 
and alr2– cells. The mouse anti-SpoIVA antibody was used as a loading control [60]. (E) 
qRT-PCR analysis of alr2 transcription in the indicated mutants. RNA was isolated from 
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the indicated strains after sporulation was induced for 18 hrs. Transcript levels were 
normalized to the housekeeping gene rpoB using the standard curve method. Data 
represents the average of three biological replicates. Error bars indicate the standard error 
of the mean. n.a. indicates not applicable, since the region amplified spans the disrupted 
alr2 gene. Statistical significance was determined using ANOVA and Tukey’s test (* p < 
0.05). 
 
Figure 2. C. difficile gerS– mutant spores have a severe germination defect. (A) Phase 
contrast microscopy of C. difficile spores isolated from wildtype, gerS–, and alr2– strains. 
gerS– and alr2– resemble wild type in size and their phase-bright appearance. Scale bars 
represent 5 µm.  (B) Germination of wildtype, gerS–, and alr2– spores following heat 
treatment. Heat-treated spores were incubated for 30 min at 60°C. Data represents the 
average of three biological replicates. Statistical significance was evaluated using 
ANOVA and Tukey’s test (* p < 0.05). (C) Western blot analysis of spores isolated from 
WT, gerS–, and alr2– strains. Anti-SpoIVA was used as a loading control [60]. 
 
Figure 3. gerS– spores process pro-SleC in response to germinant. (A) in vitro 
germination of purified spores from wildtype carrying empty vector (WT/EV) and gerS– 
carrying empty vector (gerS–/EV) or the gerS– complementation construct (gerS–/gerS) 
spores in response to increasing amounts of taurocholate. Samples were plated on BHIS 
following taurocholate exposure. Data represents the average of three biological 
replicates. Statistical significance was evaluated using ANOVA and Tukey’s test. n.s. = 
no statistical significance. (B) Western blot analyses of samples from one representative 
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replicate of the in vitro germination assay shown above. The zymogen pro-SleC is 
processed by CspB in response to taurocholate addition [23].  
 
Figure 4. gerS– spores are defective in cortex hydrolysis. (A) TEM analyses of 
wildtype, gerS– and sleC– spores at time 0’, 15’, and 45’ post exposure to taurocholate. 
The 0’ timepoint was taken before taurocholate was added. sleC– spores were used as a 
negative control, since they do not undergo cortex hydrolysis [36,37]. The average cortex 
thickness was determined for each sample from a minimum of 50 spores at each 
timepoint. n.d. designates not determined. Representative images are shown. Scale bars 
designate 100 nm. (B) Box and whiskers plot of cortex thickness of the in vitro 
germination assay shown in (A). Statistical significance was determined using ANOVA 
and Tukey’s test (**** p < 0.0001). 
 
Figure 5. Artificial germination of gerS– bypasses its germination defect. Wildtype, 
gerS–, and sleC– spores were incubated with no germinant, taurocholate (natural 
germination) or thioglycollate and lysozyme (artificial germination). Mutants defective in 
cortex hydrolysis can be artificially germinated [58]. Data represents the average of 4 
biological replicates. No statistical significance was observed between strains subjected 
to artificial germination, in contrast with natural germination. Statistical significance was 
determined using ANOVA and Tukey’s test (* p < 0.05; **** p < 0.001). 
 
Figure 6. Germination proteins localize to a coat-extractable fraction. Western blot 
analyses of “coat-extractable” (CE) and decoated spore lysate (pellet) fractions from 
 273 
wildtype and gerS– spores. It should be noted that the CE fraction likely includes proteins 
localized to the cortex and outer-forespore membrane. Input represents the whole spore 
lysate without fractionation. SpoIVA is a coat morphogenetic protein [60]. GPR 
(germination protease) is localized to the core of spores [40,61,62].  
 
Figure 7. The signal peptide of GerS, but not its lipidation site, is required for 
germination. (A) Schematic of gerS complementation constructs. C22S designates a 
construct encoding a mutation of the invariant lipidation site cysteine to serine. ΔSP 
designates a construct encoding a truncated GerS lacking its signal peptide. (B) Western 
blot analyses of GerS in sporulating cells and purified spores from wild type carrying 
empty vector (EV) and the gerS mutant carrying either empty vector or the indicated 
complementation constructs. SpoIVA was used as a loading control [60]. The efficiency 
of heat-resistant spore formation (H.R.) during sporulation is shown, as is the 
germination efficiency (G.E.) of purified spores. Data is representative of at least 4 
replicates. 
 
Figure 8. GerS is required for virulence. Kaplan-Meier survival curve of clindamycin-
treated Syrian hamsters inoculated with 1,000 isolated spores of wildtype carrying empty 
vector (WT/EV), the gerS mutant carrying either empty vector (gerS–/EV), or the 
wildtype complementation construct (gerS–/gerS). The control designates antibiotic-




Figure 9. Model of C. difficile germination regulator production and localization 
during sporulation and germination. The sporulating cell depicts transcription of 
germination regulator genes and translation of the resulting transcripts. gerS, sleC, and 
cspBAC are all controlled by σE in the mother cell. σG may regulate the expression of 
gene products involved in germination, but these are unknown. In the mother cell, 
removal of the pre-domain is depicted by the curved arrow, while interdomain cleavage 
of CspBA is demarcated by the red X; these processing events occur during spore 
maturation [23]. Solid blue arrows designate transport of proteins from the mother cell 
into the forespore compartment. In mature spores, the germination regulators, GerS, 
SleC, CspC, and CspB, likely localize to the cortex region and/or to the outer forespore 
membrane. The possible association of these regulators into a “germinosome” complex 
[86] is designated by the bracket. The taurocholate (TA) germinant is depicted by the red 
star. Red arrows depict SleC-mediated cortex hydrolysis from the outer forespore 
membrane to the inner forespore membrane. * lipidation event; ** signal peptide 
cleavage event; dashed arrow designates an unknown event. 
 
4.11. Supplemental Figure Legends 
Figure S1. Representative images of Integrated Genome Viewer software [87] used to 
visualize RNA-Seq data [41]. Histograms of RNA sequence reads obtained for the 
indicated strains are shown in grey. The direction of transcription is indicated by the 




Figure S2. Generation of gerS– and alr2– strains using Targetron gene disruption. 
(A) Schematic of the Group II Intron system [79] used for insertional mutagenesis of 
gerS and alr2. (B) Colony PCR of wildtype, gerS–, and alr2– strains using primers that 
flank the gene of interest. The Group II Intron is ~2 kb. 
 
Figure S3. Sporulation of gerS– and alr2– strains is similar to wild type. Fluorescence 
microscopy analysis of wild type, spo0A–, gerS–, and alr2– sporulating cells. Strains were 
grown on sporulation media for 20 hrs and visualized by live differential interference 
contrast (DIC). The nucleoid was stained with Hoechst (blue), and membranes were 
stained with FM4-64 (red). Orange arrows designate forespores that have not progressed 
beyond asymmetric division (flat polar septa); blue arrows designate cells that stain with 
both Hoechst and FM4-64; yellow arrows designate forespore compartments that exclude 
Hoechst but stain with FM4-64; and white arrows designate forespores that are DIC-
bright and exclude both Hoechst and FM4-64. Scale bars represent 5 µm. 
  
Figure S4. Plasmid complementation of gerS–. (A) Schematic of constructs used to 
assay for gerS– complementation. Dual (gerS) designates a complementation construct 
that includes 2 potential gerS promoters and the upstream genes acpS and CD3465. The 
P1 promoter has been mapped by RNA-Seq transcriptional start site mapping [42]. Single 
designates a complementation construct where gerS transcription is driven from the P1 
promoter alone. (B) Western blot analyses of gerS– complementation strains grown on 
sporulation media for 22 hrs. The strains carry empty vector (EV) or the indicated 
complementation constructs. The efficiency of heat-resistant spore formation was 
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determined for each strain relative to wildtype from three biological replicates. H.R. = 
heat resistance. 
 
Figure S5. gerS– does not release Ca-DPA in response to germinant. Spores isolated 
from wildtype carrying empty vector (WT/EV) and gerS– carrying empty vector (gerS–
/EV) or a gerS complementation construct (gerS–/gerS) were analyzed for total Ca-DPA 
content and Ca-DPA release in response to taurocholate germinant and glycine co-
germinant. The amount of Ca-DPA released by wildtype spores after boiling for 1 hr was 
set to 100% total Ca-DPA. Percent Ca-DPA release represents the A270 value after 
response to germinant incubation relative to the total DPA value obtained for a given 
strain. The results represent the average of 4 biological replicates. 
 
Figure S6. gerS transcript levels in gerS– complementation strains. Transcript levels 
of the gerS were analyzed by qRT-PCR for RNA isolated from wildtype carrying empty 
vector (WT/EV) or gerS– carrying either empty vector (gerS–/EV) or the indicated 
complementation constructs induced to sporulate for 24 hrs. Transcript levels were 
normalized to the housekeeping gene rpoB using the standard curve method. Data 
represents the average of three biological replicates. Error bars indicate the standard error 
of the mean. n.a. indicates not applicable, since the region amplified spans the disrupted 
gerS gene. 
Figure S7. Effect of heat-treatment on gerS– spore germination. Spores isolated from 
wildtype carrying empty vector (WT/EV) or gerS– carrying either empty vector or the 
indicated complementation constructs were heat-treated for 30 min at 60˚C prior to 
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plating on germination media. No statistically significant changes occurred between 
untreated (–) or heat-treated (+) spores for a given strain with the exception of gerS– 
spores carrying empty vector (gerS–/EV). Results represent the average of three 
biological replicates (** p < 0.01). 
 
Figure S8. Comparison of germination initiation rates in gerS complementation 
strains. Purified spores from the indicated strains were re-suspended in BHIS. 
Germination was induced by the addition of taurocholate (1% final concentration). The 
ratio of the OD600 at a given time relative to the OD600 at time zero is plotted. The data 
represent the average of three independent experiments, and error bars indicate the 





Figure 1. C. difficile gerS is highly induced during sporulation and encodes a protein 
















































Figure 9. Model of C. difficile germination regulator production and localization 





Figure S1. Representative images of Integrated Genome Viewer software of CD3464 













































CHAPTER 5: DISCUSSION AND FUTURE DIRECTIONS 
5.1. The Big Picture 
The studies presented in this dissertation focus on identifying and characterizing 
key regulators of C. difficile sporulation and spore germination. Prior to these studies, we 
knew that, during sporulation in B. subtilis, an intricate back-and-forth dialogue between 
the forespore and mother cell controls the cellular differentiation program. We now know 
that this intercompartmental dialogue is not broadly conserved in (Pepto)clostridium 
difficile [1-3] or in Clostridium spp. [4-9], despite the strict conservation of many 
signaling proteins that control the morphological events leading to spore formation [10-
14] (Figure 1 and 2). Instead, sporulation-specific sigma factors are activated with 
minimal or no intercompartmental signaling in C. difficile, with the forespore line of gene 
expression occurring largely independently of the mother cell line of gene expression 
(Figure 2). As a result, sigma factor activation occurs in a bifurcated manner in C. 
difficile [1, 3] rather than a crisscross pathway as in B. subtilis [15, 16] (Figure 2). In B. 
subtilis forspore activity is linked to mother cell activity by the formation of a channel 
known as the “feeding tube”, which is required for σG transcription during late 
sporulation [17]. We show in Chapter 3 that conserved channel components are essential 
for engulfment in C. difficile, but are dispensable for transcriptional activation of σG [1, 
17]. Indeed, sigma factor activation in C. difficile is not as tightly coupled to 
morphological events as in B. subtilis [1, 16].  
With respect to germination, the work presented in Chapter 4 describes an 
important regulator that controls cortex hydrolysis now known as GerS. While most 
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spore-formers create spores that have the same basic properties in a broad sense, and the 
principles of germination are consistent, we now show that the regulation of breaking 
down the spore is different. While important discoveries have been made that contribute 
to the understanding of how C. difficile undergoes germination, many unresolved 
questions remain.  
 
5.2. Clostridium difficile global sporulation network 
Not only are C. difficile sigma factors regulated in a different manner relative to 
B. subtilis, we show that altogether, fewer genes are regulated than in B. subtilis, with 
global transcriptional analyses identifying ~200 genes being activated in C. difficile 
relative to the ~450 genes in B. subtilis. Whether this difference is functionally 
significant, or whether the sigma factors control different cellular processes during C. 
difficile sporulation relative to B. subtilis is unknown. We can speculate that many genes 
that are not transcribed in high abundance may have been missed, since sporulation 
cannot be synchronized in C. difficile. Until a method of synchronization is determined in 
C. difficile or an alternative method for identifying genes expressed at low levels in an 
asynchronous population, identification of such sporulation genes will remain 
challenging.  
 
5.3. Clostridium difficile sigma factor activation 
5.3.1. Early sigma factor activation 
C. difficile sigma factor activity exhibits a similar compartmentalization as B. 
subtilis, with σF and σG activity being forespore-specific, and σE and σK being mother 
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cell-specific [2, 18, 19]. However, the most notable findings from the work presented in 
Chapter 2 is that i) sigG transcription does not depend on σF, ii) σG activation does not 
depend on σE, and iii) intercompartmental signaling mediated by σF for σE activation is 
not as tightly regulated, in contrast with B. subtilis [1].  
C. difficile σF is likely activated by a similar mechanism as B. subtilis based on 
the conservation of SpoIIE, SpoIIAA, and SpoIIAB. However, work presented in this 
dissertation and elsewhere indicates that gene conservation does not necessarily predict 
protein function conservation, suggesting that alternative mechanisms from those defined 
in B. subtilis could control C. difficile σF activity.  
B. subtilis σE activation occurs when the σF-dependent transmembrane protein 
SpoIIR activates the endopeptidase SpoIIGA, which cleaves the propeptide from Pro-σE, 
activating σE [20]. In contrast, C. difficile SpoIIR is regulated in a Spo0A-dependent 
manner [1]. Recent studies by Saujet et al. demonstrated C. difficile spoIIR expression is 
detected in a C. difficile sigF mutant exclusively in the forespore compartment, but not to 
wildtype levels [21]. As a result, partial σE processing and activation in the mother cell is 
observed even in the absence of σF [1]. Presumably, if SpoIIR and Pro-σE are both 
produced prior to asymmetric division, both are likely caught in the forespore 
compartment area prior to completion of the polar septum. How then is σE being 
regulated only in the mother cell compartment if SpoIIR is made before asymmetric 
division? Is something partially restricting σE activity in the forespore? In B. subtilis, 
SpoIIIE constributes to σE compartmentalized activity, since a spoIIIE mutant results in 
enhanced σE accumulation (and σE activity) in the forespore, and a forespore-expressed 
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factor is thought to be important for blocking or removing pro-σE and SpoIIGA from the 
forespore compartment through an unknown mechanism [22, 23]. In C. difficile, multiple 
SpoIIIE-like proteins are encoded in the genome, but it is unknown which, if any, are 
involved in sporulation [24]. Investigation into these SpoIIIE-like proteins may reveal 
how compartment-specific σE-activity is achieved in C. difficile. 
Analysis of the sigF mutant RNA-Seq data suggests that only the most highly 
transcribed σE-dependent genes are upregulated in a sigF mutant relative to the spo0A 
mutant that cannot initiate sporulation, albeit at reduced levels relative to the wildtype 
(Chapter 2, Table S3). While we can speculate that only the σE-dependent genes with the 
strongest promoters and most abundant transcripts are turned on in a sigF mutant, we 
cannot rule out additional regulatory elements that could be at play. Some of the most 
abundant σE-regulated transcripts are derived from coat and exosporium genes, such as 
CD1067 (cdeC), which based on the RNA-Seq data, have a dependency on both σF and 
σE, whereas σE-regulated transcripts expressed in lower amounts, do not group together 
as σF-dependent [1]. It would be interesting to analyze and compare the promoter regions 
of both high and low transcript genes; are there substitutions in the -35 or -10 boxes? Are 
the consensus sequences far away from the transcriptional start site? Or, are these 
anomalies due to there being such a low number of transcripts that expression differences 
are deemed insignificant as a result of the variation induced by pooling of heterogeneous 
populations data and the asynchronous sporulating population? 
 
5.3.2. Late sigma factor activation  
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 A major finding from Chapter 2 was that sigG transcription and translation is 
independent of σF and σE, but σG activation depends on σF through an unknown post-
translational mechanism [1, 3]. C. difficile σG activation occurs independent of both 
engulfment and σE-controlled feeding tube formation, since the σE-controlled feeding 
tube components are dispensable for σG activity [1, 14, 18]. Additionally, there are no Fin 
or Gin homologues (σF and σG inhibitors, respectively [25, 26]) in C. difficile [1, 21]. So 
the question remains, what is the mechanism for post-translationally activating σG? We 
can speculate that it is a positive regulator, since a negative regulator would result in σG 
activity in the absence of σF. Another possibility is that a Spo0A-dependent negative 
regulator exists that is subject to an anti-inhibitor produced by σF. 
In contrast with B. subtilis, C. difficile σK activity is independent of σG-mediated 
transmembrane signaling, since C. difficile σK lacks an inhibitory propeptide and is active 
upon translation [1, 19]. Production of σK nevertheless still requires skin element excision 
[2, 27] similar to B. subtilis [28], an event that may regulate the timing of σK function. 
Interestingly, the skin element is not conserved in other Clostridia spp. (Figure 3). 
In further contrast with B. subtilis, data presented in Chapter 2 demonstrates that a 
C. difficile sigK mutant produces cortex, indicating that σK is dispensable for cortex 
development [19]. These results support the finding that the forespore line of gene 
regulation regulates cortex synthesis in C. difficile [1, 3]. σK nevertheless controls coat 
polymerization, similar to B. subtilis, since no polymerized coat is observed in a C. 
difficile sigK mutant. 
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5.4. Clostridium difficile cortex regulation  
 It was interesting to find that a sigG mutant appears to make coat but does not 
appear to make cortex, indicating that σG controls cortex synthesis. In B. subtilis, the 
mother cell line of gene expression leads to coat and cortex production, so it was not 
surprising to find detectable coat in a sigG mutant, since we know now that σE and σK 
activity occurs independent of forespore factors. The question remains, what σG-
dependent factor(s) control cortex formation? CD1430 and dacF are σG-controlled genes 
that are annotated as an N-acetylmuramic acid deacetylase and a D-alanyl-D-alanine 
carboxypeptidase, which may be the key enzymes for forming the murmic-δ-lactam 
residues and regulating peptidoglycan crosslinking, respectively, during cortex formation 
[29, 30]. To investigate σG-controlled cortex formation, these genes could be disrupted or 
deleted using targeted mutagenesis and analyzed for cortex production. 
Interestingly, we found that both σF and σG control the production of the C. 
difficile SpoVT transcription factor [1, 3]. A C. difficile spoVT mutant completes 
engulfment but does not make phase bright spores [3], suggesting that cortex is absent, in 
contrast with the respective mutant in B. subtilis, which is capable of producing phase 
bright spores [31]. Similarly, analysis of a spoVT mutant by TEM confirmed that cortex 
is not present (unpublished results), adding an additional level of regulation required for 
the formation of cortex. RNA-Seq analysis of a spoVT mutant may lead us to 
understanding which forespore-specific, cortex-regulating gene products are controlled 
by SpoVT. While there have not been detailed studies analyzing C. difficile cortex, we 
speculate that it is essential for heat resistance and chemical resistance properties, based 
on studies of sigG and spoVT mutants. 
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5.5. Clostridium difficile engulfment factors 
5.5.1. SpoIID and SpoIIP are important for engulfment in B. subtilis and C. difficile 
 In B. subtilis, SpoIID (a lytic transglycosylase) and SpoIIP (an amidase and 
endopeptidase), localize to SpoIIM (an integral transmembrane protein) on the mother 
cell side of the division septum and together form the “D/P/M” complex; D/P/M degrades 
the peptidoglycan in the division septa intermembrane space and drives engulfment [32-
34]. These proteins are σE-dependent and essential for engulfment in B. subtilis.  
 How does C. difficile control engulfment? In C. difficile, a spoIID homolog is 
controlled in a σE–dependent manner, a spoIIP homolog is controlled in a σF–dependent 
manner, and a spoIIM homolog is controlled in a Spo0A-dependent manner [1]. 
Interestingly, initial studies of C. difficile spoIID, spoIIP, and spoIIM mutants revealed 
that both spoIID and spoIIP are essential for engulfment, whereas SpoIIM is not 
(unpublished results). However, it could be that SpoIIM allows for more efficient 
engulfment by controlling the localization of the peptidoglycan processing enzymes. If 
synchronization of the sporulating population was possible, time-lapse microscopy would 
be an effective way to investigate this hypothesis. 
 
5.5.2. σG is important for engulfment in C. difficile 
 It seems that there is an unidentified factor important for completing engulfment 
that is regulated in a σG-dependent manner, since the majority (87%) of sporulating sigG 
mutant cells (strain JIR8094) did not complete engulfment [1]. This is in contrast to a B. 
subtilis sigG mutant which completes engulfment [35] and results reported by Pereira et. 
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al. revealing that a C. difficile 630 sigG mutant grown in broth culture completes 
engulfment [2]. Regardless, engulfment in the JIR8094 sigG mutant (grown on solid 
media) is blocked at what appears to be the widest point of the forespore compartment 
[1]. This unknown σG-dependent engulfment factor may be involved in interacting with 
the proteins that localize to the leading edge of engulfment and help drive the machinery 
when it hits the concave curvature of the forespore compartment. sigG mutants also form 
“double forespore” compartments (Chapter 2 Figure S3). I hypothesize that this 
phenomenon is due to premature membrane fission events occurring prior to engulfment 
completion, at the site of the engulfment block. What mediates membrane fission in C. 
difficile?  
 B. subtilis SpoIIIE, a chromosomal translocase, is important for late membrane 
fission events that complete engulfment, with a similar mechanism to FtsK [36]. C. 
difficile, encodes multiple spoIIIE-like genes; however, whether or not any function 
during sporulation is unknown [24]. It would be interesting to determine if one of these 
SpoIIIE-like proteins mediates chromosomal translocation and subsequent membrane 
fission. Theoretically, if a SpoIIIE-like protein cannot migrate to the opposite pole where 
it functions to pinch off the forespore compartment, it may result in premature membrane 
fission, resulting in the appearance of multiple compartments. 
 
5.5.3. SpoIIQ and SpoIIIA proteins are necessary for engulfment in C. difficile 
 Since C. difficile σG does not require σE for activation, it was surprising to find 
that genes encoding homologs responsible for forming the B. subtilis “feeding tube” 
(SpoIIQ and SpoIIIA proteins) were induced during C. difficile sporulation. However, 
 303 
work presented in Chapter 3 demonstrated that SpoIIQ and SpoIIIA proteins are 
important for C. difficile sporulation, specifically, the processes of engulfment and coat 
localization (discussed later) [18]. It is still unclear whether C. difficile SpoIIQ and 
SpoIIIA proteins form a complex with secretion activity, what such a complex would 
secrete, and whether it has an alternative function. Even if a channel with secretion 
activity is not important in C. difficile based on some spore formation in a Walker A 
mutant, given the engulfment defects in spoIIQ and spoIIIA mutants, it is likely that 
channel components are important for anchoring the membranes during engulfment [18]. 
This is supported by the IIQ-IIIAH “ratchet-like” mechanism described by Pogliano et. 
al., in which the proteins are described to interact and form foci around the forespore 
membrane during engulfment [37]. While the ratchet-like mechanism is not essential for 
engulfment in B. subtilis, it is suggested to avoid the membranes from folding back on 
itself. Indeed, we show that C. difficile SpoIIQ and SpoIIIAH interact in vitro [18]. 
Therefore, could it be that trans-septum SpoIIQ and SpoIIIAH interactions are necessary 
for “efficient” engulfment, that is, to provide structural integrity so that the engulfing 
membrane can stay physically localized to the forespore compartment? Localization 
studies in C. difficile are important for determining if SpoIIQ and SpoIIIAH colocalize in 
vivo around the developing forespore compartment and for the additional determination 
of whether or not other SpoIIIA proteins localize to these interaction sites. Based on the 
phenotypes of the spoIIIA, spoIIIAAK167A, and spoIIIAAD244A strains, it is clear that 
SpoIIIAA and additional SpoIIIA proteins that reside downstream of spoIIIA in the 
spoIIIA operon are important for engulfment. So then, if SpoIIIA is important, what 
function does it serve? Since the D244A mutant, which is predicted to bind ATP but fails 
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to hydrolyze it, rescues some mature spore formation, channel formation alone may be 
sufficient for C. difficile engulfment and spore formation: perhaps channel complex 
formation, but not transport of small molecules, is essential for engulfment. To answer 
some of these questions, interaction studies between the channel component proteins and 
localization studies of the proteins using co-immunoprecipitation, SNAP-translational 
reporters, or co-localization immuno-EM gold labeling could be used.  
 Is there a connection between the engulfment mutation we observe in a sigG 
mutant and the engulfment mutations we observe in the spoIIQ and spoIIIA mutants? 
spoIIQ, spoIIIAA, and spoIIIAH strains, are blocked at the mid-stage of engulfment, in 
other words, the leading edge gets stuck at the widest diameter of the forespore 
compartment similar to what is observed in a sigG mutant. Perhaps σG is required for 
sustained production of SpoIIQ until the forespore completes engulfment; RNA-Seq data 
revealed that CD0125 (encoding the spoIIQ-like gene) transcription was down most 
significantly in a sigF mutant (-3.6 log2 fold change, adjP-value 3.4x10-13), and that it is 
also slightly down in a sigG mutant (-1.1 log2 fold change, adjP-value 0.05) [1]. If σG is 
required for some SpoIIQ production, or just enough to complete engulfment in most 
cases, that could explain why a small portion of the sigG mutant population is capable of 
completing engulfment and overcoming the engulfment defect [1]. This hypothesis links 
the sigG mutant phenotype to the spoIIQ and spoIIIAH mutant phenotypes if indeed a 
SpoIIQ and SpoIIIAH interaction is what is required for engulfment. 
In summary, three sigma factors, σF, σE, and σG, regulate engulfment. Both σF and 
σE regulate factors necessary for the engulfment process (σF regulates SpoIIP and SpoIIQ 
and σE regulates SpoIID and SpoIIIA proteins), and σG controls an unknown factor that 
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promotes engulfment.  
 
5.5.4. Mislocalized coat in the engulfment mutants 
 One interesting observation of the engulfment mutants was the detection of coat 
anchored to the leading edge of engulfment that was not directly associated with the 
forespore, which created a “bearded” appearance (Chapter 3, Figure 3, [18]). One could 
speculate that the equipment necessary for binding coat to the membrane is unable to 
localize or attach, or is misregulated in the engulfment mutants. B. subtilis SpoVM is 
important for establishing the basement layer of the coat and localizes to the convex 
curvature of the forespore membrane [38, 39]. While a C. difficile SpoVM homolog 
exists, it is not necessary for proper spore formation (unpublished data, Putnam and 
Shen). We can hypothesize that a novel protein anchors coat proteins to the forespore, or 
that coat does not attach to the membrane at all in C. difficile and instead surrounds the 
forespore only in cells that have completed engulfment. I support the latter statement that 
coat does not attach securely to the membrane but instead the basement layer proteins 
polymerize while engulfment is occurring, and the leading edge of engulfment is an 
attachment site for basement layer coat proteins to build from, based on TEM results of 
WT and various mutants spores and sporulating cells (unpublished data). It would be 
interesting to see if coat proteins important for coat localization in C. difficile, SpoIVA 
(the coat protein conserved in all spore-formers studied to date) and/or SipL (conserved 
in Clostridium spp.) have additional interacting partners [40], since they would likely be 
involved in forming the basement layer and potentially interacting with the proteins 
present at the leading edge of engulfment.  
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5.6. Clostridium difficile GerS 
Prior to the experiments included in this dissertation, we knew that CD3464 was 
annotated as a lipoprotein encoded by the C. difficile genome. Based on RNA-Seq 
analyses of sporulating C. difficile included in Chapter 2, we observed that CD3464 was 
highly expressed in a σE-dependent manner during sporulation. While we show that 
CD3464 (renamed GerS) is required for efficient germination in Chapter 4 and 
determined that it controls SleC activity, we have yet to understand how it regulates SleC, 
and whether the regulation is direct or indirect. Does GerS bind SleC and activate its 
hydrolase activity? Could GerS co-localize with SleC and bring other germination 
regulators such as CspC to the outer membrane to form a C. difficile germinosome? It 
would be interesting to analyze if there is a direct SleC-GerS interaction using co-
immunoprecipitation and/or affinity chromatography techniques. Additionally, while we 
have shown that the GerS signal peptide is essential for germination and the invariant 
cysteine is required for signal peptide cleavage, whether or not GerS is actually lipidated 
has not been formally demonstrated. Mass spectrometry is now widely used for 
lipoprotein identification [41]. Detection of multiple protein clusters may be more 
difficult to resolve in spores without knowing what is localizing the clusters together. In 
B. subtilis, GerD is thought to localize germinant receptors into germinosomes [42], 
while C. difficile does not encode a GerD homolog [43]. Immuno-EM could be used to 
localize the known germination regulators to the specific area of the spore, as shown in B. 
anthracis [44], and could be used to show localization of multiple proteins using 
monoclonal antibodies fused with various metal nano particles [45]. 
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 In closing, while there are many questions that need to be addressed about C. 
difficile spore formation and germination, the information presented in this dissertation 
has made important contributions to our understanding of how these developmental 
processes occur. We show that conserved regulatory elements have divergent functions 
between B. subtilis and C. difficile, including sporulation specific sigma factors and 
machinery necessary for engulfment. With this information, we can go on to ask what 
evolutionary pressures might explain this diversification in regulatory architecture? Is it 
the bacterial niche that drove divergence? While it seems that B. subtilis has refined the 
process of sporulation to tightly couple sigma factor activation to specific morphological 
events, is this a disadvantage from a population survival standpoint? Could it be that C. 
difficile, with fewer checkpoints, has a more diverse spore population, which creates a 
selective advantage to the population’s successful survival both inside and outside the 
human? It will be important to answer these questions in order to better understand how 
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5.8. Figure Legends 
 Figure 1. Morphological Phenotypes of Sigma Factor Mutants Bacillus subtilis, 
(Pepto)Clostridium difficile, Clostridium acetobutylicum, Clostridium perfringens, and 
Clostridium botulinum. Mutations in sporulation specific sigma (σ) factor genes, sigF, 
sigE, sigG, and sigK, result in a variety of phenotypes. A. Morphological stages of 
sporulation (I-VII) defined by transmission electron microscopy (TEM) studies in B. 
subtilis [46]. Stage I, decision to sporulate (no morphological phenotype); Stage II, 
completion of asymmetric division; Stage III, completion of engulfment; Stage IV cortex 
formation (pink) between the inner and outer forespore membrane; Stage V, coat 
assembly around the outer forespore membrane (blue); Stage VI, spore core maturation, 
e.g. chromosome condensation; Stage VII, release of fully mature spore following mother 
cell lysis. Key structures that comprise a mature spore are labeled. B. B. subtilis sigF– and 
sigE– complete asymmetric division (Stage II), while sigG– and sigK– complete 
engulfment but fail to make coat or cortex (Stage III). C. difficile sigF– completes 
asymmetric division; it also makes coat that mislocalizes to the mother cell cytosol 
(blue); sigE– arrests at asymmetric division (Stage II); sigG– does not complete 
engulfment in strain JIR8094 (shown, [1]), although it does in strain 630∆erm [2]. 
Regardless, both sigG– strains fail to make cortex, despite producing coat (blue) that 
localizes around the forespore; sigK– produces cortex (pink) but no detectable coat. C. 
acetobutylicum sigF–, sigE–, and sigK– do not complete asymmetric division (Stage I), 
although a small population (< 2%) of sigE– mutants complete asymmetric division [5]; 
sigG– completes engulfment and makes some cortex along with coat-like fragments that 
localize next to the forespore. C. perfringens sigE– is blocked at asymmetric division 
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(Stage II), while sigK– does not initiate asymmetric division (Stage I); sigF– and sigG– 
phenotypes have yet to be analyzed by TEM. C. botulinum sigF– and sigE– complete 
asymmetric division (Stage II); sigG– completes engulfment and appears to make coat 
fragments that localize around the forespore; sigK– TEM has not been performed.  
 
Figure 2. Conserved sporulation-specific sigma factors regulate sporulation in 
diverse ways in the Firmicutes. In B. subtilis, sigma factor activity is regulated in a 
“crisscross” pattern: σF, σE, σG, and σK are sequentially and alternately activated in the 
forespore and mother cell compartment, respectively. After Spo0A-mediated activation 
of sigF and sigE, σF becomes active in the forespore. Expression of the σF regulon leads 
to the activation of σE in the mother cell. Products of the σF and σE regulon activate σG in 
the forespore compartment. σG auto-activates its production and induces σK activation in 
the mother cell. σF and σE are required for sigG and sigK expression in the forespore and 
mother cell, respectively. In C. difficile, after Spo0A-mediated transcriptional activation 
of sigF and sigE, σF activates σG via an unknown post-translational mechanism. σF also 
activates σE, although the requirement is only partial (dotted black line) due to σF-
independent expression of spoIIR. σE activates sigK transcription; σK is active following 
translation. sigG expression is activated by Spo0A and may be subject to auto-activation. 
In C. acetobutylicum, σK activates spo0A expression. Spo0A in turn activates sigF and 
sigE transcription. The mechanisms controlling the activity of σE, σG, and/or σK are 
unknown (question marks), although initial studies suggest that σG may be dispensable 
for late σK function. It is hypothesized that σK may be epigenetically inherited so that 
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Spo0A can be activated during vegetative growth ([6], red arrow). Green arrows 
designate transcriptional activation; black arrows designate post-translational activation; 
dotted arrow indicates partial requirement for activation; question marks indicate that 
more work needs to be done to determine the mechanisms controlling sigma factor gene 
transcription and/or sigma factor activation.  
 
Figure 3. Regulation of σK activity differs in the Firmicutes. σK is regulated by 
transcriptional and post-translational mechanisms during sporulation.  In B. subtilis and 
C. difficile, a phage DNA-like skin element must excise from genomic DNA prior to sigK 
transcription. In B. subtilis, after skin element excision, σE and the σE-regulated 
transcription factor SpoIIID activate sigK expression. σK is produced with an inhibitory 
pro-peptide that undergoes proteolytic activation via SpoIVFB. In C. difficile, σK 
regulation is similar to B. subtilis with the exception that σK lacks a pro-peptide and is 
active upon translation. In C. acetobutylicum, σK acts at two stages during sporulation. 
Early σK function has been hypothesized to occur via epigenetic inheritance or by early 
activation of sigK transcription by σA [6]. However, these hypotheses have not been 
tested. Late sigK transcription is mediated by σE, although the involvement of SpoIIID 
for transcriptional activation remains to be determined. It is unclear whether σK 
undergoes proteolytic activation, although SpoIVFB would be predicted to cleave σK. In 
C. perfringens, early sigK transcription appears to occur via read-through transcription of 
CPR_1739 [7], while late transcription is mediated by σE. Whether SpoIIID activates 
sigK transcription has not been determined, although σE does not control spoIIID 
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expression. While SpoIVFB is conserved, it is unclear if it removes the pro-peptide from 
σK; whether cleaved σK is the active form has also not been determined. In C. botulinum, 
factors controlling sigK transcription are unknown. Whether σK undergoes proteolytic 
activation is also unclear. Based on gene conservation, it is hypothesized that σE and 
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